<SEC-DOCUMENT>0001104659-25-076866.txt : 20250812
<SEC-HEADER>0001104659-25-076866.hdr.sgml : 20250812
<ACCEPTANCE-DATETIME>20250812162606
ACCESSION NUMBER:		0001104659-25-076866
CONFORMED SUBMISSION TYPE:	S-3/A
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20250812
DATE AS OF CHANGE:		20250812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Verastem, Inc.
		CENTRAL INDEX KEY:			0001526119
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				273269467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-289399
		FILM NUMBER:		251207136

	BUSINESS ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 500
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
		BUSINESS PHONE:		(781) 292-4200

	MAIL ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 500
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3/A
<SEQUENCE>1
<FILENAME>tm2522593-3_s3a.htm
<DESCRIPTION>S-3/A
<TEXT>
<html>
  <head>
    <title>tm2522593-3_s3a - block - 3.937502s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">

          <div style="text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.18pt;">As filed with the Securities and Exchange Commission on August&#160;12, 2025</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
          </div>


          <div style="margin-top:0.8pt; text-align:right; width:541.31pt; line-height:9.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.18pt;">Registration No. 333-289399</font>&#8203;</div>

        <div style="margin-top:2pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 2pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.5pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.5pt; text-align:center; width:541.31pt; line-height:14.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">UNITED STATES</font>
          <br >
          <font style="letter-spacing:-0.28pt;">SECURITIES AND EXCHANGE COMMISSION</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:-1.2pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:4.29pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.29000000000001pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="margin-top:4.5pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.18pt;">Amendment No. 1 </font>
            <br >
            <font style="letter-spacing:-0.18pt;">to</font>
          </div>

        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:14.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">FORM S-3</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">REGISTRATION STATEMENT</font>
          <br >
          <font style="letter-spacing:-0.18pt;">UNDER</font>
          <br >
          <font style="letter-spacing:-0.18pt;">THE SECURITIES ACT OF 1933</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:4.3pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.29999999999998pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.5pt; text-align:center; width:541.31pt; line-height:14.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">VERASTEM, INC.</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:-2.2pt; text-align:center; width:541.31pt; line-height:7.5pt;font-size:7pt;">
          <font style="letter-spacing:0.14pt;">(Exact name of registrant as specified in its charter)</font><font style="font-size:9pt;">&#8203;<font style="letter-spacing:0.18pt;"> </font></font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:541.31pt;margin-top:3.29999999999998pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
          <tr style="line-height:9pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:264.66pt;">
              <div style="text-align:center;font-weight:bold;font-size:9pt;">
                <font style="letter-spacing:-0.18pt;">Delaware</font>
              </div>
              <div style="text-align:center; line-height:8pt;">
                <font style="letter-spacing:0.14pt;">(State or other jurisdiction</font>
                <br >
                <font style="letter-spacing:0.14pt;">of incorporation or organization)</font><font style="font-size:9pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:264.65pt;">
              <div style="text-align:center;font-weight:bold;font-size:9pt;">
                <font style="letter-spacing:-0.18pt;">27-3269467</font>
              </div>
              <div style="text-align:center; line-height:8pt;">
                <font style="letter-spacing:0.14pt;">(I.R.S Employer</font>
                <br >
                <font style="letter-spacing:0.14pt;">Identification No.)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.7pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">117 Kendrick Street, Suite 500 </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Needham, Massachusetts 02494 </font>
          <br >
          <font style="letter-spacing:-0.18pt;">(781)292-4200</font>
        </div>
        <div style="margin-top:0.5pt; text-align:center; width:541.31pt; line-height:7.5pt;font-size:7pt;">
          <font style="letter-spacing:0.14pt;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</font><font style="font-size:9pt;">&#8203;<font style="letter-spacing:0.18pt;"> </font></font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Daniel W. Paterson </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Chief Executive Officer</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Verastem, Inc.</font>
          <br >
          <font style="letter-spacing:-0.18pt;">117 Kendrick Street, Suite 500 </font>
          <br >
          <font style="letter-spacing:-0.18pt;">Needham, Massachusetts 02494 </font>
          <br >
          <font style="letter-spacing:-0.18pt;">(781)292-4200</font>
        </div>
        <div style="margin-top:0.5pt; text-align:center; width:541.31pt; line-height:7.5pt;font-size:7pt;">
          <font style="letter-spacing:0.14pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font><font style="font-size:9pt;">&#8203;<font style="letter-spacing:0.18pt;"> </font></font>
        </div>
        <div style="margin-top:4.3pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.30000000000001pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.5pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">With copies to:</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">Marko Zatylny</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Thomas Danielski</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Ropes &amp; Gray LLP</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Prudential Tower</font>
          <br >
          <font style="letter-spacing:-0.18pt;">800 Boylston St.</font>
          <br >
          <font style="letter-spacing:-0.18pt;">Boston, Massachusetts 02199</font>
          <br >
          <font style="letter-spacing:-0.18pt;">(617) 951-7000</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:3pt; text-align:center; width:541.31pt; line-height:9.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.18pt;">From time to time after the effectiveness of the registration statement</font>
          <br >
          <font style="letter-spacing:0.18pt;">(Approximate date of commencement of proposed sale to the public) </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:5.5pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the&#160;Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </font>
        </div>
        <div style="margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">Large accelerated filer&nbsp;&nbsp;&nbsp; &#9744; </font><font style="margin-left:1.64pt;letter-spacing:0.18pt;">Accelerated filer&nbsp;&nbsp;&nbsp;&#9744; </font><font style="margin-left:1.64pt;letter-spacing:0.18pt;">Non-accelerated filer&nbsp;&nbsp;&nbsp;&#9746; </font><font style="margin-left:1.64pt;letter-spacing:0.18pt;">Smaller reporting company&nbsp;&nbsp;&nbsp;&#9746; </font><font style="float:right;letter-spacing:0.18pt;">Emerging growth company&nbsp;&nbsp;&nbsp;&#9744;</font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.18pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of Securities Act. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.18pt;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said section 8(a), may determine.</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:4.1pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 4.10000000000002pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.6pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.60000000000002pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPLANATORY NOTE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This registration statement contains: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a base prospectus which covers the offer, issuance and sale of up to $300,000,000 of our common stock, preferred stock, warrants and debt securities; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an at-the-market offering prospectus supplement covering the offer, issuance and sale of up to a maximum aggregate offering price of $100,000,000 of our common stock that may be issued and sold under our sales agreement with Cantor Fitzgerald &amp; Co., dated August&#160;8, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The base prospectus immediately follows this explanatory note. The at-the-market offering prospectus supplement immediately follows the base prospectus. Upon termination of the sales agreement with Cantor Fitzgerald &amp; Co., any amounts included in the at-the-market offering prospectus supplement that remain unsold will be available for sale in other offerings pursuant to the base prospectus, and if no shares are sold under the sales agreement, the full amount of this registration statement may be sold in other offerings pursuant to the base prospectus and a corresponding prospectus supplement.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="position:relative;overflow:hidden;min-height:775.71pt;page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="position:absolute;top:738.85pt;left:48.64pt;height:30pt;width:706.02pt;transform-origin:0pt -0pt;transform:rotate(-90deg) translate(0%, 0%);">
        <div style="text-align:justify; width:706pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-family:Helvetica, Arial, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.08pt;">The information in this prospectus is not complete and may be changed. We may not sell these securities or accept an offer to buy these securities until the Securities and Exchange Commission declares the registration statement effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font><font style="color:#000000;letter-spacing:-0.08pt;"> </font>
          <br >
        </div>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-bottom:21.86pt;margin-left:87.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
            <font style="letter-spacing:-0.2pt;">Subject to Completion, dated August&#160;12, 2025</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
          <font style="letter-spacing:-0.2pt;">PROSPECTUS</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_verastemoncology-4c.jpg" alt="[MISSING IMAGE: lg_verastemoncology-4c.jpg]" height="66" width="293" >
        </div>
        <div style="margin-top:16.4pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">$300,000,000</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:15.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Common Stock</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Preferred Stock</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Warrants</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Debt Securities</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:19.167pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:11.7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may offer and sell from time to time, in one or more series or issuances and in an amount and on terms that we will determine at the time of the respective offering, any combination, up to $300,000,000 in the aggregate, of the securities described in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will provide specific terms of any offering in a supplement to this prospectus. We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. Any prospectus supplement may also add, update, or change information contained in this prospectus. You should carefully read this prospectus and any amendments or prospectus supplements as well as the documents incorporated or deemed to be incorporated by reference in this prospectus before you purchase any of the securities offered hereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These securities may be offered and sold in the same offering or in separate offerings; to or through underwriters, dealers, and agents; or directly to purchasers. The names of any underwriters, dealers, or agents involved in the sale of our securities and their compensation will be described in the applicable prospectus supplement. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;VSTM.&#8221; On August&#160;11, 2025, the last reported sale price of our common stock par value $0.0001 per share was $7.70 per share. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investing in our securities involves a high degree of risk. Before making an investment decision, please read the information under the heading. See &#8220;Risk Factors&#8221; on page <a href="#sRIFA">4</a> of this prospectus, in any applicable prospectus supplement, and under similar headings in the other documents that are incorporated by reference into this prospectus.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18.3pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:11.8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18.3pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:135.8pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Prospectus dated&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2025</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:372.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:218.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sATP"><font style="letter-spacing:0.2pt;">ABOUT THIS PROSPECTUS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sATP">1</a></font> <a href="#sATP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sATC"><font style="letter-spacing:0.2pt;">ABOUT THE COMPANY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sATC">3</a></font> <a href="#sATC"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sRIFA">4</a></font> <a href="#sRIFA"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sFOST"><font style="letter-spacing:0.2pt;">FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sFOST">5</a></font> <a href="#sFOST"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sUOP"><font style="letter-spacing:0.2pt;">USE OF PROCEEDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sUOP">7</a></font> <a href="#sUOP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sPOD"><font style="letter-spacing:0.2pt;">PLAN OF DISTRIBUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sPOD">8</a></font> <a href="#sPOD"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sDOCS"><font style="letter-spacing:0.2pt;">DESCRIPTION OF COMMON STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sDOCS">10</a></font> <a href="#sDOCS"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sDOPS"><font style="letter-spacing:0.2pt;">DESCRIPTION OF PREFERRED STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sDOPS">11</a></font> <a href="#sDOPS"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sDOW"><font style="letter-spacing:0.2pt;">DESCRIPTION OF WARRANTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sDOW">12</a></font> <a href="#sDOW"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sDODS"><font style="letter-spacing:0.2pt;">DESCRIPTION OF DEBT SECURITIES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sDODS">13</a></font> <a href="#sDODS"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sWYCF"><font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND MORE INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sWYCF">21</a></font> <a href="#sWYCF"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sIOCD"><font style="letter-spacing:0.2pt;">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sIOCD">22</a></font> <a href="#sIOCD"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sLEMA"><font style="letter-spacing:0.2pt;">LEGAL MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sLEMA">23</a></font> <a href="#sLEMA"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#sEXP"><font style="letter-spacing:0.2pt;">EXPERTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#sEXP">23</a></font>
            </td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sATP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;), under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), using a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may from time to time offer to sell any combination of the securities described in this prospectus in one or more offerings for an aggregate offering amount of up to $300,000,000. Each time we sell securities under this prospectus, we will provide a prospectus supplement and, if necessary, a free writing prospectus, that will contain specific information about the terms of that offering. The prospectus supplement and, if necessary, a free writing prospectus, may also add to, update or change information contained in this prospectus. Accordingly, to the extent inconsistent, the information in this prospectus will be deemed to be modified or superseded by any inconsistent information contained in a prospectus supplement or a free writing prospectus. You should read this prospectus and the applicable prospectus supplement and any free writing prospectus carefully, including all documents incorporated herein and therein by reference, together with the additional information described below under &#8220;Where You Can Find More Information&#8221; before making an investment in our securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus does not include all of the information that is in the registration statement. We omitted certain parts of the registration statement from this prospectus as permitted by the SEC. We refer you to the registration statement and its exhibits for additional information about us and the securities that may be sold under this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have not authorized any dealer, agent or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus and any accompanying prospectus supplement or any free writing prospectus provided in connection with an offering. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or an accompanying prospectus supplement. This prospectus and the accompanying prospectus supplement, if any, do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor do this prospectus and the accompanying prospectus supplement constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus and any accompanying prospectus supplement, if any, is accurate on any date subsequent to the date set forth on the front of the document or that any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though this prospectus and any accompanying prospectus supplement is delivered or securities are sold on a later date. Our business, financial condition, results of operations and prospects may have changed since those dates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under &#8220;Where You Can Find More Information.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">References in this prospectus to &#8220;Verastem,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or similar terms refer to Verastem, Inc. and our subsidiaries on a consolidated basis, as appropriate, unless we state otherwise or the context otherwise requires. The phrase &#8220;this prospectus&#8221; refers to this prospectus and any applicable prospectus supplement, unless the context otherwise requires. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trademarks and Tradenames</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Verastem name and logo are our trademarks. This prospectus and any applicable prospectus supplement and documents incorporated by reference herein and therein contain references to our trademarks and to trademarks belonging to other entities. Each of the other trademarks, trade names and service marks included in this prospectus belongs to its respective holder. Solely for convenience, trademarks, trade names and service marks referred to in this prospectus, including logos, artwork and other visual displays, may appear without the </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> or </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> symbols, but such references are not intended to indicate in any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:580pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">way that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks, trade names and service marks. We do not intend our use or display of other entities&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other entity. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sATC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:192pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THE COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with ras sarcoma (&#8220;RAS&#8221;)/ mitogen activated pathway kinase (&#8220;MAPK&#8221;) pathway-driven cancers. We market AVMAPKI FAKZYNJA CO-PACK (avutometinib capsules; defactinib tablets) in the United States. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including rapidly accelerated fibrosarcoma (&#8220;RAF&#8221;)/ mitogen-activated protein kinase kinase (&#8220;MEK&#8221;) inhibition, focal adhesion kinase (&#8220;FAK&#8221;) inhibition and Kirsten rat sarcoma viral oncogene homolog (&#8220;KRAS&#8221;) G12D inhibition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;8, 2025, the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) approved AVMAPKI FAKZYNJA CO-PACK for the treatment of adult patients with KRAS mutant (&#8220;KRAS mt&#8221;) recurrent low grade serous ovarian cancer (&#8220;LGSOC&#8221;) who received prior systemic therapy. The KRAS mt recurrent LGSOC indication has been granted approval by the FDA under the accelerated approval pathway based on the tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. We intend to initiate discussions with other global regulatory authorities, including those in Europe and Japan with the objective of ultimately seeking approval for the combination therapy in additional regions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AVMAPKI (avutometinib) inhibits MEK kinase activity while also blocking the compensatory reactivation of MEK by upstream RAF. RAF and MEK proteins are regulators of the RAS/RAF/MEK/ extracellular-signal-regulated-kinase (&#8220;ERK&#8221;) MAPK pathway. Blocking RAF and/or MEK activates FAK, a key mediator of drug resistance. FAKZYNJA (defactinib) is a FAK inhibitor and together, the avutometinib and defactinib combination is designed to provide a more complete blockade of the signaling that drives the growth and drug resistance of RAS/MAPK pathway-dependent tumors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Avutometinib, alone or in combination with defactinib, has received orphan drug designation for the treatment of all patients with LGSOC in the United States. Defactinib has received orphan drug designation in ovarian cancer in the United States, the European Union, and Australia. In addition, the FDA granted orphan drug designation to avutometinib, in combination with defactinib, for the treatment of pancreatic cancer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our principal executive offices are located at 117 Kendrick Street, Suite 500, Needham, MA 02494, and our telephone number is (781) 292-4200. Our website address is: www.verastem.com. We have included our website address as a factual reference and do not intend it to be an active link to our website. The information that can be accessed through our website is not part of this prospectus, and investors should not rely on any such information in deciding whether to purchase our securities.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:464pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investing in our securities involves a high degree of risk. See &#8220;Item&#160;1A&#8201;&#8212;&#8201;Risk Factors&#8221; in our most recent Annual Report on Form 10-K incorporated by reference in this prospectus and in any subsequent Quarterly Report on Form&#160;10-Q and the &#8220;Risk Factors&#8221; section in the applicable prospectus supplement for a discussion of the factors you should carefully consider before deciding to purchase our securities. Before making a decision about investing in our securities, you should carefully consider these risks as well as other information we include or incorporate by reference into this prospectus and the applicable prospectus supplement. The risks and uncertainties we have described are not the only ones facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business operations, operating results and financial condition. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities. The discussion of risks includes or refers to forward-looking statements; you should read the explanation of the qualifications and limitations on such forward-looking statements discussed elsewhere in this prospectus. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sFOST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus, any prospectus supplement and the other documents we have filed with the SEC that are incorporated herein by reference, contain forward-looking statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These forward-looking statements generally can be identified by the use of words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;potentially,&#8221; &#8220;project,&#8221; and other words of similar meaning. All statements, other than statements related to present facts or current conditions or historical facts, contained incorporated by reference into this prospectus, are forward-looking statements, including statements regarding our strategy, future operations, future financial position, including our ability to continue as a going concern through one year from the date of the financial statements for the quarter ended June&#160;30, 2025, future revenues, projected costs, prospects, plans and objectives of management. Such statements relate to, among other things, the commercial success of our marketed product AVMAPKI FAKZYNJA CO-PACK, the development and activity of our programs and product candidates, avutometinib (RAF MEK program) and defactinib (FAK program), the structure and potential clinical value of our completed, planned and pending clinical trials, including the RAMP 201, RAMP&#160;203, RAMP 205 and RAMP 301 trials; the timing of commencing and completing trials, including topline data reports, our interactions with regulators; the timeline and indications for clinical development, regulatory submissions and the potential for and timing of commercialization of our product candidates; the potential for additional development programs involving the Company&#8217;s lead compound and the potential market opportunities thereof; the expected outcome and benefits of our collaboration with GenFleet Therapeutics (Shanghai), Inc. (&#8220;GenFleet&#8221;) and the estimated addressable markets for, and anticipated market opportunities of our drug candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement. Applicable risks and uncertainties include the risks and uncertainties, among other things, regarding: the success in the development and potential commercialization of our product candidates, including avutometinib in combination with other compounds, including defactinib, LUMAKRAS</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> and others; the uncertainties inherent in research and development, such as negative or unexpected results of clinical trials; the occurrence or timing of applications for our product candidates that may be filed with regulatory authorities in any jurisdictions; whether and when regulatory authorities in any jurisdictions may approve applications that may be filed for our product candidates and, if approved, whether our product candidates will be commercially successful in such jurisdictions; the impact of current and future healthcare reforms, including those affecting the delivery of or payment for healthcare products and services; our ability to obtain, maintain and enforce patent and other intellectual property protection for our product candidates; the scope, timing, and outcome of any legal proceedings; decisions by regulatory authorities regarding trial design, labeling and other matters that could affect the timing, availability or commercial potential of our product candidates; whether preclinical testing of our product candidates and preliminary or interim data from clinical trials will be predictive of the results or success of ongoing or later clinical trials; that the timing, scope and rate of reimbursement for our product candidates is uncertain; actions or advice of regulatory agencies and our ability to obtain and maintain regulatory approval for AVMAPKI FAKZYNJA CO-PACK; that the market opportunities of AVMAPKI FAKZYNJA CO-PACK are based on internal and third-party estimates which may prove to be incorrect; that third-party payors (including government agencies) may not reimburse; that there may be competitive developments affecting our product candidates; that data may not be available when expected; that enrollment of clinical trials may take longer than expected; risks associated with preliminary and interim data, which may not be representative of more mature data, including with respect to interim duration of therapy data; that our product candidates may cause adverse safety events and/or unexpected concerns may arise from additional data or analysis, or result in unmanageable safety profiles as compared to their levels of efficacy; that we may be unable to successfully validate, develop and obtain regulatory approval for companion diagnostic tests for our product candidates that require or would commercially benefit from such tests, or experience significant delays in doing so; that we may not be able to expand the approved indication for AVMAPKI FAKZYNJA CO-PACK; that our product candidates may experience manufacturing or supply interruptions or failures; that any of our third party contract research organizations, contract manufacturing organizations, clinical sites, or contractors, among others, who we rely on may fail to fully perform; that we face substantial competition, which may result in others developing or commercializing products before or more successfully than we do which could result in reduced market </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:260pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">share or market potential for our product candidates; that we may be unable to successfully initiate or complete the clinical development and eventual commercialization of our product candidates; that the development and commercialization of our product candidates may take longer or cost more than planned, including as a result of conducting additional studies or our decisions regarding execution of such commercialization; that we may not have sufficient cash to fund our contemplated operations, including certain of our product development programs; that we may not attract and retain high quality personnel; that we or Chugai Pharmaceutical, Co. Ltd. may fail to fully perform under the avutometinib license agreement; that we or Secura Bio, Inc. (&#8220;Secura&#8221;) may fail to fully perform under the asset purchase agreement with Secura, including in relation to milestone payments; that we may not see a return on investment on the payments we have and may continue to make pursuant to the collaboration and option agreement with GenFleet or that GenFleet may fail to fully perform under the agreement; that we may not be able to establish new or expand on existing collaborations or partnerships, including with respect to in-licensing of our product candidates, on favorable terms, or at all; that we may be unable to obtain adequate financing in the future through product licensing, co-promotional arrangements, public or private equity, debt financing or otherwise; that we may not pursue or submit regulatory filings for our product candidates; and that our product candidates will not receive regulatory approval, become commercially successful products, or result in new treatment options being offered to patients. Other risks and uncertainties include those identified under the heading &#8220;Risk Factors&#8221; contained in this in <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2024, as filed with the SEC on March&#160;20, 2025</a>, each incorporated by reference in this prospectus, in any subsequent filings with the SEC, and in the applicable &#8220;Risk Factors&#8221; section in the applicable prospectus supplement. See &#8220;Where You Can Find More Information.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of these and other factors, we may not achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make. The forward-looking statements contained in this prospectus reflect our views as of the date hereof. We do not assume and specifically disclaim any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in the applicable prospectus supplement, in connection with an offering of securities pursuant to this prospectus, we currently intend to use the net proceeds we receive from the sale of any securities offered by us under this prospectus primarily for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures, clinical trial expenditures, commercial expenditures, milestone payments under in-license agreements, and possible acquisitions. Additional information on the use of net proceeds we receive from the sale of securities covered by this prospectus may be set forth in the prospectus supplement relating to the specific offering.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sPOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLAN OF DISTRIBUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are registering securities, with an aggregate offering price not to exceed $300,000,000, to be sold by us under a &#8220;shelf&#8221; registration process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we offer any securities under this prospectus, we will amend or supplement this prospectus by means of an accompanying prospectus supplement setting forth the specific terms and conditions and other information about that offering as is required or necessary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell the securities in any of the following ways (or in any combination thereof) from time to time: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to or through one or more underwriters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">through dealers, who may act as agents or principal (including a block trade in which a broker or dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">through one or more agents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">through registered direct offerings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">as part of a collaboration with a third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">as part of an acquisition or merger with a third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">through at-the-market issuances; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in privately negotiated transactions; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">directly to purchasers or to a single purchaser. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The distribution of the securities by us may be effected from time to time in one or more transactions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at a fixed price, or prices, which may be changed from time to time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at market prices prevailing at the time of sale; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at prices related to such prevailing market prices; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at negotiated prices. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each prospectus supplement will describe the method of distribution of the securities and any applicable restrictions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The prospectus supplement will describe the terms of the offering of the securities, including the following, as applicable: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the terms of the securities being offered, including the public offering price of the securities and the proceeds to us; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the name or names of any underwriters, dealers or agents and the amounts of securities underwritten or purchased by each of them; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any underwriting discounts and commissions or agency fees and other items constituting underwriters&#8217; or agents&#8217; compensation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any options under which underwriters may purchase additional securities from us; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any discounts or concessions allowed or reallowed or paid to dealers; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any securities exchanges on which the securities may be listed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Only the agents or underwriters named in each prospectus supplement are agents or underwriters in connection with the securities being offered thereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may authorize underwriters, dealers or other persons acting as our agents to solicit offers by certain institutions to purchase securities from us pursuant to delayed delivery contracts providing for payment and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">delivery on a specified date in the future. Each contract will be for an amount not less than, and the aggregate amount of securities sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in each applicable prospectus supplement. Institutions with whom the contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions, but shall in all cases be subject to our approval. Delayed delivery contracts will be subject only to those conditions set forth in each applicable prospectus supplement, and each prospectus supplement will set forth any commissions we pay for solicitation of these contracts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may indemnify agents, underwriters, dealers, their affiliates, or other third parties who participate in the distribution of securities against certain liabilities, including liabilities under the Securities Act, and agree to contribute to payments which these agents, underwriters, dealers, or other third parties may be required to make. Agents, underwriters, dealers and such other third parties may be customers of, engage in transactions with, or perform services for us in the ordinary course of business. We may also use underwriters or such other third parties with whom we have a material relationship. We will describe the nature of any such relationship in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">One or more firms, referred to as &#8220;remarketing firms,&#8221; may also offer or sell the securities, if a prospectus supplement so indicates, in connection with a remarketing arrangement upon their purchase. Remarketing firms will act as principals for their own accounts or as our agents. These remarketing firms will offer or sell the securities in accordance with the terms of the securities. Each prospectus supplement will identify and describe any remarketing firm and the terms of its agreement, if any, with us and will describe the remarketing firm&#8217;s compensation. Remarketing firms may be deemed to be underwriters in connection with the securities they remarket. Remarketing firms may be entitled under agreements that may be entered into with us to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, and may engage in transactions with or perform services for us in the ordinary course of business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain underwriters may use this prospectus and any accompanying prospectus supplement for offers and sales related to market-making transactions in the securities. These underwriters may act as principal or agent in these transactions, and the sales will be made at prices related to prevailing market prices at the time of sale. Any underwriters involved in the sale of the securities may qualify as &#8220;underwriters&#8221; within the meaning of Section&#160;2(a)(11) of the Securities Act. In addition, the underwriters&#8217; commissions, discounts or concessions may qualify as underwriters&#8217; compensation under the Securities Act and the rules of the Financial Industry Regulatory Authority. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our common stock is listed on The Nasdaq Capital Market. Underwriters may make a market in our common stock, but will not be obligated to do so and may discontinue any market making at any time without notice. We can make no assurance as to the development, maintenance or liquidity of any trading market for the securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain persons participating in an offering may engage in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with rules and regulations under the Exchange Act. Overallotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. Short covering transactions involve purchases of the securities in the open market after the distribution is completed to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a short covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are subject to the applicable provisions of the Exchange Act and the rules and regulations under the Exchange Act, including Regulation&#160;M, which may limit the timing of purchases and sales of any of the securities offered in this prospectus by any other person. The anti-manipulation rules under the Exchange Act may apply to sales of securities in the market and to the actions of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent required, this prospectus may be amended and/or supplemented from time to time to describe a specific plan of distribution. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sDOCS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:572pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF COMMON STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The description of our common stock is incorporated by reference to <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000155837025003372/vstm-20241231xex4d2.htm">Exhibit&#160;&#160;4.2</a> of our Annual Report on Form 10-K for the year ended December&#160;31, 2024, as filed with the SEC on March&#160;&#160;20, 2025, including any amendments or reports filed for the purpose of updating such description. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sDOPS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:52pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF PREFERRED STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of our amended and restated certificate of incorporation, our board of directors is authorized to issue up to 5,000,000 shares of our preferred stock, par value $0.0001 per share, in one or more series without stockholder approval. Our board of directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock upon the rights of the holders of common stock until the board of directors determines the specific rights of the holders of preferred stock. However, effects of the issuance of preferred stock include restricting dividends on common stock, diluting the voting power of common stock, impairing the liquidation rights of common stock, and making it more difficult for a third party to acquire us, which could have the effect of discouraging a third party from acquiring, or deterring a third party from paying a premium to acquire, a majority of our outstanding voting stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we offer any additional specific class or series of preferred stock under this prospectus, we will describe the terms of the preferred stock in the prospectus supplement for such offering and will file a copy of the certificate establishing the terms of the preferred stock with the SEC. To the extent required, this description will include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the title and stated value; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares offered, the liquidation preference per share and the purchase price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the dividend rate(s), period(s) and/or payment date(s), or method(s) of calculation for such dividends; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the procedures for any auction and remarketing, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the provisions for a sinking fund, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the provisions for redemption, if applicable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any listing of the preferred stock on any securities exchange or market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether the preferred stock will be convertible into our common stock, and, if applicable, the conversion price (or how it will be calculated) and conversion period; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price (or how it will be calculated) and exchange period; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">voting rights, if any, of the preferred stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a discussion of any material U.S. federal income tax considerations applicable to the preferred stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the relative ranking and preferences of the preferred stock as to dividend rights and rights upon liquidation, dissolution or winding up of the affairs of the Company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any material limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights upon liquidation, dissolution or winding up of the Company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preferred stock offered by this prospectus, when issued, will not have, or be subject to, any preemptive or similar rights. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sDOW">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:48pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF WARRANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue warrants to purchase shares of our common stock, preferred stock and/or debt securities in one or more series together with other securities or separately, as described in each applicable prospectus supplement. Below is a description of certain general terms and provisions of the warrants that we may offer. Particular terms of the warrants will be described in the applicable warrant agreements and the applicable prospectus supplement for the warrants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The applicable prospectus supplement will contain, where applicable, the following terms of and other information relating to the warrants: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the specific designation and aggregate number of, and the price at which we will issue, the warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the currency or currency&#160;units in which the offering price, if any, and the exercise price are payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the designation, amount and terms of the securities purchasable upon exercise of the warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if applicable, the exercise price for shares of our common stock and the number of shares of common stock to be received upon exercise of the warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if applicable, the exercise price for shares of our preferred stock, the number of shares of preferred stock to be received upon exercise, and a description of that class or series of our preferred stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if applicable, the exercise price for our debt securities, the amount of our debt securities to be received upon exercise, and a description of that series of debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the date on which the right to exercise the warrants will begin and the date on which that right will expire or, if the warrants may not be continuously exercised throughout that period, the specific date or dates on which the warrants may be exercised; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any applicable material U.S. federal income tax consequences; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if applicable, the date from and after which the warrants and the common stock, preferred stock and/or debt securities will be separately transferable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">information with respect to book-entry procedures, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the anti-dilution provisions of the warrants, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any redemption or call provisions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether the warrants are to be sold separately or with other securities as parts of&#160;units; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any additional terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sDODS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF DEBT SECURITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may issue the debt securities offered by this prospectus and any accompanying prospectus supplement under an indenture to be entered into between us and the trustee identified in the applicable prospectus supplement. The terms of the debt securities will include those stated in the indenture and those made part of the indenture by reference to the Trust Indenture Act of 1939, as in effect on the date of the indenture. We have filed a copy of the form of indenture as an exhibit to the registration statement in which this prospectus is included. The indenture will be subject to and governed by the terms of the Trust Indenture Act of 1939. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may offer debt securities as described in this prospectus that, unless otherwise specified in the applicable prospectus supplement, will represent direct, unsecured obligations of the Company and will rank equally with all of our other unsecured indebtedness. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The applicable prospectus supplement will describe the terms and features of any debt securities which we may offer, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. The following description and any description of debt securities in the applicable prospectus supplement may not be complete and is subject to, and are qualified in their entirety by reference to, the indenture, any supplemental indentures or forms of debt securities, in each case that we will file with the SEC in connection with a public offering of debt securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may issue the debt securities in one or more series with the same or various maturities, at par, at a premium, or at a discount. We will describe the particular terms of each series of debt securities in the applicable prospectus supplement relating to that series, which we will file with the SEC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The prospectus supplement will set forth, to the extent required, the following terms of the debt securities in respect of which the prospectus supplement is delivered: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the title of the series (which shall distinguish the debt securities of that particular series from the debt securities of any other series); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any limit upon the aggregate principal amount of the debt securities of the series which may be authenticated and delivered under the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the price or prices (expressed as a&#160;percentage of the principal amount thereof) at which the series of debt securities will be issued; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the date or dates on which principal of the securities of the series is payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rate or rates (which may be fixed or variable) per annum or, if applicable, the method used to determine such rate or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the debt securities of the series shall bear interest, if any, the date or dates from which such interest, if any, shall accrue, the date or dates on which such interest, if any, shall commence and be payable and any regular record date for the interest payable on any interest payment date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the place or places where the principal, interest and premium, if any, on the debt securities of the series are payable, or the method of such payment, if by wire transfer, mail or other means; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if applicable, the period or periods within which, the price or prices at which and the terms and conditions upon which the debt securities of the series may be redeemed, in whole or in part, at our option; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our obligation, if any, to redeem or purchase the debt securities of the series pursuant to any sinking fund or analogous provisions or at the option of a holder thereof, and the period or periods within which, the price or prices at which and the terms and conditions upon which debt securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the dates, if any, on which and the price or prices at which the debt securities of the series will be repurchased by us at the option of the holders thereof, and other detailed terms and provisions of such repurchase obligations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if other than denominations of $1,000 and any integral multiple thereof, the denominations in which the debt securities of the series shall be issuable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the forms of the debt securities of the series in bearer (if to be issued outside of the United States of America) or fully registered form (and, if in fully registered form whether the debt securities will be issuable as global securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if other than the principal amount thereof, the portion of the principal amount of the debt securities of the series that shall be payable upon declaration of acceleration of the maturity thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the currency of denomination of the debt securities of the series, which may be dollars or any foreign currency, and the agency or organization, if any, responsible for overseeing such composite currency; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the designation of the currency, currencies or currency&#160;units in which payment of the principal of, and interest and premium, if any, on the debt securities of the series will be made; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if payments of principal of, or interest or premium, if any, on the debt securities of the series are to be made in one or more currencies or currency&#160;units other than the that or those in which such securities are denominated are, the manner in which the exchange rate with respect to such payments will be determined; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the manner in which the amounts of payment of principal of, or interest and premium, if any, on the debt securities of the series will be determined if such amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the provisions, if any, relating to any collateral provided for the debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any addition to or change in the covenants in the indenture which applies to the debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any addition to or change in the events of default which applies to any debt securities of the series, and any change in the right of the trustee or the requisite holders of such debt securities to declare the principal amount thereof due and payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the terms and conditions, if any, for conversion of the debt securities into or exchange of the debt securities for shares of common stock or preferred stock of the Company that apply to debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to debt securities of such series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the terms and conditions, if any, upon which the debt securities shall be subordinated in right of payment to other indebtedness of the Company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if applicable, that the debt securities of the series, in whole or any specified part, shall be defeasible; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any other terms of the debt securities of the series (which terms shall not be inconsistent with the provisions of the indenture, except as permitted by the indenture, but which may modify or delete any provision of the indenture insofar as it applies to such series). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may issue discount debt securities that provide for an amount less than the stated principal amount to be due and payable upon acceleration of the maturity of such debt securities in accordance with the terms of the indenture. We may also issue debt securities in bearer form, with or without coupons. If we issue discount debt securities or debt securities in bearer form, we will describe material U.S. federal income tax considerations and other material special considerations which apply to these debt securities in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may issue debt securities denominated in or payable in a foreign currency or currencies or a foreign currency unit or&#160;units. If we do, we will describe the restrictions, elections, and general tax considerations relating to the debt securities and the foreign currency or currencies or foreign currency unit or&#160;units in the applicable prospectus supplement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exchange and/or Conversion Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may issue debt securities which can be exchanged for or converted into shares of our common stock or preferred stock. If we do, we will describe the terms of exchange or conversion in the applicable prospectus supplement relating to these debt securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer and Exchange</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue debt securities that will be represented by either: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;book-entry,&#8221; which means that there will be one or more global securities registered in the name of a depositary or a nominee of a depositary; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;certificated securities,&#8221; which means that they will be represented by a certificate issued in definitive registered form. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will specify in the prospectus supplement applicable to a particular offering whether the debt securities offered will be book-entry or certificated securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certificated Debt Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we issue certificated debt securities, a holder may transfer or exchange such debt securities at the trustee&#8217;s office or at the paying agent&#8217;s office or agency in accordance with the terms of the indenture. A holder will not be charged a service charge for any transfer or exchange of certificated debt securities but may be required to pay an amount sufficient to cover any tax or other governmental charge payable in connection with such transfer or exchange. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A holder may effect the transfer of certificated debt securities and of the right to receive the principal of, premium, and/or interest, if any, on the certificated debt securities only by surrendering the certificate representing the certificated debt securities and having us or the trustee issue a new certificate to the new holder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Global Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we decide to issue debt securities in the form of one or more global securities, then we will register the global securities in the name of the depositary for the global securities or the nominee of the depositary, and the global securities will be delivered by the trustee to the depositary for credit to the accounts of the holders of beneficial interests in the debt securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The prospectus supplement will describe the specific terms of the depositary arrangement for debt securities of a series that are issued in global form. None of our Company, the trustee, any payment agent or the security registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in a global debt security or for maintaining, supervising or reviewing any records relating to these beneficial ownership interests. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No Protection in the Event of Change of Control</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless we indicate otherwise in a prospectus supplement with respect to a particular series of debt securities, the debt securities will not contain any provisions that may afford holders of debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Covenants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will set forth in the applicable prospectus supplement any restrictive covenants applicable to any issue of debt securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidation, Merger and Sale of Assets</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless we indicate otherwise in a prospectus supplement, we will not in any transaction or series of transactions, merge or consolidate with or into, or sell, assign, convey or transfer, lease or otherwise dispose of all or substantially all of our properties and assets, unless: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">either (A)&#160;if the transaction or series of transactions is a merger or consolidation, the Company shall be the surviving person of such merger or consolidation, or (B)&#160;the person formed by such consolidation or into which the Company is merged or to which the properties and assets of the Company are transferred shall be a corporation or entity treated as a corporation for U.S. federal income tax purposes organized and existing under the laws of the United States of America, any state thereof or the District of Columbia, or a corporation or comparable legal entity treated as a corporation for U.S. federal income tax purposes organized under the laws of a foreign jurisdiction and shall expressly assume by a supplemental indenture executed and delivered to the trustee, in form reasonably satisfactory to the trustee, all of the obligations of the Company (including, without limitation, the obligation to pay the principal of, and premium and interest, if any, on, the securities and the performance of the other covenants) under the indenture as supplemented, and in each case, the indenture shall remain in full force and effect; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">immediately before and immediately after giving effect to such transaction or series of transactions on a pro&#160;forma basis (including, without limitation, any indebtedness incurred or anticipated to be incurred in connection with or in respect of such transaction or series of transactions), no default or event of default shall have occurred and be continuing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Events of Default</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise specified in the applicable prospectus supplement, the following events will be events of default under the indenture with respect to debt securities of any series: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we default in the payment of any principal of, or premium, if any, on, the debt securities when it becomes due and payable at maturity, upon acceleration, redemption or otherwise; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we default in the payment of any interest on any debt security of a series when the same becomes due and payable, and the default continues for a period of 30&#160;days; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we default in observance or performance of any other covenant in the debt securities of a series or the indenture for 60&#160;days after written notice from the trustee or the holders of not less than 25% in the aggregate principal amount of the debt securities of such series then outstanding which notice must specify the default, demand that it be remedied and state that the notice is a &#8220;Notice of Default&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain events involving bankruptcy, insolvency or reorganization of Verastem or any of our significant subsidiaries; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any other event of default provided for in such series of debt securities as may be specified in the applicable prospectus supplement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Holders of a majority in principal amount of the debt securities of any series then outstanding have the right to waive any existing default or event of default with respect to such series or compliance with any provision of the indenture (with respect to such series) or the debt securities of such series with written notice to the trustee. Upon any such waiver, such default with respect to such series shall cease to exist, and any event of default with respect to such series arising therefrom shall be deemed to have been cured for every purpose of the indenture; but no such waiver shall extend to any subsequent or other default or event of default or impair any right consequent thereto. If an event of default (other than an event of default resulting from certain events of bankruptcy, insolvency or reorganization with respect to the Company) occurs, and is continuing, then the trustee, by written notice, or the holders of not less than 25% in aggregate principal amount of the outstanding debt securities of that series may declare that the entire principal amount, plus the premium, if any, of all the debt securities of that series then outstanding plus accrued and unpaid interest to the date of acceleration are immediately due and payable. At any time after the acceleration, but before a judgment or decree based on such acceleration is obtained by the trustee, the holders of a majority in aggregate principal amount of outstanding debt securities of such series may rescind and annul such acceleration if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">all existing events of default (other than nonpayment of accelerated principal, premium or interest) have been cured or waived; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">all lawful interest on overdue installments of interest and overdue principal have been paid; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rescission would not conflict with any judgment or decree. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if the acceleration occurs at any time when we have outstanding indebtedness which is senior to the debt securities, the payment of the principal amount of outstanding debt securities may be subordinated in right of payment to the prior payment of any amounts due under the senior indebtedness, in which case the holders of debt securities will be entitled to payment under the terms prescribed in the instruments evidencing the senior indebtedness and the indenture. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an event of default resulting from certain events of bankruptcy, insolvency or reorganization with respect to the Company occurs, such principal, premium, if any, and interest amount with respect to all the debt securities of that series shall be due and payable immediately without any declaration or other act on the part of the trustee or the holders of the debt securities of that series. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of a majority in principal amount of the outstanding debt securities of a series will have the right to waive any existing default or compliance with any provision of the indenture or the debt securities of that series and to direct the time, method and place of conducting any proceeding for any remedy available to the trustee, subject to certain limitations specified in the indenture. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No holder of any debt security of a series will have any right to institute any proceeding with respect to the indenture or for any remedy under the indenture, unless: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the holder gives to the trustee written notice of a continuing event of default with respect to the debt securities of that series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the holders of at least 25% in aggregate principal amount of the outstanding debt securities of the affected series make a written request to the trustee; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the holder or holders offer to the trustee indemnity satisfactory to the trustee against any loss, liability or expense to be incurred in compliance with such request; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the trustee does not comply with the request within 60&#160;days after such request; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the holders of a majority in aggregate principal amount of the outstanding debt securities of the affected series do not give the trustee a direction inconsistent with such request during such 60-day period. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Modification and Waiver</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we and the trustee may, without the consent of holders of the debt securities of one or more series, amend the indenture or the debt securities of one or more series, or supplement the indenture, for certain specified purposes, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to provide that the surviving entity following a change of control of Verastem permitted under the indenture will assume all of our obligations under the indenture and debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to provide for certificated debt securities in addition to uncertificated debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to comply with any requirements of the SEC under the Trust Indenture Act of 1939; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to cure any mistake, ambiguity, defect or inconsistency, or make any other change that does not materially and adversely affect the rights of any holder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to provide for the issuance of and establish the form and terms and conditions of debt securities of any series as permitted by the indenture; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to evidence and provide for the acceptance of the appointment of a successor trustee under the indenture with respect to one or more series and to add to or change any of the provisions of the indenture as shall be necessary to provide for or facilitate the administration of the trusts by more than one trustee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time we and the trustee may, with the consent of holders of not less than a majority of the aggregate principal amount of an outstanding series of debt securities, amend or supplement the indenture or the debt securities series, or waive compliance in a particular instance by us with any provision </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of the indenture or the debt securities. We may not, however, without the consent of each holder affected by such action, modify or supplement the indenture or the debt securities or waive compliance with any provision of the indenture or the debt securities in order to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reduce the amount of debt securities whose holders must consent to an amendment, supplement, or waiver to the indenture or such debt security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reduce the rate of or change the time for payment of interest on any of the debt securities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reduce the principal of or change the stated maturity of the debt securities, or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">make any debt security payable in money other than that stated in the debt security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">change the amount or time of any payment required by the debt securities or reduce the premium payable upon any redemption of the debt securities, or change the time before which no such redemption may be made; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">waive a default or event of default in the payment of the principal of, or interest or premium, if any, on any debt securities (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in principal amount of the outstanding debt securities of such series and a waiver of the payment default that resulted from such acceleration); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">waive a redemption payment with respect to any debt securities or change any provision with respect to redemption of debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">take any other action otherwise prohibited by the indenture to be taken without the consent of each holder affected by the action; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">make any changes to the above provisions or the acceleration provisions of the indenture, except to increase any&#160;percentage of debt securities the holders of which must consent to any matter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Defeasance of Debt Securities and Certain Covenants in Certain Circumstances</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The indenture permits us, at any time, to elect to discharge our obligations with respect to one or more series of debt securities by following certain procedures described in the indenture. These procedures will allow us either: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to defease and be discharged from any and all of our obligations with respect to any debt securities except for the following obligations (which discharge is referred to as &#8220;legal defeasance&#8221;): </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">to replace temporary or mutilated, destroyed, lost or stolen debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">the rights, powers, trusts, duties and immunities of the trustee; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">to maintain an office or agency in respect of the debt securities and to hold monies for payment in trust; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to be released from our obligations with respect to the debt securities under certain covenants contained in the indenture, as well as any additional covenants which may be contained in an applicable supplemental indenture (which release is referred to as &#8220;covenant defeasance&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to exercise either defeasance option, we must irrevocably deposit with the trustee or other qualifying trustee, in trust for that purpose: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">money; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. Government Obligations (as described below) or Foreign Government Obligations (as described below) which through the scheduled payment of principal and interest in accordance with their terms will provide, not later than the due date of any payment, money; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a combination of money and/or U.S. Government Obligations and/or Foreign Government Obligations sufficient in the written opinion of a nationally-recognized firm of independent accountants to provide money; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which in each case specified above, provides an amount sufficient to pay the principal of, premium, if any, and interest, if any, on the debt securities of the series, on the scheduled due dates or on a selected date of redemption in accordance with the terms of the indenture. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, defeasance may be effected only if, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in the case of either legal or covenant defeasance, we deliver to the trustee an opinion of counsel, as specified in the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in the case of legal defeasance, we deliver to the trustee an opinion of counsel stating that we have received from, or there has been published by, the Internal Revenue Service a ruling to the effect that, or there has been a change in any applicable federal income tax law with the effect that or there has been a change in any applicable U.S. Federal income tax law with the effect that, and such opinion shall confirm that, the holders of the outstanding debt securities of such series or persons will not recognize income, gain or loss for U.S. federal income tax purposes solely as a result of such legal defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner, including as a result of prepayment, and at the same times as would have been the case if legal defeasance had not occurred; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in the case of covenant defeasance, we deliver to the trustee an opinion of counsel to the effect that the holders of the outstanding debt securities will not recognize income, gain or loss for U.S. federal income tax purposes as a result of covenant defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if covenant defeasance had not occurred; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain other conditions described in the indenture are satisfied. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we fail to comply with our remaining obligations under the indenture and any applicable supplemental indenture after a covenant defeasance of the indenture and any applicable supplemental indenture, and the debt securities are declared due and payable because of the occurrence of any undefeased event of default, the amount of money and/or U.S. Government Obligations and/or Foreign Government Obligations on deposit with the trustee could be insufficient to pay amounts due under the debt securities of the affected series at the time of acceleration. We will, however, remain liable in respect of these payments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The term &#8220;U.S. Government Obligations&#8221; as used in the above discussion means direct non-callable obligations of or non-callable obligations guaranteed by the United States of America for the payment of which obligation or guarantee the full faith and credit of the United States of America is pledged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The term &#8220;Foreign Government Obligations&#8221; as used in the above discussion means, with respect to Securities that are denominated in a foreign currency (i)&#160;direct obligations of the government that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged or (ii)&#160;obligations of a person controlled or supervised by or acting as an agency or instrumentality of such government the timely payment of which is unconditionally guaranteed as a full faith and credit obligation by such government, which in either case under clauses (i)&#160;and (ii), are not callable or redeemable at the option of the issuer thereof. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regarding the Trustee</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will identify the trustee with respect to any series of debt securities in the prospectus supplement relating to the applicable debt securities. You should note that if the trustee becomes a creditor of Verastem, the indenture and the Trust Indenture Act of 1939 limit the rights of the trustee to obtain payment of claims in certain cases, or to realize on certain property received in respect of any such claim, as security or otherwise. The trustee and its affiliates may engage in, and will be permitted to continue to engage in, other transactions with us and our affiliates. If, however, the trustee acquires any &#8220;conflicting interest&#8221; within the meaning of the Trust Indenture Act of 1939, it must eliminate such conflict or resign. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The holders of a majority in principal amount of the then outstanding debt securities of any series may direct the time, method and place of conducting any proceeding for exercising any remedy available to the trustee. If an event of default occurs and is continuing, the trustee, in the exercise of its rights and powers, must use the degree of care and skill of a prudent person under the same circumstances in the conduct of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">his or her own affairs. Subject to that provision, the trustee will be under no obligation to exercise any of its rights or powers under the indenture at the request of any of the holders of the debt securities, unless they have offered to the trustee indemnity or security against the costs, expenses and liabilities which may be incurred therein or thereby. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Governing Law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The indenture and the debt securities, including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the laws of the State of New York. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:472pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is part of a registration statement we filed with the SEC. This prospectus does not contain all of the information set forth in the registration statement and the exhibits to the registration statement. For further information, we refer you to the registration statement and the exhibits and schedules filed as a part of the registration statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy statements and other information regarding issuers that file electronically with the SEC, including us. The address of the SEC website is www.sec.gov. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We maintain a website at www.verastem.com. Information contained in, or accessible through, our website is not a part of, and is not incorporated into, this prospectus, and you should not consider it part of this prospectus. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sIOCD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:90pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC allows us to &#8220;incorporate by reference&#8221; into this prospectus certain information we file with it, which means that we can disclose important information about us by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus, and information in documents that we file later with the SEC will automatically update and supersede information in this prospectus. We incorporate by reference into this prospectus the documents listed below and any future filings, including all filings made after the date of the filing of the registration statement of which this prospectus is part and prior to the effectiveness of such registration statement, made by us with the SEC under Sections&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act, except for information &#8220;furnished&#8221; under Items&#160;2.02, 7.01 or 9.01 on Form 8-K or other information &#8220;furnished&#8221; to the SEC which is not deemed filed and not incorporated in this prospectus, until the termination of the offering of securities described in the applicable prospectus supplement. We hereby incorporate by reference the following documents: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">our Annual Report on Form 10-K for the year ended December&#160;31, 2024, as filed with the SEC on March&#160;20, 2025</a>; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our Quarterly Reports on Form 10-Q for the quarter ended <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025007570/vstm-20250331x10q.htm">March&#160;30, 2025</a>, as filed with the SEC on May&#160;13, 2025, and for the quarter ended <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025010757/vstm-20250630x10q.htm">June&#160;30, 2025</a>, as filed with the SEC on August&#160;7, 2025; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our Current Reports on Form 8-K filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925002859/tm253090d1_8k.htm">January&#160;13, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925004918/tm253996d1_8k.htm">January&#160;21, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925005460/tm254144d1_8k.htm">January&#160;23, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925026130/tm259913d1_8k.htm">March&#160;20, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925039098/tm2513177d1_8k.htm">April&#160;25, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925046175/tm2514525d1_8k.htm">May&#160;8, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925052220/tm2516049d1_8k.htm">May&#160;23, 2025</a>, and <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925055286/tm2516844d1_8k.htm">June&#160;2, 2025</a>; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the information specifically incorporated by reference into <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">our Annual Report on Form 10-K for the year ended December&#160;31, 2024</a> from our <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025004597/vstm-20250522xdef14a.htm">Definitive Proxy Statement on Schedule&#160;14A</a> for the 2025 Annual Meeting of Stockholders, as filed with the SEC on April&#160;8, 2025; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the description of our common stock, which is in our Registration Statement on Form 8-A, dated <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465912003382/a11-28014_58a12b.htm">January&#160;23, 2012</a>, as supplemented by the description of our common stock and preferred stock contained in <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000155837025003372/vstm-20241231xex4d2.htm">Exhibit&#160;4.2</a> to our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024, filed with the SEC on March&#160;20, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed modified, superseded or replaced for purposes of this prospectus to the extent that a statement contained in this prospectus modifies, supersedes or replaces such statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may request a copy of these filings, at no cost, by writing or telephoning us at the following address: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investor Relations</font>
          <br >
          <font style="letter-spacing:0.2pt;">Verastem, Inc.</font>
          <br >
          <font style="letter-spacing:0.2pt;">117 Kendrick Street, Suite 500</font>
          <br >
          <font style="letter-spacing:0.2pt;">Needham, Massachusetts 02494</font>
          <br >
          <font style="letter-spacing:0.2pt;">(781) 292-4279</font>
          <br >
          <font style="letter-spacing:0.2pt;">email address: investors@verastem.com </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Copies of these filings are also available, without charge, on the SEC&#8217;s website at www.sec.gov and on our website at www.verastem.com as soon as reasonably practicable after they are filed electronically with the SEC. The information contained on our website is not a part of this prospectus. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="sLEMA">&#8203;</a><a name="sEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:480pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The validity of the issuance of the securities offered pursuant to this prospectus will be passed upon for us by Ropes &amp; Gray LLP, Boston, Massachusetts. The validity of any securities will be passed upon for any underwriters or agents by counsel that we will name in the applicable prospectus supplement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of Verastem, Inc. appearing in Verastem, Inc.&#8217;s <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">Annual Report on Form 10-K for the year ended December&#160;31, 2024</a>, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="position:relative;overflow:hidden;min-height:775.71pt;page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="position:absolute;top:738.85pt;left:48.64pt;height:30pt;width:706.02pt;transform-origin:0pt -0pt;transform:rotate(-90deg) translate(0%, 0%);">
        <div style="text-align:justify; width:706pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-family:Helvetica, Arial, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.08pt;">The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font><font style="color:#000000;letter-spacing:-0.08pt;"> </font>
          <br >
        </div>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-bottom:21.86pt;margin-left:87.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
            <font style="letter-spacing:-0.2pt;">Subject to Completion, dated August&#160;12, 2025</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTUS SUPPLEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:14pt; text-align:center; width:456pt;">
          <img src="lg_verastemoncology-4c.jpg" alt="[MISSING IMAGE: lg_verastemoncology-4c.jpg]" height="66" width="293" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Up to $100,000,000 of Shares</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:23.167pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:21pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We entered into a sales agreement, or, sales agreement, with Cantor Fitzgerald &amp; Co., or Cantor, relating to shares of our common stock, par value $0.0001, offered by this prospectus supplement. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock from time to time through Cantor, acting as sales agent. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;VSTM.&#8221; On August&#160;11, 2025, the last reported sale price of our common stock was $7.70 per share. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sales of our common stock, if any, under this prospectus supplement may be made in sales deemed to be &#8220;at-the-market&#8221; equity offerings as defined in Rule&#160;415 promulgated under the Securities Act of 1933, as amended, or the Securities Act. Cantor will act as sales agent on a best efforts basis and use commercially reasonable efforts to sell on our behalf all of the shares of common stock requested to be sold by us, consistent with its normal trading and sales practices, on mutually agreed terms between Cantor and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cantor will be entitled to compensation at a commission rate of up to 3.0% of the gross sales price per share sold. In connection with the sale of our common stock on our behalf, Cantor will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act and the compensation of Cantor will be deemed to be underwriting commissions or discounts. </font>
        </div>
        <div style="margin-top:22.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:21pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investing in our common stock involves a high degree of risk. Before making an investment decision, please read the information under the heading &#8220;Risk Factors&#8221; beginning on page <a href="#bRIFA">S-4</a> of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:26pt; text-align:center; width:456pt;">
          <img src="lg_cantor-4c.jpg" alt="[MISSING IMAGE: lg_cantor-4c.jpg]" height="39" width="205" >
        </div>
        <div style="margin-top:113pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The date of this prospectus supplement is&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;, 2025</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:402.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:188.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:425.15pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bATPS"><font style="letter-spacing:0.2pt;">ABOUT THIS PROSPECTUS SUPPLEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bATPS">S-1</a></font> <a href="#bATPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bPSS"><font style="letter-spacing:0.2pt;">PROSPECTUS SUPPLEMENT SUMMARY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bPSS">S-2</a></font> <a href="#bPSS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bTHOF"><font style="letter-spacing:0.2pt;">THE OFFERING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bTHOF">S-3</a></font> <a href="#bTHOF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bRIFA">S-4</a></font> <a href="#bRIFA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bFOST"><font style="letter-spacing:0.2pt;">FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bFOST">S-5</a></font> <a href="#bFOST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bUOP"><font style="letter-spacing:0.2pt;">USE OF PROCEEDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bUOP">S-7</a></font> <a href="#bUOP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bPOD"><font style="letter-spacing:0.2pt;">PLAN OF DISTRIBUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bPOD">S-8</a></font> <a href="#bPOD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bDOCS"><font style="letter-spacing:0.2pt;">DESCRIPTION OF COMMON STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bDOCS">S-9</a></font> <a href="#bDOCS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bLEMA"><font style="letter-spacing:0.2pt;">LEGAL MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bLEMA">S-10</a></font> <a href="#bLEMA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bEXP"><font style="letter-spacing:0.2pt;">EXPERTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bEXP">S-10</a></font> <a href="#bEXP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bWYCF"><font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND MORE INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bWYCF">S-10</a></font> <a href="#bWYCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:425.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#bIOCD"><font style="letter-spacing:0.2pt;">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#bIOCD">S-10</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bATPS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:176pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROSPECTUS SUPPLEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering. The second part, the accompanying prospectus, gives more general information, some of which may not apply to this offering. In the event that the description of this offering varies between this prospectus supplement and the accompanying prospectus, you should rely on the information contained in this prospectus supplement. This prospectus supplement includes or incorporates by reference important information about us, our common stock, and other matters you should know before investing. You should read this prospectus supplement as well as additional information described under the sections of this prospectus supplement entitled &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation of Certain Documents by Reference&#8221; before making an investment decision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should rely only on this prospectus supplement and the information incorporated or deemed to be incorporated by reference in this prospectus supplement or in any free writing prospectus supplement that we may authorize for use in connection with this offering. We have not, and Cantor has not, authorized anyone to provide you with information that is in addition to, or different from, that contained or incorporated by reference in this prospectus supplement. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and Cantor is not, making an offer to sell or soliciting an offer to buy our securities in any jurisdiction in which an offer or solicitation is not authorized or in which the person making that offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. You should not assume that the information contained or incorporated by reference in this prospectus supplement is accurate as of any date other than as of the date of this prospectus supplement or in the case of the documents incorporated by reference, the date of such documents regardless of the time of delivery of this prospectus supplement or any sale of shares of our common stock. Our business, financial condition, liquidity, results of operations and prospects may have changed since those dates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are offering to sell, and seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the offering of the common stock in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus supplement must inform themselves about, and observe any restrictions relating to, the offering of the common stock and the distribution of this prospectus supplement outside the United States. This prospectus supplement does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">References in this prospectus supplement to &#8220;Verastem,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or similar terms refer to Verastem, Inc. and our subsidiaries on a consolidated basis, as appropriate, unless we state otherwise or the context otherwise requires. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bPSS">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUPPLEMENT SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">This summary highlights selected information included or incorporated by reference in this prospectus supplement and does not contain all of the information that may be important to you. You should carefully review this entire prospectus supplement and any free writing prospectus supplement we have authorized for use in connection with this offering carefully, including the risk factors and financial statements included or incorporated by reference herein or therein.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Company Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We are a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with ras sarcoma (&#8220;RAS&#8221;)/ mitogen activated pathway kinase (&#8220;MAPK&#8221;) pathway-driven cancers. We market AVMAPKI FAKZYNJA CO-PACK (avutometinib capsules; defactinib tablets) in the United States. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including rapidly accelerated fibrosarcoma (&#8220;RAF&#8221;)/ mitogen-activated protein kinase kinase (&#8220;MEK&#8221;) inhibition, focal adhesion kinase (&#8220;FAK&#8221;) inhibition and Kirsten rat sarcoma viral oncogene homolog (&#8220;KRAS&#8221;) G12D inhibition. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On May&#160;8, 2025, the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) approved AVMAPKI FAKZYNJA CO-PACK for the treatment of adult patients with KRAS mutant (&#8220;KRAS mt&#8221;) recurrent low grade serous ovarian cancer (&#8220;LGSOC&#8221;) who received prior systemic therapy. The KRAS mt recurrent LGSOC indication has been granted approval by the FDA under the accelerated approval pathway based on the tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. We intend to initiate discussions with other global regulatory authorities, including those in Europe and Japan with the objective of ultimately seeking approval for the combination therapy in additional regions. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">AVMAPKI (avutometinib) inhibits MEK kinase activity while also blocking the compensatory reactivation of MEK by upstream RAF. RAF and MEK proteins are regulators of the RAS/RAF/MEK/ extracellular-signal-regulated-kinase (&#8220;ERK&#8221;) MAPK pathway. Blocking RAF and/or MEK activates FAK, a key mediator of drug resistance. FAKZYNJA (defactinib) is a FAK inhibitor and together, the avutometinib and defactinib combination is designed to provide a more complete blockade of the signaling that drives the growth and drug resistance of RAS/MAPK pathway-dependent tumors. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Avutometinib, alone or in combination with defactinib, has received orphan drug designation for the treatment of all patients with LGSOC in the United States. Defactinib has received orphan drug designation in ovarian cancer in the United States, the European Union, and Australia. In addition, the FDA granted orphan drug designation to avutometinib, in combination with defactinib, for the treatment of pancreatic cancer. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our principal executive offices are located at 117 Kendrick Street, Suite 500, Needham, MA 02494, and our telephone number is (781) 292-4200. Our website address is: www.verastem.com. We have included our website address as a factual reference and do not intend it to be an active link to our website. The information that can be accessed through our website is not part of this prospectus, and investors should not rely on any such information in deciding whether to purchase our common stock. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bTHOF">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:6pt; margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">THE OFFERING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Common stock offered by us </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Shares of our common stock having an aggregate offering price of up to $100,000,000. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Manner of offering </font>
            </div>
          </div>

            <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">&#8220;At-the-market&#8221; offering that may be made from time to time through our sales agent, Cantor. See &#8220;Plan of Distribution&#8221; on page <a href="#bPOD">S-8</a>. </font>
            </div>

          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Use of proceeds </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If we receive all $100,000,000 of gross proceeds from the sale of the shares of our common stock under this prospectus supplement, we anticipate that our net proceeds, after deducting estimated commissions and expenses payable by us, will be approximately $97.6 million. We intend to use the net proceeds from this offering to fund commercial launch activities for the AVMAPKI FAKZYNJA CO-PACK in LGSOC, continued clinical research and development of product candidates, and for working capital and other general corporate purposes, which may include capital expenditures, research and development expenditures, clinical trial expenditures, potential commercial launch expenditures, milestone payments under collaboration and in-license agreements, and possible acquisitions. See &#8220;Use of Proceeds&#8221; on page <a href="#bUOP">S-7</a>. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Risk factors </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">You should read the &#8220;Risk Factors&#8221; section of this prospectus supplement and in the documents incorporated by reference in this prospectus supplement for a discussion of factors to consider before deciding to purchase shares of our common stock. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">The Nasdaq Capital Market symbol </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">VSTM </font>
          </div>
          <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The number of shares of common stock shown above to be outstanding after this offering is based on 61,523,425 shares outstanding as of June&#160;30, 2025, and excludes: </font>
          </div>

            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">2,945,631 shares of our common stock issuable upon the exercise of stock options outstanding under our Amended and Restated 2012 Incentive Plan, our Amended and Restated 2021 Equity Incentive Plan, and our inducement award program (our &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Equity Incentive Plans</font><font style="letter-spacing:0.2pt;">&#8221;), at a weighted average exercise price of $10.56 per share; </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">1,498,103 shares of our common stock issuable upon the vesting of restricted stock&#160;units under our Equity Incentive Plans; </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">1,526,691 shares of our common stock reserved and available for future issuance under our Amended and Restated 2021 Equity Incentive Plan; </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">158,044 shares of our common stock reserved and available for future issuance under our inducement award program, of which 45,000 shares are issuable upon the exercise of stock options granted subsequent to June&#160;30, 2025 through the date hereof under the inducement award program at a weighted-average exercise price of $4.29 per share; </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">51,441 shares of our common stock reserved for future issuance under our Amended and Restated 2018 Employee Stock Purchase Plan; </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">14,129,169 shares of our common stock issuable upon the exercise of our currently outstanding warrants at an exercise price equal to $3.50 per share; </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">2,500,000 shares of our common stock issuable upon the exercise of our currently outstanding pre-funded warrants at an exercise price equal to $0.001 per share; and </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">7,285,713 shares of our common stock issuable upon the exercise of our currently outstanding pre-funded warrants at an exercise price equal to $0.0001 per share. </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Unless otherwise indicated, all information in this prospectus supplement reflects or assumes no issuance or exercise of stock options or warrants after June&#160;30, 2025.</font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:240pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">You should consider carefully the risks described below and discussed under the section captioned &#8220;Risk Factors&#8221; contained in <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">our annual report on Form 10-K for the year ended December&#160;31, 2024</a> and in any subsequent quarterly reports on Form 10-Q and annual reports on Form 10-K, as updated by our subsequent filings under the Exchange Act, each of which is incorporated by reference in this prospectus supplement, together with other information in this prospectus supplement, and the information and documents incorporated by reference in this prospectus supplement, and any free writing prospectus that we have authorized for use in connection with this offering before you make a decision to invest in our common stock. If any of the following events actually occur, our business, operating results, prospects or financial condition could be materially and adversely affected. This could cause the trading price of our common stock to decline and you may lose all or part of your investment. The risks described below are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business operations.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional Risks Relating to this Offering and Our Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may allocate the net proceeds from this offering in ways that you and other stockholders may not approve.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently intend to use the net proceeds of this offering, if any, for commercial preparation and launch costs, pending successful development and a favorable regulatory outcome for our lead product candidates avutometinib and defactinib, for the continued clinical development of our lead product candidates and to fund working capital, capital expenditures and other general corporate purposes, which may include milestone payments under in-license agreements,, and the possible acquisition or in-license of additional compounds, product candidates or technology. This expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our development efforts, the status of and results from clinical trials, as well as any collaborations that we may enter into with third parties for our product candidates, and any unforeseen cash needs. Because the number and variability of factors that will determine our use of the proceeds from this offering, their ultimate use may vary substantially from their currently intended use. As a result, our management will retain broad discretion over the allocation of the net proceeds from this offering and could spend the proceeds in ways that do not necessarily improve our operating results or enhance the value of our common stock. See &#8220;Use of Proceeds.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bFOST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus supplement and the other documents we have filed with the SEC that are incorporated herein by reference, contain forward-looking statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These forward-looking statements generally can be identified by the use of words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;potentially,&#8221; &#8220;project,&#8221; and other words of similar meaning. All statements, other than statements related to present facts or current conditions or historical facts, contained incorporated by reference into this prospectus supplement, are forward-looking statements, including statements regarding our strategy, future operations, future financial position, including our ability to continue as a going concern through one year from the date of the financial statements for the quarter ended June&#160;30, 2025, future revenues, projected costs, prospects, plans and objectives of management. Such statements relate to, among other things, the commercial success of our marketed product AVMAPKI FAKZYNJA CO-PACK, the development and activity of our programs and product candidates, avutometinib (RAF MEK program) and defactinib (FAK program), the structure and potential clinical value of our completed, planned and pending clinical trials, including the RAMP 201, RAMP 203, RAMP 205 and RAMP 301 trials; the timing of commencing and completing trials, including topline data reports, our interactions with regulators; the timeline and indications for clinical development, regulatory submissions and the potential for and timing of commercialization of our product candidates; the potential for additional development programs involving the Company&#8217;s lead compound and the potential market opportunities thereof; the expected outcome and benefits of our collaboration with GenFleet Therapeutics (Shanghai), Inc. (&#8220;GenFleet&#8221;) and the estimated addressable markets for, and anticipated market opportunities of our drug candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement. Applicable risks and uncertainties include the risks and uncertainties, among other things, regarding: the success in the development and potential commercialization of our product candidates, including avutometinib in combination with other compounds, including defactinib, LUMAKRAS</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> and others; the uncertainties inherent in research and development, such as negative or unexpected results of clinical trials; the occurrence or timing of applications for our product candidates that may be filed with regulatory authorities in any jurisdictions; whether and when regulatory authorities in any jurisdictions may approve applications that may be filed for our product candidates and, if approved, whether our product candidates will be commercially successful in such jurisdictions; the impact of current and future healthcare reforms, including those affecting the delivery of or payment for healthcare products and services; our ability to obtain, maintain and enforce patent and other intellectual property protection for our product candidates; the scope, timing, and outcome of any legal proceedings; decisions by regulatory authorities regarding trial design, labeling and other matters that could affect the timing, availability or commercial potential of our product candidates; whether preclinical testing of our product candidates and preliminary or interim data from clinical trials will be predictive of the results or success of ongoing or later clinical trials; that the timing, scope and rate of reimbursement for our product candidates is uncertain; actions or advice of regulatory agencies and our ability to obtain and maintain regulatory approval for AVMAPKI FAKZYNJA CO-PACK; that the market opportunities of AVMAPKI FAKZYNJA CO-PACK are based on internal and third-party estimates which may prove to be incorrect; that third- party payors (including government agencies) may not reimburse; that there may be competitive developments affecting our product candidates; that data may not be available when expected; that enrollment of clinical trials may take longer than expected; risks associated with preliminary and interim data, which may not be representative of more mature data, including with respect to interim duration of therapy data; that our product candidates may cause adverse safety events and/or unexpected concerns may arise from additional data or analysis, or result in unmanageable safety profiles as compared to their levels of efficacy; that we may be unable to successfully validate, develop and obtain regulatory approval for companion diagnostic tests for our product candidates that require or would commercially benefit from such tests, or experience significant delays in doing so; that we may not be able to expand the approved indication for AVMAPKI FAKZYNJA CO-PACK; that our product candidates may experience manufacturing or supply interruptions or failures; that any of our third party contract research organizations, contract manufacturing organizations, clinical sites, or contractors, among others, who we rely on may fail to fully perform; that we face substantial competition, which may result in others developing or commercializing products before or more successfully than we do which could result in reduced market </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:272pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">share or market potential for our product candidates; that we may be unable to successfully initiate or complete the clinical development and eventual commercialization of our product candidates; that the development and commercialization of our product candidates may take longer or cost more than planned, including as a result of conducting additional studies or our decisions regarding execution of such commercialization; that we may not have sufficient cash to fund our contemplated operations, including certain of our product development programs; that we may not attract and retain high quality personnel; that we or Chugai Pharmaceutical, Co. Ltd. may fail to fully perform under the avutometinib license agreement; that we or Secura Bio, Inc. (&#8220;Secura&#8221;) may fail to fully perform under the asset purchase agreement with Secura, including in relation to milestone payments; that we may not see a return on investment on the payments we have and may continue to make pursuant to the collaboration and option agreement with GenFleet or that GenFleet may fail to fully perform under the agreement; that we may not be able to establish new or expand on existing collaborations or partnerships, including with respect to in-licensing of our product candidates, on favorable terms, or at all; that we may be unable to obtain adequate financing in the future through product licensing, co-promotional arrangements, public or private equity, debt financing or otherwise; that we may not pursue or submit regulatory filings for our product candidates; and that our product candidates will not receive regulatory approval, become commercially successful products, or result in new treatment options being offered to patients. Other risks and uncertainties include those identified under the heading &#8220;Risk Factors&#8221; contained in this in our Annual Report on Form 10-K for the year ended December&#160;31, 2024, as filed with the SEC on March&#160;20, 2025, and in any subsequent filings with the SEC. See &#8220;Where You Can Find More Information.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of these and other factors, we may not achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make. The forward-looking statements contained in this prospectus supplement reflect our views as of the date hereof. We do not assume and specifically disclaim any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:308pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we receive all $100,000,000 of gross proceeds from the sale of the shares of our common stock under this prospectus supplement, we anticipate that the net proceeds we will receive from this offering will be approximately $97.6 million, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. The amount of the proceeds from this offering will depend upon the number of shares of our common stock sold and the market price at which they are sold. There can be no assurance that we will be able to sell any shares under or fully utilize the sales agreement with Cantor as a source of financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently estimate that we will use the net proceeds from this offering to fund commercial launch activities for the AVMAPKI FAKZYNJA CO-PACK in LGSOC, continued clinical research and development of product candidates, and for working capital and other general corporate purposes, which may include capital expenditures, research and development expenditures, clinical trial expenditures, potential commercial launch expenditures, milestone payments under collaboration and in-license agreements, and possible acquisitions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our development efforts, the status of and results from clinical trials, as well as any collaborations that we may enter into with third parties for our product candidates, and any unforeseen cash needs. As a result, we cannot estimate with certainty the amount of net proceeds to be used for the purposes described above, and our management will retain broad discretion over the allocation of the net proceeds from this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pending our use of the net proceeds from this offering described above, we intend to invest the net proceeds in a variety of capital preservation investments, including short-term, investment grade, interest bearing instruments and U.S. government securities. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bPOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:72pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLAN OF DISTRIBUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have entered into a sales agreement with Cantor, under which we may issue and sell shares of our common stock having an aggregate gross sales price of up to $100,000,000 from time to time through Cantor acting as sales agent. The sales agreement has been incorporated by reference as an exhibit to our registration statement on Form S-3 of which this prospectus supplement forms a part. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon delivery of a placement notice and subject to the terms and conditions of the sales agreement, Cantor may sell shares of our common stock by any method permitted by law deemed to be an &#8220;at-the-market&#8221; offering as defined in Rule&#160;415 promulgated under the Securities Act. We may instruct Cantor not to sell common stock if the sales cannot be effected at or above the price designated by us from time to time. We or Cantor may suspend the offering of common stock upon notice and subject to other conditions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will pay Cantor commissions, in cash, for its services in acting as agent in the sale of our common stock. Cantor will be entitled to compensation at a commission rate of up to 3.0% of the gross sales price per share sold. Because there is no minimum offering amount required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. We have also agreed to reimburse Cantor for the out-of-pocket reasonable fees and disbursements of its legal counsel, payable upon execution of the Sales Agreement, in an amount not to exceed $75,000, in addition to ongoing disbursements of legal counsel payable in the amount not to exceed $25,000 in connection with each diligence bring-down or program refresh thereafter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Settlement for sales of shares of common stock will occur on the first business day following the date on which any sales are made, or on some other date that is agreed upon by us and Cantor in connection with a particular transaction, in return for payment of the net proceeds to us. Sales of our common stock as contemplated in this prospectus supplement will be settled through the facilities of The Depository Trust Company or by such other means as we and Cantor may agree upon. There is no arrangement for funds to be received in an escrow, trust or similar arrangement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cantor will use its commercially reasonable efforts, consistent with its sales and trading practices, to solicit offers to purchase the shares of common stock under the terms and subject to the conditions set forth in the sales agreement. In connection with the sale of the shares of common stock on our behalf, Cantor will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act and the compensation of Cantor will be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to Cantor against certain civil liabilities, including liabilities under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The offering of shares of our common stock pursuant to the sales agreement will terminate upon the earlier of (i)&#160;the sale of all the shares of our common stock that are subject to the sales agreement having an aggregate offering price of $100,000,000 or (ii)&#160;termination of the sales agreement as permitted therein. We and Cantor may each terminate the sales agreement at any time upon ten days&#8217; prior notice. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cantor and its affiliates may in the future provide various investment banking, commercial banking and other financial services for us and our affiliates, for which services they may in the future receive customary fees. To the extent required by Regulation&#160;M, Cantor will not engage in any market making activities involving our common stock while the offering is ongoing under this prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus supplement in electronic format may be made available on a website maintained by Cantor, and Cantor may distribute this prospectus supplement electronically. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bDOCS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:572pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF COMMON STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The description of our common stock is incorporated by reference to Exhibit&#160;4.2 of our Annual Report on most recent Form 10-K, including any amendments or reports filed for the purpose of updating such description. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">S-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="bLEMA">&#8203;</a><a name="bEXP">&#8203;</a><a name="bWYCF">&#8203;</a><a name="bIOCD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:4pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The validity of the issuance of the securities offered hereby will be passed upon by our counsel, Ropes&#160;&amp; Gray LLP, Boston, Massachusetts. Cantor is being represented in connection with this offering by Latham &amp; Watkins LLP, San Diego, California. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of Verastem, Inc. appearing in Verastem, Inc.&#8217;s <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">Annual Report on Form 10-K for the year ended December&#160;31, 2024</a>, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus supplement is part of a registration statement we filed with the SEC. This prospectus supplement does not contain all of the information set forth in the registration statement and the exhibits to the registration statement. For further information, we refer you to the registration statement and the exhibits and schedules filed as a part of the registration statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy statements and other information regarding issuers that file electronically with the SEC, including us. The address of the SEC website is www.sec.gov. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We maintain a website at www.verastem.com. Information contained in, or accessible through, our website is not a part of, and is not incorporated into, this prospectus supplement, and you should not consider it part of this prospectus supplement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC allows us to &#8220;incorporate by reference&#8221; the information we file with it which means that we can disclose important information about us by referring you to those documents instead of having to repeat the information in this prospectus supplement. The information incorporated by reference is considered to be part of this prospectus supplement, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference into this prospectus supplement the documents listed below and any future filings, including all filings made after the date of the filing of the registration statement of which this prospectus supplement is part and prior to the effectiveness of such registration statement, made by us with the SEC under Section&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act, except for information &#8220;furnished&#8221; under Items&#160;2.02, 7.01 or 9.01 on Form 8-K or other information &#8220;furnished&#8221; to the SEC which is not deemed filed and not incorporated in this prospectus supplement, until the termination of the offering of securities described in this prospectus supplement. We hereby incorporate by reference the following documents: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">our Annual Report on Form 10-K for the year ended December&#160;31, 2024, as filed with the SEC on March&#160;20, 2025</a>; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our Quarterly Reports on Form 10-Q for the quarter ended March&#160;30, 2025, as filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025007570/vstm-20250331x10q.htm">May&#160;13, 2025</a>, and for the quarter ended <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025010757/vstm-20250630x10q.htm">June&#160;30, 2025</a>, as filed with the SEC on August&#160;7, 2025; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our Current Reports on Form 8-K filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925002859/tm253090d1_8k.htm">January&#160;13, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925004918/tm253996d1_8k.htm">January&#160;21, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925005460/tm254144d1_8k.htm">January&#160;23, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925026130/tm259913d1_8k.htm">March&#160;20, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925039098/tm2513177d1_8k.htm">April&#160;25, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925046175/tm2514525d1_8k.htm">May&#160;8, 2025</a>, <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925052220/tm2516049d1_8k.htm">May&#160;23, 2025</a>, and <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925055286/tm2516844d1_8k.htm">June&#160;2, 2025</a>; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the information specifically incorporated by reference into our <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025003372/vstm-20241231x10k.htm">Annual Report on Form 10-K for the year ended December&#160;31, 2024</a> from our <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000155837025004597/vstm-20250522xdef14a.htm">Definitive Proxy Statement on Schedule&#160;14A</a> for the 2025 Annual Meeting of Stockholders, as filed with the SEC on April&#160;8, 2025; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:368pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the description of our common stock, which is in our Registration Statement on Form 8-A, dated <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465912003382/a11-28014_58a12b.htm">January&#160;23, 2012</a>, as supplemented by the description of our common stock and preferred stock contained in <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000155837025003372/vstm-20241231xex4d2.htm">Exhibit&#160;4.2</a> to our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024, filed with the SEC on March&#160;20, 2025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus supplement will be deemed modified, superseded or replaced for purposes of this prospectus to the extent that a statement contained in this prospectus supplement modifies, supersedes or replaces such statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may request a copy of these filings, at no cost, by writing or telephoning us at the following address: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investor Relations</font>
          <br >
          <font style="letter-spacing:0.2pt;">Verastem, Inc.</font>
          <br >
          <font style="letter-spacing:0.2pt;">117 Kendrick Street, Suite 500</font>
          <br >
          <font style="letter-spacing:0.2pt;">Needham, Massachusetts 02494</font>
          <br >
          <font style="letter-spacing:0.2pt;">(781) 292-4279</font>
          <br >
          <font style="letter-spacing:0.2pt;">email address: investors@verastem.com </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Copies of these filings are also available, without charge, on the SEC&#8217;s website at www.sec.gov and on our website at www.verastem.com as soon as reasonably practicable after they are filed electronically with the SEC. The information contained on our website is not a part of this prospectus supplement.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">S-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 3pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="position:relative;margin-top:86.5pt; text-align:center; width:456pt;">
          <img src="lg_verastemoncology-4c.jpg" alt="[MISSING IMAGE: lg_verastemoncology-4c.jpg]" height="66" width="293" >
        </div>
        <div style="margin-top:77pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Up to $100,000,000 of Shares</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:83.167pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 83.1666666666667pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">PROSPECTUS SUPPLEMENT</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:14.833pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 14.8333333333333pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="position:relative;margin-top:85.5pt; text-align:center; width:456pt;">
          <img src="lg_cantor-4c.jpg" alt="[MISSING IMAGE: lg_cantor-4c.jpg]" height="39" width="205" >
        </div>
        <div style="margin-top:89pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;, 2025</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:98.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 98.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 3pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;14.&nbsp;&nbsp;&nbsp;Other Expenses of Issuance and Distribution.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the various expenses to be incurred in connection with the issuance and distribution of the offered securities being registered, other than underwriting discounts and commissions. </font>
        </div>

          <table style="width:416pt;height:115.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 1pt 0pt; width:358.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Securities and Exchange Commission registration fee </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:0pt 0pt 1pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">45,930.00 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Printing and engraving expenses </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
                <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>*</font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Legal fees and expenses </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
                <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>*</font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Accounting fees and expenses </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
                <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>*</font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Transfer Agent and Registrar fees </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
                <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>*</font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Trustee&#8217;s fees and expenses </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
                <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>*</font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Miscellaneous </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">
                <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>*</font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:358.59pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Total </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
                <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:9pt;"></font>*</font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.4pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Estimated expenses are not presently known and will be reflected in the applicable prospectus supplement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;15.&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;102 of the Delaware General Corporation Law permits a corporation to eliminate the personal liability of its directors or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his or her duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our amended and restated certificate of incorporation provides that no director shall be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that the Delaware General Corporation Law prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145 of the Delaware General Corporation Law provides that a corporation has the power to indemnify a director, officer, employee or agent of the corporation and certain other persons serving at the request of the corporation in related capacities against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlements actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he or she is party or is threatened to be made a party by reason of such position, if such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnification for such expenses which the Court of Chancery or such other court shall deem proper. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of incorporation provides that we will indemnify each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding whether civil, criminal, administrative or investigative (other than an action by or in the right of us) by reason of the fact that he or she is or was, or has agreed to become, our director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (all such persons being referred to as an &#8220;Indemnitee&#8221;), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees), judgments, fines and amounts </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding and any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of incorporation also provides that we will indemnify any Indemnitee who was or is a party to an action or suit by or in the right of us to procure a judgment in our favor by reason of the fact that the Indemnitee is or was, or has agreed to become, our director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee or, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees) and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding, and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, except that no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including attorneys&#8217; fees) actually and reasonably incurred by him or her or on his or her behalf in connection therewith. If we do not assume the defense, expenses must be advanced to an Indemnitee under certain circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have entered into indemnification agreements with our directors. In general, these agreements provide that we will indemnify the director to the fullest extent permitted by law for claims arising in his or her capacity as a director of our Company or in connection with his or her service at our request for another corporation or entity. The indemnification agreements also provide for procedures that will apply in the event that a director makes a claim for indemnification and establish certain presumptions that are favorable to the director. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We maintain a general liability insurance policy which covers certain liabilities of our directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also see &#8220;Undertakings.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;16.&nbsp;&nbsp;&nbsp;Exhibits.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:257.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:24.75pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:419.25pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Description </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">1.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:419.25pt;">
                <font style="letter-spacing:0.2pt;">Form of Underwriting Agreement* </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">1.2 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1526119/000110465925075498/tm2522593d2_ex1-2.htm">Sales Agreement, dated August&#160;8, 2025, by and between the Company and Cantor Fitzgerald&#160;&amp; Co. (incorporated by reference to Exhibit 1.2 to the Registration Statement on Form S-3 filed by the Registrant with the Securities and Exchange Commission on August 8, 2025)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000155837019001852/vstm-20181231ex3015107bc.htm">Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit&#160;3.1 of the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2018 as filed with the SEC on March&#160;12, 2019)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.2 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000155837019001852/vstm-20181231ex3023a9464.htm">Certificate of Amendment to the Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit&#160;3.2 to the Annual Report on Form 10-K filed by the Registrant on March&#160;12, 2019)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.3 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465920064756/tm2020393d1_ex3-1.htm">Certificate of Amendment to the Restated Certificate of Incorporation of Verastem, Inc. (incorporated by reference to Exhibit&#160;3.1 to the Form 8-K filed by the Registrant with the SEC on May&#160;21, 2020)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.4 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465923066363/tm2317400d1_ex3-1.htm">Certificate of Amendment to Restated Certificate of Incorporation of Verastem, Inc. (incorporated by reference to Exhibit&#160;3.1 to the Form 8-K filed by the Registrant with the SEC on May&#160;31, 2023)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.5 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000104746912000187/a2206820zex-3_4.htm">Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit&#160;3.4 to Amendment No. 3 to the Registration Statement on Form S-1 as filed with the SEC on January&#160;13, 2012)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:458.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:24.75pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:419.25pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Description </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.6 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465922115103/tm2229823d1_ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series&#160;A Convertible Preferred Stock (incorporated by reference to Exhibit&#160;3.1 to the Form 8-K filed by the Registrant with the SEC on November&#160;7, 2022)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">3.7 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465923006382/tm234327d2_ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series&#160;B Convertible Preferred Stock (incorporated by reference to Exhibit&#160;3.1 to the Form 8-K filed by the Registrant with the SEC on January&#160;25, 2023)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000104746912000187/a2206820zex-4_1.htm">Specimen certificate evidencing shares of common stock (incorporated by reference to Exhibit&#160;4.1 to Amendment No. 3 to the Registration Statement on Form S-1 as filed with the SEC on January&#160;13, 2012)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.2 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000155837025003372/vstm-20241231xex4d2.htm">Description of Securities (incorporated by reference to Exhibit&#160;4.2 to the Annual Report on Form&#160;10-K filed by the Registrant on March&#160;20, 2025)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.3 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465925039098/tm2513177d1_ex10-3.htm">Form of Pre-Funded Warrant to Purchase Common Stock (incorporated by referenced to Exhibit&#160;10.3 to the Form 8-K filed by the Registrant with the Securities and Exchange Commission on April&#160;25, 2025)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.4 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1526119/000110465925039098/tm2513177d1_ex10-2.htm">Registration Rights Agreement, dated April&#160;25, 2025, by and among Verastem, Inc. and the investors party thereto (incorporated by reference to Exhibit&#160;10.2 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on April&#160;25, 2025)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.5 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <font style="letter-spacing:0.2pt;">Form of Common Stock Warrant Agreement and Warrant Certificate* </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.6 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <font style="letter-spacing:0.2pt;">Form of Preferred Stock Warrant Agreement and Warrant Certificate* </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.7 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <font style="letter-spacing:0.2pt;">Form of Debt Securities Warrant Agreement and Warrant Certificate* </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.8 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1526119/000110465925075498/tm2522593d2_ex4-8.htm">Form of Indenture (incorporated by reference to Exhibit 4.8 to the Registration Statement on Form S-3 filed by the Registrant with the Securities and Exchange Commission on August 8, 2025)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">5.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2522593d4_ex5-1.htm">Opinion of Ropes &amp; Gray LLP relating to the base prospectus (filed herewith)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">5.2 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2522593d4_ex5-2.htm">Opinion of Ropes &amp; Gray LLP relating to the at-the-market offering prospectus supplement (filed herewith)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="letter-spacing:0.2pt;">23.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2522593d4_ex5-1.htm">Consent of Ropes &amp; Gray LLP (included in Exhibit&#160;5.1)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="letter-spacing:0.2pt;">23.2 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2522593d4_ex5-2.htm">Consent of Ropes &amp; Gray LLP (included in Exhibit&#160;5.2)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="letter-spacing:0.2pt;">23.3 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2522593d4_ex23-3.htm">Consent of Ernst &amp; Young LLP (filed herewith)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24.75pt;">
                <font style="letter-spacing:0.2pt;">23.4</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1526119/000110465925075498/tm2522593-1_s3.htm#tPOA">Power of Attorney (incorporated by reference to the Registration Statement on Form S-3 filed by the Registrant with the Securities and Exchange Commission on August 8, 2025) </a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="letter-spacing:0.2pt;">25.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.25pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2522593d4_ex25-1.htm">Statement of Eligibility of Trustee Under Debt Indenture (filed herewith)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; width:24.75pt;">
                <font style="letter-spacing:0.2pt;">107 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; width:419.25pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1526119/000110465925075498/tm2522593d1_ex-filingfees.htm">Filing Fee Table (incorporated by reference to Exhibit 107 to the Registration Statement on Form&#160;S-3 filed by the Registrant with the Securities and Exchange Commission on August 8, 2025)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">To be filed, if necessary, subsequent to the effectiveness of this registration statement by an amendment to this registration statement or incorporated by reference pursuant to a Current Report on Form 8-K in connection with the offering of securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;17.&nbsp;&nbsp;&nbsp;Undertakings.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20&#160;percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that the undertakings set forth in paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this registration statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of this registration statement. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">If the registrant is relying on Rule&#160;430B: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:7.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Each prospectus filed by the registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii), or (x)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font><font style="font-style:italic;letter-spacing:0.2pt;">Provided, however,</font><font style="letter-spacing:0.2pt;"> that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">If the registrant is subject to Rule&#160;430C, each prospectus filed pursuant to Rule&#160;424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. </font><font style="font-style:italic;letter-spacing:0.2pt;">Provided, however</font><font style="letter-spacing:0.2pt;">, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: (i)&#160;any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; (ii)&#160;any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; (iii)&#160;the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv)&#160;any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or 15(d) of the Securities Exchange Act of&#160;1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&#160;15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for purposes of determining any liability under the Securities Act of 1933: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">the information omitted from the form of prospectus filed as part of the registration statement in reliance upon Rule&#160;430A and contained in the form of prospectus filed by the Registrant pursuant to Rule&#160;424(b)(1) or (4)&#160;or 497(h) under the Securities Act of 1933 shall be deemed to be part of the registration statement as of the time it was declared effective; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a)&#160;of Section&#160;310 of the Trust Indenture Act of 1939 in accordance with the rules and regulations prescribed by the Commission under Section&#160;305(b)(2) of the Trust Indenture Act of&#160;1939. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, and will be governed by the final adjudication of such issue.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Needham, Commonwealth of Massachusetts on August&#160;12, 2025. </font>
          </div>

        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">VERASTEM, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:19.2pt; margin-bottom:0pt; text-align:center; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">By:</font>
            <br >
          </div>
          <div style=" margin-top:19.2pt; margin-bottom:0pt; line-height:12pt; text-align:center; margin-left:260pt;">
            <font style="letter-spacing:0.2pt;">/s/ Daniel W. Paterson </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="white-space:nowrap; margin-left:260pt; margin-top:3pt; width:196pt;">
          <div style="margin-left: 0pt; width: 196pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:260pt; margin-top:2.49pt; text-align:center; width:196pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Daniel W. Paterson</font>
          <br >
          <font style="font-style:italic;letter-spacing:0.2pt;">President and Chief Executive Officer</font>
        </div>

          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">POWER OF ATTORNEY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated. </font>
        </div>

          <table style="width:456pt;height:422.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:159.93pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">SIGNATURES </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:204pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">TITLE </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:68.07pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">DATE </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46.25pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:18.917pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Daniel W. Paterson</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Daniel W. Paterson </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:18.917pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">President, Chief Executive Officer and Director</font>
                <br >
                <font style="letter-spacing:0.2pt;">(Principal executive officer) </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:18.917pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Daniel Calkins</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Daniel Calkins </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Chief Financial Officer</font>
                <br >
                <font style="letter-spacing:0.2pt;">(Principal financial and accounting officer) </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Brian M. Stuglik </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Paul A. Bunn, M.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Robert Gagnon </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">John H. Johnson </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Anil Kapur </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Michael Kauffman, M.D., Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Michelle Robertson </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.167pt 0pt 0.5pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:452.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:159.93pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">SIGNATURES </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:204pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">TITLE </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:68.07pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">DATE </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46.5pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:20.167pt 0pt 1pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Eric Rowinsky, M.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:20.167pt 0pt 1pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:20.167pt 0pt 1pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025 </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;height:46pt; white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:21pt 0pt 1pt 0pt; width:159.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 159.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Karin Tollefson </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:21pt 0pt 1pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:21pt 0pt 1pt 0pt; width:68.07pt;text-align:center;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">August&#160;12, 2025</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:20.167pt 0pt 0.5pt 0pt; width:159.93pt;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; line-height:10pt; text-align:left; width:24pt;white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">*By:</font>
                  <br >
                </div>
                <div style=" line-height:10pt; text-align:left; margin-left:24pt;">
                  <font style="letter-spacing:0.2pt;">/s/ Daniel W. Paterson</font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style="margin-left:24pt; margin-top:2.5pt; line-height:0pt;">
                  <div style="margin-left: 0pt; width: 135.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-left:24pt; margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Daniel W. Paterson, </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Attorney-in-Fact</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm2522593d4_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="5" STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="tm2522593d4_ex5-1img01.jpg" ALT=""></B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROPES&nbsp;&amp; GRAY LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRUDENTIAL TOWER</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800 BOYLSTON STREET</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOSTON, MA 02199-3600</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WWW.ROPESGRAY.COM</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">August&nbsp;12, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Verastem,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">117 Kendrick Street, Suite&nbsp;500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Needham, MA 02494</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: Registration of Securities by Verastem,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have acted as counsel to
Verastem,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the Registration Statement on
Form&nbsp;S-3 (File No. 333-289399) (as amended or supplemented, the &ldquo;<U>Registration Statement</U>&rdquo;) filed on the date
hereof by the Company with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act of
1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), relating to the registration under the Securities Act and the proposed
issuance and sale from time to time pursuant to Rule&nbsp;415 under the Securities Act of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i)&nbsp;shares of the Company&rsquo;s common stock,
$0.0001 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ii)&nbsp;one or more series of debt securities
of the Company (the &ldquo;<U>Debt Securities</U>&rdquo;), which Debt Securities may include senior debt securities or subordinated debt
securities issued under an indenture, including any supplemental indenture related thereto, and may be convertible into or exchangeable
for shares of the Common Stock or Preferred Stock (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(iii)&nbsp;warrants representing the right to receive
or the obligation to sell, upon exercise, a number of shares of Common Stock, shares of Preferred Stock and/or Debt Securities (the &ldquo;<U>Warrants</U>&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(iv)&nbsp;shares of preferred stock of the Company,
$0.0001 par value per share (the &ldquo;<U>Preferred Stock</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Common Stock, the Debt Securities, the Warrants
and the Preferred Stock are referred to herein collectively as the &ldquo;<U>Securities</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with this opinion letter, we have
examined such certificates, documents and records and have made such investigation of fact and such examination of law as we have deemed
appropriate in order to enable us to render the opinions set forth herein. In conducting such investigation, we have relied, without independent
verification, upon certificates of officers of the Company, public officials and other appropriate persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The opinions expressed below are limited to the
laws of the State of New York and the Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based upon and subject to the foregoing and the
assumptions, qualifications and limitations set forth below, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. When (i)&nbsp;the issuance and sale of any shares
of Common Stock have been duly authorized by all necessary corporate action of the Company and (ii)&nbsp;such shares have been issued
and delivered against payment of the purchase price therefor (in an amount in excess of the par value thereof) in accordance with the
applicable purchase, underwriting or other agreement, and as contemplated by the Registration Statement, such shares of Common Stock will
be validly issued, fully paid and nonassessable. The Common Stock covered in the opinion in this paragraph includes any shares of Common
Stock that may be issued upon exercise, conversion or exchange pursuant to the terms of any other Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. When (i)&nbsp;the terms of any Debt Securities
and their issuance and sale have been duly authorized by all necessary corporate action of the Company and (ii)&nbsp;such Debt Securities
have been duly executed, authenticated and delivered against payment of the purchase price therefor in accordance with the applicable
definitive purchase, underwriting or similar agreement, as contemplated by the Registration Statement, and in the manner provided for
in the applicable indenture, such Debt Securities will constitute valid and binding obligations of the Company enforceable against the
Company in accordance with their respective terms. The Debt Securities covered in the opinion in this paragraph include any Debt Securities
that may be issued upon exercise, conversion or exchange pursuant to the terms of any other Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3. When (i)&nbsp;the terms of any Warrants and
their issuance and sale have been duly authorized by all necessary corporate action of the Company and (ii)&nbsp;such Warrants have been
duly executed, countersigned and delivered in accordance with the applicable warrant agreement and against payment of the purchase price
therefor in accordance with the applicable purchase, underwriting or other agreement, and as contemplated by the Registration Statement,
such Warrants will constitute valid and binding obligations of the Company enforceable against the Company in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4. When (i)&nbsp;the terms of any Preferred Stock
of a particular series and their issuance and sale have been duly authorized by all necessary corporate action of the Company, (ii)&nbsp;a
certificate of designations with respect to such series of Preferred Stock has been duly adopted by the Company and filed with the Secretary
of State of the State of Delaware, and (iii)&nbsp;such shares of Preferred Stock have been issued and delivered against payment of the
purchase price therefor (in an amount in excess of the par value thereof) in accordance with the applicable purchase, underwriting or
other agreement, and as contemplated by the Registration Statement, such shares of Preferred Stock will be validly issued, fully paid,
and nonassessable. The Preferred Stock covered in the opinion in this paragraph includes any shares of Preferred Stock that may be issued
upon exercise, conversion or exchange pursuant to the terms of any other Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In rendering the opinions set forth above, we
have assumed that (i)&nbsp;the Registration Statement will have become effective under the Securities Act, a prospectus supplement will
have been prepared and filed with the Commission describing the Securities offered thereby and such Securities will have been issued
and sold in accordance with the terms of such prospectus supplement; (ii)&nbsp;a definitive purchase, underwriting, or similar agreement,
and any applicable indenture (including any supplemental indenture) or warrant agreement, pursuant to which such Securities may be issued,
will have been duly authorized, executed and delivered by the Company and the other parties thereto, and the specific terms of such Securities
will have been duly established in conformity with the applicable agreement and the certificate of incorporation and bylaws of the Company
(if applicable); (iii)&nbsp;at the time of the issuance of any Securities, the Company will be a validly existing corporation under the
law of its jurisdiction of incorporation; (iv)&nbsp;the number of shares of Common Stock issued pursuant to the Registration Statement,
together with the number of shares outstanding or reserved at the time of issuance, will not exceed the respective number of shares authorized
by the Company&rsquo;s certificate of incorporation in effect at the time of such issuance; (v)&nbsp;the number of shares of Preferred
Stock issued pursuant to the Registration Statement, together with the <FONT STYLE="background-color: fuchsia"></FONT>number of shares
outstanding or reserved at the time of issuance, will not exceed the respective number of shares authorized by the Company&rsquo;s certificate
of incorporation in effect at the time of such issuance; and (vi)&nbsp;all the foregoing actions to be taken by the Company will have
been taken so as not to violate any applicable law and so as to comply with any requirement or restriction imposed by any court or governmental
or regulatory body having jurisdiction over the Company or any of its property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our opinions set forth above are subject to (a)&nbsp;bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance and similar laws affecting the rights and remedies of creditors generally
and (b)&nbsp;general principles of equity. Our opinions are also subject to the qualification that the enforceability of provisions in
the indenture (including any supplemental indenture) providing for indemnification or contribution, broadly worded waivers, waivers of
rights to damages or defenses, waivers of unknown or future claims, and waivers of statutory, regulatory or constitutional rights may
be limited on public policy or statutory grounds. In addition, we express no opinion with respect to the enforceability of rights to receive
prepayment premiums or the unaccrued portion of original issue discount upon acceleration of any Debt Securities, in each case to the
extent determined to be unreasonable or to constitute unmatured interest or judgment currency provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We hereby consent to the filing of this opinion
letter as an exhibit to the Registration Statement and to the use of our name therein and in the related prospectus under the caption
 &ldquo;Legal Matters.&rdquo; In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required
under Section&nbsp;7 of the Securities Act or the rules&nbsp;and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ropes&nbsp;&amp; Gray LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ropes&nbsp;&amp; Gray LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>3
<FILENAME>tm2522593d4_ex5-2.htm
<DESCRIPTION>EXHIBIT 5.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD ROWSPAN="5" STYLE="width: 10%; font-size: 10pt"><IMG SRC="tm2522593d4_ex5-2img02.jpg" ALT="">&#8239;<FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROPES&nbsp;&amp; GRAY LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRUDENTIAL TOWER</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800 BOYLSTON STREET</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOSTON, MA 02199-3600</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WWW.ROPESGRAY.COM</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">August&nbsp;12, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Verastem,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">117 Kendrick Street, Suite&nbsp;500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Needham, MA 02494</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">Re: Registration Statement on Form&nbsp;S-3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have acted as counsel to
Verastem,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with its filing of a Registration
Statement on Form&nbsp;S-3 (File No. 333-289399) (as amended or supplemented, the &ldquo;<U>Registration Statement</U>&rdquo;) with
the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act of 1933, as amended (the
 &ldquo;<U>Securities Act</U>&rdquo;), relating to the issuance and sale of up to $100,000,000 of shares (the
 &ldquo;<U>Shares</U>&rdquo;) of the common stock of the Company, $0.0001 par value (the &ldquo;<U>Common Stock</U>&rdquo;). The
Shares will be sold pursuant to a Controlled Equity Offering Sales Agreement, dated August&nbsp;7, 2025, by and between the Company
and Cantor Fitzgerald&nbsp;&amp; Co. (the &ldquo;<U>Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with this opinion letter, we have
examined such certificates, documents and records and have made such investigation of fact and such examination of law as we have deemed
appropriate in order to enable us to render the opinions set forth herein. In conducting such investigation, we have relied, without independent
verification, upon certificates of officers of the Company, public officials and other appropriate persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The opinion expressed below is limited to the Delaware
General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based upon and subject to the foregoing, we are
of the opinion that when the Shares are issued out of the Company&rsquo;s duly authorized Common Stock and issued and delivered in accordance
with the terms of the Agreement against payment of the consideration set forth therein, the Shares will be duly authorized, validly issued,
fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We hereby consent to your filing this opinion as
an exhibit to the Registration Statement and to the use of our name therein and in the related prospectus under the caption &ldquo;Legal
Matters.&rdquo; In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under
Section&nbsp;7 of the Securities Act or the rules&nbsp;and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ropes&nbsp;&amp; Gray LLP</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ropes&nbsp;&amp; Gray LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>tm2522593d4_ex23-3.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 23.3</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the reference to our firm under the caption &ldquo;Experts&rdquo; and to the use of our report dated March 20, 2025, in
Amendment No.1 to the Registration Statement (Form S-3 No. 333-289399) and related Prospectus of Verastem, Inc. for the registration of
shares of its common stock, preferred stock, warrants and debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">/s/ Ernst&nbsp;&amp; Young LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Boston, Massachusetts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">August&nbsp;12, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-25.1
<SEQUENCE>5
<FILENAME>tm2522593d4_ex25-1.htm
<DESCRIPTION>EXHIBIT 25.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 25.1</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>securities
and exchange commission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;T-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Statement
of Eligibility Under</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>The
Trust Indenture Act of 1939 of a</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Corporation
Designated to Act as Trustee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Check if an Application to Determine Eligibility
of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">a Trustee Pursuant to Section&nbsp;305(b)(2)&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Trustee as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>91-1821036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">I.R.S. Employer Identification No.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border: Black 1pt solid; font-size: 10pt; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">800 Nicollet Mall</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Minneapolis, Minnesota</P></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">55402</P></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">David Jason</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">U.S. Bank Trust Company, National Association</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">One California Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">San Francisco, CA 94111</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(415) 677-3622</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address and telephone number of agent for
service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VERASTEM,&nbsp;INC.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Issuer with respect to the Securities)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border: Black 1pt solid; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">Delaware</TD>
    <TD STYLE="border-top: Black 1pt solid; width: 50%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">27-3269467</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">117 Kendrick Street, Suite&nbsp;500</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Needham, MA</P></TD>
    <TD STYLE="font-size: 10pt; width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">02494</P></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Address of Principal Executive Offices)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><B>% Notes
Due 20</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Title of the Indenture
Securities)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM&nbsp;T-1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 1. </B></TD>
  <TD><B>GENERAL INFORMATION<I>.</I></B> Furnish the following information as to the Trustee.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a)</TD><TD><I>Name and address of each examining or supervising authority to which it is subject.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 1in">Comptroller of the Currency</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 1in">Washington, D.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify"><I>Whether it is authorized to exercise corporate trust powers.</I></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 1.5in">Yes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 2. </B></TD>
  <TD><B>AFFILIATIONS WITH THE OBLIGOR. </B> <I>If the obligor is an affiliate of the Trustee, describe each such affiliation.</I></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">None</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.75in"><B>Items 3-15</B></TD>
  <TD><I>Items 3-15 are not applicable because to the best of the Trustee's knowledge, the obligor is not in default under any Indenture
for which the Trustee acts as Trustee.</I></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 16. </B></TD>
  <TD><B>LIST OF EXHIBITS:</B> <I>List below all exhibits filed as a part of this statement of eligibility and qualification.</I></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">A copy of the Articles of Association of the Trustee, attached
as Exhibit&nbsp;1.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">A copy of the certificate of authority of the Trustee to commence
business, attached as Exhibit&nbsp;2.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">A copy of the authorization of the Trustee to exercise corporate
trust powers, included as Exhibit&nbsp;2.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>A copy of the existing bylaws of the Trustee, attached as Exhibit&nbsp;4.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>A copy of each Indenture referred to in Item 4. Not applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">6.</TD><TD>The consent of the Trustee required by Section&nbsp;321(b)&nbsp;of the Trust Indenture Act of 1939, attached as Exhibit&nbsp;6.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">7.</TD><TD>Report of Condition of the Trustee as of June&nbsp;30, 2025, published pursuant to law or the requirements of its supervising or examining
authority, attached as Exhibit&nbsp;7.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Trust Indenture
Act of 1939, as amended, the Trustee, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION<FONT STYLE="font-size: 10pt">, </FONT>a national banking
association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility and qualification
to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of San Francisco, State of California on the
8th of August, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"> /s/ David Jason</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">David Jason</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Vice President</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>OF</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U. S. BANK TRUST COMPANY, NATIONAL ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purpose of organizing an association (the
 &ldquo;Association&rdquo;) to perform any lawful activities of national banks, the undersigned enter into the following Articles of Association:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-size: 10pt"><B>FIRST.
</B></FONT>The title of this Association shall be U. S. Bank Trust Company, National Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>SECOND.
</B></FONT>The main office of the Association shall be in the city of Portland, county of Multnomah, state of Oregon. The business of
the Association will be limited to fiduciary powers and the support of activities incidental to the exercise of those powers. The Association
may not expand or alter its business beyond that stated in this article without the prior approval of the Comptroller of the Currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIRD.</B> The board of directors of the Association
shall consist of not less than five nor more than twenty-five persons, the exact number to be fixed and determined from time to time by
resolution of a majority of the full board of directors or by resolution of a majority of the shareholders at any annual or special meeting
thereof. Each director shall own common or preferred stock of the Association or of a holding company owning the Association, with an
aggregate par, fair market, or equity value of not less than $1,000, as of either (i)&nbsp;the date of purchase, (ii)&nbsp;the date the
person became a director, or (iii)&nbsp;the date of that person's most recent election to the board of directors, whichever is more recent.
Any combination of common or preferred stock of the Association or holding company may be used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any vacancy in the board of directors may be filled
by action of a majority of the remaining directors between meetings of shareholders. The board of directors may increase the number of
directors up to the maximum permitted by law. Terms of directors, including directors selected to fill vacancies, shall expire at the
next regular meeting of shareholders at which directors are elected, unless the directors resign or are removed from office. Despite the
expiration of a director's term, the director shall continue to serve until his or her successor is elected and qualified or until there
is a decrease in the number of directors and his or her position is eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Honorary or advisory members of the board of directors,
without voting power or power of final decision in matters concerning the business of the Association, may be appointed by resolution
of a majority of the full board of directors, or by resolution of shareholders at any annual or special meeting. Honorary or advisory
directors shall not be counted to determined the number of directors of the Association or the presence of a quorum in connection with
any board action, and shall not be required to own qualifying shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>FOURTH. </B></FONT>There
shall be an annual meeting of the shareholders to elect directors and transact whatever other business may be brought before the
meeting. It shall be held at the main office or any other convenient place the board of directors may designate, on the day of each
year specified therefor in the Bylaws, or <FONT STYLE="font-size: 10pt">if that</FONT> day falls on a legal holiday in the state in
which the Association is located, on the next following banking day. <FONT STYLE="font-size: 10pt">If </FONT>no election is held on
the day fixed or in the event of a legal holiday on the following banking day, an election may be held on any subsequent day within
60 days of the day fixed, to be designated by the board of directors, or, <FONT STYLE="font-size: 10pt">if </FONT>the directors fail
to fix the day, by shareholders representing two-thirds of the shares issued and outstanding. In all cases, at least 10 days&rsquo;
advance notice of the meeting shall be given to the shareholders by first-class mail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In all elections of directors, the number of votes
each common shareholder may cast will be determined by multiplying the number of shares he or she owns by the number of directors to be
elected. Those votes may be cumulated and cast for a single candidate or may be distributed among two or more candidates in the manner
selected by the shareholder. On all other questions, each common shareholder shall be entitled to one vote for each share of stock held
by him or her.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A director may
resign at any time by delivering written notice to the board of directors, its chairperson, or to the Association, which resignation shall
be effective when the notice is delivered unless the notice specifies a later effective date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A director may be removed by the shareholders
at a meeting called to remove him or her, when notice of the meeting stating that the purpose or one of the purposes is to remove <FONT STYLE="font-size: 10pt">him
</FONT>or her is provided, <FONT STYLE="font-size: 10pt">if </FONT>there is a failure to fulfill one of the affirmative requirements for
qualification, or for cause; provided, however, that a director may not be removed <FONT STYLE="font-size: 10pt">if </FONT>the number
of votes sufficient to elect him or her under cumulative voting is voted against his or her removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FIFTH. </B>The authorized amount of capital
stock of the Association shall be 1,000,000 shares of common stock of the par value of ten dollars ($10) each; but said capital stock
may be increased or decreased from time to time, according to the provisions of the laws of the United States. The Association shall have
only one class of capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No holder of shares of the capital stock of any
class of the Association shall have any preemptive or preferential right of subscription to any shares of any class of stock of the Association,
whether now or hereafter authorized, or to any obligations convertible into stock of the Association, issued, or sold, nor any right of
subscription to any thereof other than such, if any, as the board of directors, in its discretion, may from time to time determine and
at such price as the board of directors may from time to time fix.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transfers of the Association's stock are subject
to the prior written approval of a federal depository institution regulatory agency. <FONT STYLE="font-size: 10pt">If no</FONT> other
agency approval is required, the approval of the Comptroller of the Currency must be obtained prior to any such transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the Articles
of Association or required by law, (1)&nbsp;all matters requiring shareholder action, including amendments to the Articles of
Association must be approved by shareholders owning a majority voting interest in the outstanding voting stock, and (2)&nbsp;each
shareholder shall be entitled to one vote per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the Articles of
Association or required by law, all shares of voting stock shall be voted together as a class, on any matters requiring shareholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise provided in the Bylaws, the record
date for determining shareholders entitled to notice of and to vote at any meeting is the close of business on the day before the first
notice is mailed or otherwise sent to the shareholders, provided that in no event may a record date be more than 70 days before the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Association,
at any time and from time to time, may authorize and issue debt obligations, whether subordinated, without the approval of the shareholders.
Obligations classified as debt, whether subordinated, which may be issued by the Association without the approval of shareholders, do
not carry voting rights on any issue, including an increase or decrease in the aggregate number of the securities, or the exchange or
reclassification of all or part of securities into securities of another class or series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>SIXTH. </B></FONT>The
board of directors shall appoint one of its members president of this Association and one of its members chairperson of the board and
shall have the power to appoint one or more vice presidents, a secretary who shall keep minutes of the directors' and shareholders' meetings
and be responsible for authenticating the records of the Association, and such other officers and employees as may be required to transact
the business of this Association. A duly appointed officer may appoint one or more officers or assistant officers if authorized by the
board of directors in accordance with the Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors shall have the power to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>Define the duties of the officers, employees, and agents of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Delegate the performance of its duties, but not the responsibility for its duties, to the officers, employees,
and agents of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Fix the compensation and enter employment contracts with its officers and employees upon reasonable terms
and conditions consistent with applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>Dismiss officers and employees.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(5)</TD><TD>Require bonds from officers and employees and to fix the penalty thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">Ratify written policies authorized by the Association's management or committees of the board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(7)</TD><TD STYLE="text-align: justify">Regulate the manner any increase or decrease of the capital of the Association shall be made; provided
that nothing herein shall restrict the power of shareholders to increase or decrease the capital of the Association in accordance with
law, and nothing shall raise or lower from two-thirds the percentage required for shareholder approval to increase or reduce the capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(8)</TD><TD>Manage and administer the business and affairs of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(9)</TD><TD>Adopt initial Bylaws, not inconsistent with law or the Articles of Association, for managing the business and regulating the affairs
of the Association.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(10)</TD><TD>Amend or repeal Bylaws, except to the extent that the Articles of Association reserve this power in whole or in part to the shareholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(11)</TD><TD>Make contracts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(12)</TD><TD>Generally perform all acts that are legal for a board of directors to perform.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>SEVENTH. </B></FONT>The
board of directors shall have the power to change the location of the main office to any authorized branch within the limits of the city
of Portland, Oregon, without the approval of the shareholders, or with a vote of shareholders owning two-thirds of the stock of the Association
for a location outside such limits and upon receipt of a certificate of approval from the Comptroller of the Currency, to any other location
within or outside the limits of the city of Portland, Oregon, but not more than thirty miles beyond such limits. The board of directors
shall have the power to establish or change the location of any office or offices of the Association to any other location permitted under
applicable law, without approval of shareholders, subject to approval by the Comptroller of the Currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-size: 10pt"><B>EIGHTH.
</B></FONT>The corporate existence of this Association shall continue until termination according to the laws of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NINTH. </B></FONT>The
board of directors of the Association, or any shareholder owning, in the aggregate, not less than 25 percent of the stock of the Association,
may call a special meeting of shareholders at any time. Unless otherwise provided by the Bylaws or the laws of the United States, or waived
by shareholders, a notice of the time, place, and purpose of every annual and special meeting of the shareholders shall be given by first-class
mail, postage prepaid, mailed at least 10, and no more than 60, days prior to the date of the meeting to each shareholder of record at
his/her address as shown upon the books of the Association. Unless otherwise provided by the Bylaws, any action requiring approval of
shareholders must be effected at a duly called annual or special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>TENTH. </B></FONT>These
Articles of Association may be amended at any regular or special meeting of the shareholders by the affirmative vote of the holders of
a majority of the stock of the Association, unless the vote of the holders of a greater amount of stock is required by law, and in that
case by the vote of the holders of such greater amount; provided, that the scope of the Association's activities and services may not
be expanded without the prior written approval of the Comptroller of the Currency. The Association's board of directors may propose one
or more amendments to the Articles of Association for submission to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In witness whereof, we have hereunto set our hands
this <FONT STYLE="font-size: 10pt; text-decoration: underline solid">11<SUP>th</SUP></FONT> of June, 1997.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%">/s/ Jeffrey T. Grubb</TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Jeffrey T. Grubb</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Robert D. Sznewajs</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Robert D. Sznewajs</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Dwight V. Board</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Dwight V. Board</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ P. K. Chatterjee</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">P. K. Chatterjee</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Robert Lane</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Robert Lane</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2522593d4_ex25-1img03.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Exhibit&nbsp;4</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. BANK TRUST COMPANY, NATIONAL
ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>AMENDED AND RESTATED BYLAWS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Meetings of Shareholders</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.1. <U>Annual
Meeting</U>. The annual meeting of the shareholders, for the election of directors and the transaction of any other proper business, shall
be held at a time and place as the Chairman or President may designate. Notice of such meeting shall be given not less than ten (10)&nbsp;days
or more than sixty (60) days prior to the date thereof, to each shareholder of the Association, unless the Office of the Comptroller of
the Currency (the &ldquo;OCC&rdquo;) determines that an emergency circumstance exists. In accordance with applicable law, the sole shareholder
of the Association is permitted to waive notice of the meeting. If, for any reason, an election of directors is not made on the designated
day, the election shall be held on some subsequent day, as soon thereafter as practicable, with prior notice thereof. Failure to hold
an annual meeting as required by these Bylaws shall not affect the validity of any corporate action or work a forfeiture or dissolution
of the Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.2. <U>Special
Meetings</U>. Except as otherwise specially provided by law, special meetings of the shareholders may be called for any purpose, at any
time by a majority of the board of directors (the &ldquo;Board&rdquo;), or by any shareholder or group of shareholders owning at least
ten percent of the outstanding stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Every such special meeting, unless otherwise provided
by law, shall be called upon not less than ten (10)&nbsp;days nor more than sixty (60) days prior notice stating the purpose of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.3. <U>Nominations
for Directors</U>. Nominations for election to the Board may be made by the Board or by any shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.4. <U>Proxies</U>.
Shareholders may vote at any meeting of the shareholders by proxies duly authorized in writing. Proxies shall be valid only for one meeting
and any adjournments of such meeting and shall be filed with the records of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.5. <U>Record
Date</U>. The record date for determining shareholders entitled to notice and to vote at any meeting will be thirty days before the date
of such meeting, unless otherwise determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.6. <U>Quorum
and Voting</U>. A majority of the outstanding capital stock, represented in person or by proxy, shall constitute a quorum at any
meeting of shareholders, unless otherwise provided by law, but less than a quorum may adjourn any meeting, from time to time, and
the meeting may be held as adjourned without further notice. A majority of the votes cast shall decide every question or matter
submitted to the shareholders at any meeting, unless otherwise provided by law or by the Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.7. <U>Inspectors</U>.
The Board may, and in the event of its failure so to do, the Chairman of the Board may appoint Inspectors of Election who shall determine
the presence of quorum, the validity of proxies, and the results of all elections and all other matters voted upon by shareholders at
all annual and special meetings of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.8. <U>Waiver
and Consent</U>. The shareholders may act without notice or a meeting by a unanimous written consent by all shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.9. <U>Remote
Meetings</U>. The Board shall have the right to determine that a shareholder meeting not be held at a place, but instead be held solely
by means of remote communication in the manner and to the extent permitted by the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;II</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Directors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.1. <U>Board
of Directors</U>. The Board shall have the power to manage and administer the business and affairs of the Association. Except as expressly
limited by law, all corporate powers of the Association shall be vested in and may be exercised by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.2. <U>Term
of Office</U>. The directors of this Association shall hold office for one year and until their successors are duly elected and qualified,
or until their earlier resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.3. <U>Powers</U>.
In addition to the foregoing, the Board shall have and may exercise all of the powers granted to or conferred upon it by the Articles
of Association, the Bylaws and by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.4. <U>Number</U>.
As provided in the Articles of Association, the Board of this Association shall consist of no less than five nor more than
twenty-five members, unless the OCC has exempted the Association from the twenty-five- member limit. The Board shall consist of a
number of members to be fixed and determined from time to time by resolution of the Board or the shareholders at any meeting
thereof, in accordance with the Articles of Association. Between meetings of the shareholders held for the purpose of electing
directors, the Board by a majority vote of the full Board may increase the size of the Board but not to more than a total of
twenty-five directors, and fill any vacancy so created in the Board; provided that the Board may increase the number of directors
only by up to two directors, when the number of directors last elected by shareholders was fifteen or fewer, and by up to four
directors, when the number of directors last elected by shareholders was sixteen or more. Each director shall own a qualifying
equity interest in the Association or a company that has control of the Association in each case as required by applicable law. Each
director shall own such qualifying equity interest in his or her own right and meet any minimum threshold ownership required by
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.5. <U>Organization
Meeting</U>. The newly elected Board shall meet for the purpose of organizing the new Board and electing and appointing such officers
of the Association as may be appropriate. Such meeting shall be held on the day of the election or as soon thereafter as practicable,
and, in any event, within thirty days thereafter, at such time and place as the Chairman or President may designate. If, at the time fixed
for such meeting, there shall not be a quorum present, the directors present may adjourn the meeting until a quorum is obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.6. <U>Regular
Meetings</U>. The regular meetings of the Board shall be held, without notice, as the Chairman or President may designate and deem suitable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.7. <U>Special
Meetings</U>. Special meetings of the Board may be called at any time, at any place and for any purpose by the Chairman of the Board or
the President of the Association, or upon the request of a majority of the entire Board. Notice of every special meeting of the Board
shall be given to the directors at their usual places of business, or at such other addresses as shall have been furnished by them for
the purpose. Such notice shall be given at least twelve hours (three hours if meeting is to be conducted by conference telephone) before
the meeting by telephone or by being personally delivered, mailed, or electronically delivered. Such notice need not include a statement
of the business to be transacted at, or the purpose of, any such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.8. <U>Quorum
and Necessary Vote</U>. A majority of the directors shall constitute a quorum at any meeting of the Board, except when otherwise provided
by law; but less than a quorum may adjourn any meeting, from time to time, and the meeting may be held as adjourned without further notice.
Unless otherwise provided by law or the Articles or Bylaws of this Association, once a quorum is established, any act by a majority of
those directors present and voting shall be the act of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.9. <U>Written
Consent</U>. Except as otherwise required by applicable laws and regulations, the Board may act without a meeting by a unanimous written
consent by all directors, to be filed with the Secretary of the Association as part of the corporate records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.10. <U>Remote
Meetings</U>. Members of the Board, or of any committee thereof, may participate in a meeting of such Board or committee by means of conference
telephone, video or similar communications equipment by means of which all persons participating in the meeting can hear each other and
such participation shall constitute presence in person at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.11. <U>Vacancies</U>.
When any vacancy occurs among the directors, the remaining members of the Board may appoint a director to fill such vacancy at any regular
meeting of the Board, or at a special meeting called for that purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;III</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Committees</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.1. <U>Advisory
Board of Directors</U>. The Board may appoint persons, who need not be directors, to serve as advisory directors on an advisory board
of directors established with respect to the business affairs of either this Association alone or the business affairs of a group of affiliated
organizations of which this Association is one. Advisory directors shall have such powers and duties as may be determined by the Board,
provided, that the Board's responsibility for the business and affairs of this Association shall in no respect be delegated or diminished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.2. <U>Trust
Audit Committee</U>. At least once during each calendar year, the Association shall arrange for a suitable audit (by internal or external
auditors) of all significant fiduciary activities under the direction of its trust audit committee, a function that will be fulfilled
by the Audit Committee of the financial holding company that is the ultimate parent of this Association. The Association shall note the
results of the audit (including significant actions taken as a result of the audit) in the minutes of the Board. In lieu of annual audits,
the Association may adopt a continuous audit system in accordance with 12 C.F.R. &sect; 9.9(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee of the financial holding company
that is the ultimate parent of this Association, fulfilling the function of the trust audit committee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(1)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Must
not include any officers of the Association or an affiliate who participate significantly in the administration of the Association&rsquo;s
fiduciary activities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(2)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Must
consist of a majority of members who are not also members of any committee to which the Board has delegated power to manage and control
the fiduciary activities of the Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.3. <U>Executive
Committee</U>. The Board may appoint an Executive Committee which shall consist of at least three directors and which shall have, and
may exercise, to the extent permitted by applicable law, all the powers of the Board between meetings of the Board or otherwise when the
Board is not meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.4. <U>Trust
Management Committee</U>. The Board of this Association shall appoint a Trust Management Committee to provide oversight of the fiduciary
activities of the Association. The Trust Management Committee shall determine policies governing fiduciary activities. The Trust Management
Committee or such sub-committees, officers or others as may be duly designated by the Trust Management Committee shall oversee the processes
related to fiduciary activities to assure conformity with fiduciary policies it establishes, including ratifying the acceptance and the
closing out or relinquishment of all trusts. The Trust Management Committee will provide regular reports of its activities to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.5. <U>Other
Committees</U>. The Board may appoint, from time to time, committees of one or more persons who need not be directors, for such purposes
and with such powers as the Board may determine; however, the Board will not delegate to any committee any powers or responsibilities
that it is prohibited from delegating under any law or regulation. In addition, either the Chairman or the President may appoint, from
time to time, committees of one or more officers, employees, agents or other persons, for such purposes and with such powers as either
the Chairman or the President deems appropriate and proper. Whether appointed by the Board, the Chairman, or the President, any such committee
shall at all times be subject to the direction and control of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.6. <U>Meetings,
Minutes and Rules</U>. An advisory board of directors and/or committee shall meet as necessary in consideration of the purpose of
the advisory board of directors or committee, and shall maintain minutes in sufficient detail to indicate actions taken or
recommendations made; unless required by the members, discussions, votes or other specific details need not be reported. An advisory
board of directors or a committee may, in consideration of its purpose, adopt its own rules&nbsp;for the exercise of any of its
functions or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;IV</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Officers</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.1. <U>Chairman
of the Board</U>. The Board may appoint one of its members to be Chairman of the Board to serve at the pleasure of the Board. The Chairman
shall supervise the carrying out of the policies adopted or approved by the Board; shall have general executive powers, as well as the
specific powers conferred by these Bylaws; and shall also have and may exercise such powers and duties as from time to time may be conferred
upon or assigned by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.2. <U>President</U>.
The Board may appoint one of its members to be President of the Association. In the absence of the Chairman, the President shall preside
at any meeting of the Board. The President shall have general executive powers, and shall have and may exercise any and all other powers
and duties pertaining by law, regulation or practice, to the office of President, or imposed by these Bylaws. The President shall also
have and may exercise such powers and duties as from time to time may be conferred or assigned by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.3. <U>Vice
President</U>. The Board may appoint one or more Vice Presidents who shall have such powers and duties as may be assigned by the Board
and to perform the duties of the President on those occasions when the President is absent, including presiding at any meeting of the
Board in the absence of both the Chairman and President.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.4. <U>Secretary</U>.
The Board shall appoint a Secretary, or other designated officer who shall be Secretary of the Board and of the Association, and shall
keep accurate minutes of all meetings. The Secretary shall attend to the giving of all notices required by these Bylaws to be given; shall
be custodian of the corporate seal, records, documents and papers of the Association; shall provide for the keeping of proper records
of all transactions of the Association; shall, upon request, authenticate any records of the Association; shall have and may exercise
any and all other powers and duties pertaining by law, regulation or practice, to the Secretary, or imposed by these Bylaws; and shall
also perform such other duties as may be assigned from time to time by the Board. The Board may appoint one or more Assistant Secretaries
with such powers and duties as the Board, the President or the Secretary shall from time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.5. <U>Other
Officers</U>. The Board may appoint, and may authorize the Chairman, the President or any other officer to appoint, any officer as
from time to time may appear to the Board, the Chairman, the President or such other officer to be required or desirable to transact
the business of the Association. Such officers shall exercise such powers and perform such duties as pertain to their several
offices, or as may be conferred upon or assigned to them by these Bylaws, the Board, the Chairman, the President or such other
authorized officer. Any person may hold two offices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.6. <U>Tenure
of Office</U>. The Chairman or the President and all other officers shall hold office until their respective successors are elected and
qualified or until their earlier death, resignation, retirement, disqualification or removal from office, subject to the right of the
Board or authorized officer to discharge any officer at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;V</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Stock</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.1. The Board
may authorize the issuance of stock either in certificated or in uncertificated form. Certificates for shares of stock shall be in such
form as the Board may from time to time prescribe. If the Board issues certificated stock, the certificate shall be signed by the President,
Secretary or any other such officer as the Board so determines. Shares of stock shall be transferable on the books of the Association,
and a transfer book shall be kept in which all transfers of stock shall be recorded. Every person becoming a shareholder by such transfer
shall, in proportion to such person's shares, succeed to all rights of the prior holder of such shares. Each certificate of stock shall
recite on its face that the stock represented thereby is transferable only upon the books of the Association properly endorsed. The Board
may impose conditions upon the transfer of the stock reasonably calculated to simplify the work of the Association for stock transfers,
voting at shareholder meetings, and related matters, and to protect it against fraudulent transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;VI</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Corporate Seal</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;6.1. The Association
shall have no corporate seal; provided, however, that if the use of a seal is required by, or is otherwise convenient or advisable pursuant
to, the laws or regulations of any jurisdiction, the following seal may be used, and the Chairman, the President, the Secretary and any
Assistant Secretary shall have the authority to affix such seal:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;VII</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Miscellaneous Provisions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.1. <U>Execution
of Instruments</U>. All agreements, checks, drafts, orders, indentures, notes, mortgages, deeds, conveyances, transfers, endorsements,
assignments, certificates, declarations, receipts, discharges, releases, satisfactions, settlements, petitions, schedules, accounts, affidavits,
bonds, undertakings, guarantees, proxies and other instruments or documents may be signed, countersigned, executed, acknowledged, endorsed,
verified, delivered or accepted on behalf of the Association, whether in a fiduciary capacity or otherwise, by any officer of the Association,
or such employee or agent as may be designated from time to time by the Board by resolution, or by the Chairman or the President by written
instrument, which resolution or instrument shall be certified as in effect by the Secretary or an Assistant Secretary of the Association.
The provisions of this section are supplementary to any other provision of the Articles of Association or Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.2. <U>Records</U>.
The Articles of Association, the Bylaws as revised or amended from time to time and the proceedings of all meetings of the shareholders,
the Board, and standing committees of the Board, shall be recorded in appropriate minute books provided for the purpose. The minutes of
each meeting shall be signed by the Secretary, or other officer appointed to act as Secretary of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.3. <U>Trust
Files</U>. There shall be maintained in the Association files all fiduciary records necessary to assure that its fiduciary responsibilities
have been properly undertaken and discharged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.4. <U>Trust
Investments</U>. Funds held in a fiduciary capacity shall be invested according to the instrument establishing the fiduciary relationship
and according to law. Where such instrument does not specify the character and class of investments to be made and does not vest in the
Association a discretion in the matter, funds held pursuant to such instrument shall be invested in investments in which corporate fiduciaries
may invest under law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.5. <U>Notice</U>.
Whenever notice is required by the Articles of Association, the Bylaws or law, such notice shall be by mail, postage prepaid, e- mail,
in person, or by any other means by which such notice can reasonably be expected to be received, using the address of the person to receive
such notice, or such other personal data, as may appear on the records of the Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except where specified otherwise in these Bylaws,
prior notice shall be proper if given not more than 30 days nor less than 10 days prior to the event for which notice is given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;VIII</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Indemnification</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;8.1. The Association
shall indemnify such persons for such liabilities in such manner under such circumstances and to such extent as permitted by Section&nbsp;145
of the Delaware General Corporation Law, as now enacted or hereafter amended. The Board may authorize the purchase and maintenance of
insurance and/or the execution of individual agreements for the purpose of such indemnification, and the Association shall advance all
reasonable costs and expenses (including attorneys&rsquo; fees) incurred in defending any action, suit or proceeding to all persons entitled
to indemnification under this Section&nbsp;8.1. Such insurance shall be consistent with the requirements of 12 C.F.R. &sect; 7.2014 and
shall exclude coverage of liability for a formal order assessing civil money penalties against an institution-affiliated party, as defined
at 12 U.S.C. &sect; 1813(u).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;8.2.
Notwithstanding Section&nbsp;8.1, however, (a)&nbsp;any indemnification payments to an institution-affiliated party, as defined at
12 U.S.C. &sect; 1813(u), for an administrative proceeding or civil action initiated by a federal banking agency, shall be
reasonable and consistent with the requirements of 12 U.S.C. &sect; 1828(k)&nbsp;and the implementing regulations thereunder; and
(b)&nbsp;any indemnification payments and advancement of costs and expenses to an institution-affiliated party, as defined at 12
U.S.C. &sect; 1813(u), in cases involving an administrative proceeding or civil action not initiated by a federal banking agency,
shall be in accordance with Delaware General Corporation Law and consistent with safe and sound banking practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;IX</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Bylaws: Interpretation and Amendment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;9.1. These Bylaws
shall be interpreted in accordance with and subject to appropriate provisions of law, and may be added to, altered, amended, or repealed,
at any regular or special meeting of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;9.2. A copy of
the Bylaws and all amendments shall at all times be kept in a convenient place at the principal office of the Association, and shall be
open for inspection to all shareholders during Association hours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ARTICLE&nbsp;X</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Miscellaneous Provisions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.1. <U>Fiscal
Year</U>. The fiscal year of the Association shall begin on the first day of January&nbsp;in each year and shall end on the thirty-first
day of December&nbsp;following.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.2. <U>Governing
Law</U>. This Association designates the Delaware General Corporation Law, as amended from time to time, as the governing law for its
corporate governance procedures, to the extent not inconsistent with Federal banking statutes and regulations or bank safety and soundness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">***</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">(February&nbsp;8, 2021)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;6</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with Section&nbsp;321(b)&nbsp;of
the Trust Indenture Act of 1939, the undersigned, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION hereby consents that reports of examination
of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange
Commission upon its request therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Dated: August 12, 2025</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ David Jason</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">David Jason</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Vice President</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;7</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>U.S. Bank Trust Company, National Association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Statement of Financial Condition</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">as of 6/30/2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($000&rsquo;s)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>6/30/2025</B></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 87%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Cash and Balances Due From Depository Institutions</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,823,165</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in">Securities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,619</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Federal Funds</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Loans&nbsp;&amp; Lease Financing Receivables</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Fixed Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">804</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Intangible Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">575,138</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Other Assets</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">172,200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Total Assets</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,575,926</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in">Deposits</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Fed Funds</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Treasury Demand Notes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Trading Liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Other Borrowed Money</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in">Acceptances</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Subordinated Notes and Debentures</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Other Liabilities</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">213,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Total Liabilities</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">213,000</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Common and Preferred Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">200</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in">Surplus</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,171,635</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Undivided Profits</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,191,091</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.25in">Minority Interest in Subsidiaries</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.5in">Total Equity Capital</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,362,926</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0.5in">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Total Liabilities and Equity Capital</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,575,926</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>lg_verastemoncology-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_verastemoncology-4c.jpg
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M 0$  @,! 0$             ! 8#!0<" 0@0  $# P$#!@0-#@T#! $%  $
M @,1! 4&(1(',4%181,(<8$B%)%"<H(CDQ55=187-QBAL3)28I*BLG.STR24
M5M'2,T.#-%1TA+34-3;!4R7"8Z/#1&3$A29&$0 " 0("! L&!00" 04! 0
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MFI0\#Z'P=Q;<OOO/6[+Q+I)L6@-L$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M@4Z8H0]X\;5-H6->MIA!M='.R+5NJ5/Q22-"N.]5PCA>6QW=[<-^WBLW@?\
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MX+J"*YMI636TS&R0S1N#V/8\5:YKA4$$&H(5+::>#UEF336*.1?#Z$ 0! $
M0%:N]UKSW-P-AH&QEI=Y=PO<F&G:+.!WL;3^4E%?Z/K5K]/VN]-U7JCH7'_;
MK-!F]?=BJ:VZ7Q>W45EX::SGT!K?$:HBWC!:3!M]$WEDM)?(F;3G.X26U],
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M-8T -:!0 #D "TYL34.)6?\ <+3,[8G;M[?UM;>G* \>R.\3:[>DA5GU'?\
MTMI))_%/X5RZWS=.!O\ (K/ZBY6/AA\3[.DKP"N(X'6#ZJO.!\/JJ\X F_A/
M@VXS!RYRZ 9-D-K'.V;MM%6AV\F\:N\%%U_TAE_DV[K27Q5-7Y5WOL.:>I+W
MS*WEI_#3U\?]%VD3ZMSCM19^\R=3V#W]G:M/-#'Y+-G-4>4>LKI,(X+ _/\
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MM$7A+@>LTUS95*&O2N$CM;,@EJ>ZCQ4N#<NX99N<R0O:^XT](\U+',!?+;>
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M_4^PJ&;_ +_(B"58C3'J5@/]BQ?]TM_S35R&KXY<;.B4_"N(R*Q&0( @" (
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MH.0?QOU/L*AF_P"_R(@E6(TQZGXG_:K'^[Q?B!<?J>)\9T:'A1W%X/00! $
M0! $ 0%5>^9F*0:5T^QVU[[J_F;Z@,BC/X4BN'IRGIG/B17,YGHC'C94Y7,K
M1LF@-67&A]98;5-M4^YUPU\\;>62W?Y$S/71N<U1;N@J]*5-[5T["1;U72J*
M:V'IC:75O?6L%[:2-FM+F-DT$S#5KXY&AS7 ]!!JN42BXMIZT7]--8HYEY/H
M0! 5R[W.MO<K2EAHNTDI=YV7SB]:#M%E:N#@#T;\N[3U!5H]/VV_5=1ZHZN-
M_P!.LT6;U]V"@OQ=13%7LJAVL7?RXO)V63@_EK*>*YCYO*A>'CZH7B<%*+B]
MJ/49;K3X#U+M+J&]M(+VW.]!<1LFB=TLD:' ^@5R&47%M/8=%3Q6)S+R?0@"
M ("%^+N!\SRD&=@;2"_'9W%.03QC8?7-_%*Y'ZQR_P NM&XBM%30_P R[UU,
MZ+Z:O-^DZ+UPTKB?<^LC94 MX0'8LKR?'WD%];.W;BVD;+$[[IAJ%FH5I4:D
M:D?%%IKD,56E&I!PEJDL"=]36,&O-#F>R;O3R1-O+$<I$\8-6>$^5&5^CLOO
M(UZ<*T=4U[<S.#9WETG&=%^*#T<G>NLK<3TJP'*CY+E]P!\ER]8 G#@GJ/SO
M'76F[A]9K$FXM03M,$A\L#U+S7UR@7,,'O%VR&ZWH.D]<=*XO[]9*ZA%I" P
M.LL^W36G;W*5 N&L[*T!YYY/)9LYZ?9'J"U>:7GTMM*IMU+C>KO-IE=F[JXC
M3V:WQ+7W%73(Y[B]Y+G.-7..TDGG*X;)-O%G:-W#0C]#EC<1@?8<O#1Y)EX,
MX#L[:ZU)<-\N<FVLZ_\ ;::R.'A< WQ%=*](6&[&5Q):_ACQ;7SZ.1G/O5%Y
MC*-!;/BEQ[.C3RHTWB/G_=W4UQV3MZRL?U6WIR'</EN\;J[>BBZC3C@C\^9O
M=>?</#5'0NWI-160TP0&;TG@GZBS]GBP#V+W;]RX>EA9M>:\U1L'65YG+!8D
MZQMG<5HPV;>+:6:8QD;&QQM#8V -:T;  -@ 6O.J))+!'TA]" ( @(+[TNA/
MC1H'XQ6<6_E=,N==5:/*=924%PWUM&R]0:>E6'([KRJ^X]4]'+L[C3YI0\RE
MO+7'JVE&%T(IY;7N@ZZ[:URG#V^E\NV)R>)#C_-/(9<1BO0XM> /MG%4OU#:
MX.-9;=#["S9/7Q3IOC7:6F50+$$ 0%?^]?KOW T7!I*REW<EJ-Y$^Z?*;8VY
M#I.3DWW[C.MN\K+D-KYE9U'JAUOVZC29M7W*>XM<NHI(K\5(N)W1=!^YV#O]
M?WT5+K+DV6,+AM%G _V5PZI)6[O]'UJC^H+K>FJ2U1TOC_MUEIRBWW8NH]NA
M<19=50WX0! 4:[VOSJ1?!5K^<F70<@_C?J?85#-_W^1$$JQ&F/4K ?[%B_[I
M;_FFKD-7QRXV=$I^%<1D5B,@0! $ 0! $!%'>3^9?4O^"_ST"W.3?RX<O_5F
MMS+^/+DZT>?:Z44DMIW,/ZGK+\KC_P 6Y5+]1ZZ?ZNPLN2ZI\G:6G50+&$ 0
M! 43[UUQ;S<698X2#);X^TBN*<HD(?(*^L>U=#R%-6NG:V4[-FG7Y$0ARJP&
MH/4W"Q208?'P2C=EBMH6/;T.;&T$>BN05'C-OWG18+"*XCO+&>P@" (#SKXY
M:\^4#B)DLG;R=IA[(^Y^)H:M-M;DC?'Y1Y=)X' <RZ?EEK]/047K>E\;[M11
MKZOYU5O8M"-<T!I&ZUUK'$:6M:CW0G:VXE;RQV[/+FD]:QKB.O8I5W<*A2E4
M>Q=.PP6]%U:B@MI8+O8\.+;'6>"UGA+80V5I%'A+Z*,>2R*)I\U=3H #HR3]
MP%6LAO')RIR>E_$NWOYS=YM;**C..I:.XJRK>5P]!N[WKSX]<.+%UU+VF9PU
M,9D:FKG&%H[*0UVG?C+:GG<'+FF;VOD7#P\,M*[>DNV7U_-I+'6M#)56G-D$
M 0! 4A[V^ FQW$>VS>Z?-,U8Q.;)389K0F%[?$WLSXU?\@JJ5NX[8OK]F5'-
MZ>[5WOF740$"000:$<A5D-*>@G WB]C>).F[>TN[AL>L<=$V/*6;R ^;< ;Y
MS&/3-?RNI]B[8=FZ3S7-,OE;5&TO@>I]A=K&\5:&#\2U]Y*ZTQL@@" ( @"
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M^-^I]A4,W_?Y$02K$:8]2L!_L6+_ +I;_FFKD-7QRXV=$I^%<1D5B,@0! $
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M7J.9VTFDIK%GR5C72Q<61\MF02U?=!UYNOR?#R^EV.KD\0''G%&W$8KU;L@
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M)N6@-N$ 0! $ 0! :1K;A'H'B%>6^1U5BO.[^VC[".YCEEMY.RJ7!CC$]N\
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M_#'2_;C+&*"=," ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M&UP=8F]8^R\T?9]F=DG:!PDWNEK:4W5[G#=-=EF9?5[V,=W=PVXZS<%B-T$
M0&$S^K,'IJ,.RER&S.%8[:,;\SAU-'(.LT"]Q@Y:B!=7U&V7QO3P;2.[_C5,
M7EN+Q;6QCD?<R%Q/K64I]\5G5'A96JOJ-X_!#G?<=*+C1G6NK-86CV=#>T::
M>$N=]9??)1@CZBK;8QZ>\VG!\7,%D7M@RD3\9,[8)''M(*];@ 1XVTZUCE1:
MU&WML^HU'A-;CYT2#')'*QLL3@^-X#F/:06D':"".4+ 6---8H^D/H0'S)+'
M#&Z69[8XF N>]Y#6M Y22=@"'QM)8O41]F^+N!Q[W08N)^3F;4&1I[*"O4X@
MD^)M.M9XT6]97+G/J--X06^^9&K2\:,ZYU8<?:,97D=VCS3PAS?K+)Y*-1+U
M%6V1CT]YWK#C5*'AN4Q;3&>5]M(0X>M?6OWR^.CP,D4O4;Q^.',^\D3 :KP>
MI8B_%W(?*T5DMGC<F8.MIYNL5"P2@XZRRVM]1N5\#T\&TS2\$X( @--USKIV
MCY+.)EB+MUV'N)=)V8:(RT<S75K5980WC29EF?TCBE'>WL=N!L&G\L,[AK/+
M"+L/.H]\Q$[VZ:D$5H*[0O$E@\#8VM?SZ4:F&&\C)+R2@@" (#Y>]D;'22.#
M(V@N<YQH !M))*'QM)8LT'.\6L!C'N@QK'Y.=M07QD1P5]602?6M(ZUFC2;U
ME=N<^HTWA#XWT<YJ<W&C..=6#'VL;*[ _M'FGA#F_667R4:>7J*MLC'I.Y8<
M:K@/ R>+8Z,\K[:0M</6OK7[X+XZ/ S/2]1RQ^.',R1-/ZNP6I65QER#<-%7
MVLGD3-'J3RCK;4+!*#CK++:W]&Y7P/3P;3.+P3P@" (#'9C.XK 6OG>6N6V\
M1J& [7O(YFM%23X%Z46]1&N+FG0CO5'@B.,GQIB:\LP^-,C!6DUT_<KZQE?Q
MEG5'A*Q6]1)/"G#G[OZF)'&?/A]76-F6?:@2@^COKUY*(?\ L5;'PQZ>\V##
M\9,9<O;%F;-]E79V\1[:,=9% X#P57AT7L-E;^H:<GA4CN^]:5[<Y(]G>VF0
MMV7=C.RXMI!5DL;@YI\86!K LU.I&I'>B\4SG7PR&AZTXA7>DLE'8C%><02Q
M"2.Y?+V;7&I#@T!COL>?:LT*>\M97LQS:5K44=S%-:\?Z&SZ=S]EJ3%0Y2R-
M&R>3+$35T<K?LF.\'U1M6.4=UX&VM+J%Q34X_P!GP&57DEA 8;4^I+/2^*DR
M5WY;Z[EO;@T=+*>1H.VG23S!>XQWG@0;V\A;4W.7(N%F!T1KVZU?>7-N[%^;
M6]O&'NN6R]HT/)H&&K6[2*D>!>YT]W::_+<TE=R:W,$EKQZ-1NZPF^" ( @"
M ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @,#K'!#4.G[O
M'M:#<AO;6A/--'M;]]M;XUI<ZL/K;2=/\6N/YEJY]7*;3++OZ:XC/9J?$_;$
MK:06DM<*.&P@[""%^?FL#L">)^( @)RX49[W2P3L7,ZMUC'!C:\I@?4L] U;
MX*+LGI',//M72D_BI?\ 5ZN;2N8YIZBL_*K^8M53K6OOYRI7&3AM-I_BQ)@,
M?'V>*S\@O\>YH\F.WF),S138!$X/ 'VN[TKN]E?IVGF2UP6#X]G.<<S&AY%5
M\#TKVXS>H88K:&.V@;N00L;'$P<S&"@'H!5)R<FV];*Q)XO$^U\/(0$V\(,!
MYEBIL[.VEQD#V<!/*((S0GUSOK!1*TL7@7O(+7<INJ]<M7$N]]1)2P%H" (
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M=;(1TR]ZT;K'#;# =H;U.=RN\0Z5CJSQ>!M,FR[R(>9-?'+H7MK-_6$L00!
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M #=R=K@>C>^R'CZ%,I2Q6!S_ #NR=*KYL?#+HE_76;]H#75OJ.SCQ]_((\[
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>lg_cantor-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_cantor-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#,VAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@.2XQ+6,P,#(@-SDN9C,U-&5F8S<P+" R,#(S+S$Q+S Y+3$R.C U
M.C4S(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"\B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UP.D-R96%T;W)4
M;V]L/2)!9&]B92!);&QU<W1R871O<B R."XS("A-86-I;G1O<V@I(B!X;7!-
M33I);G-T86YC94E$/2)X;7 N:6ED.C!%1#$Q0S8U-D(R-C$Q1C Y0C$S0C%"
M,C="1C<W1#)&(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.C!%1#$Q0S8V
M-D(R-C$Q1C Y0C$S0C%",C="1C<W1#)&(CX@/'AM<$U-.D1E<FEV961&<F]M
M('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z,$5$,3%#-C,V0C(V,3%&,#E"
M,3-",4(R-T)&-S=$,D8B('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z,$5$
M,3%#-C0V0C(V,3%&,#E",3-",4(R-T)&-S=$,D8B+SX@/"]R9&8Z1&5S8W)I
M<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0]
M(G(B/S[_[@ .061O8F4 9,     !_]L A  $ P,# P,$ P,$!@0#! 8'!00$
M!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,$1$1$1$4%!04%!04%!04
M 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!3_P  1"  \ 4 # 1$  A$! Q$!_\0 O
M @(# 0$!            !P@&"0 $!0,! @$  @,! 0$             !08
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MC,S(ZL\>0VEUI8ZT+ 4D_&#CYT10T*=0:BJ%?F(W-&VFWLN1!>Y>I+QFM]F
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M:BM+4?TU(QNT9E92[@%DU1U(P.)2*8;TM+,119B**QWRV;C>\';6$)CO,O\
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M,^XRGD==&U.JR)'J2F@&++=F2-K> "XF?F>3Q*C>+U2GR\FE@;MVV4V^%/\
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MDQ9:3'W"W(9 ?9/9?@:<0JI0H=*5RE@!:3^0,IHI)P):X7,]1]$?6[]$1+?
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M>OMO+*S^Z<,K6Y0!P0-QJ25J8Z7*L+\I%F\*V:@RU(RKO$V9./I(#G=DG\#
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M5S^&*I?%IV,OMJK8_#KVJ^Q.=L9^S-SV/8#N_M3_ -WXUF\5S\/U7>.SF_\
M;X5;[SE/R?3RV>GK3!:>6_AMY[?3U)B,!$57)U+[,^#O^V'<? *H[SXMR>YU
MSC)GY_8_'IEKUTZ\61Y\W8K7EM7#\M.U2G-07_\ .?\ T3_RG&S^W]__ $LO
M]?[.I?/_ ,Y]?L3_ ,IQ/[?W_P#2G]?[.I$]OE\M')R\K*.7DIERTX4IPI3
M\K:OUB*(8*_9USJS^Q6>ISYO"JYJ\:UZZX(?VOO_ .EC_K_;U+=LGN.\7A^S
M?LIX]S#W#P[P[OG,RFO*Y/;KES5R]5<</\SE.;/3G6BZ9X%>SEKRHI7IWV8[
KF_[)]Q[AWE[O/AG)Y/>\WUV?D]GF9OQZ\:].,\F>O;K7GP5S,M.S3V+_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2522593d4_ex25-1img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2522593d4_ex25-1img03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *Z BX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN8'&R6)&P*^\[*\MM1L[34+*43V=];07EI.H95FMKF))X)55U5U$D3HX#JK
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%-KX!LC)X!^)]CX.7XD7FBIX@A^%NH?$O4/!5K\-='^*ZZ8X-S\+=7\6V/Q
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M_P!!/X/_ /@C\:?_ #0U[!17Y\>\>/\ D?'W_H)_!_\ \$?C3_YH:/(^/O\
MT$_@_P#^"/QI_P#-#7L%% 'C_D?'W_H)_!__ ,$?C3_YH:/(^/O_ $$_@_\
M^"/QI_\ -#7L%% 'C_D?'W_H)_!__P $?C3_ .:&CR/C[_T$_@__ ."/QI_\
MT->P44 >/^1\??\ H)_!_P#\$?C3_P":&CR/C[_T$_@__P""/QI_\T->P44
M>/\ D?'W_H)_!_\ \$?C3_YH:/(^/O\ T$_@_P#^"/QI_P#-#7L%% 'C_D?'
MW_H)_!__ ,$?C3_YH:/(^/O_ $$_@_\ ^"/QI_\ -#7L%% 'C_D?'W_H)_!_
M_P $?C3_ .:&CR/C[_T$_@__ ."/QI_\T->P44 >/^1\??\ H)_!_P#\$?C3
M_P":&CR/C[_T$_@__P""/QI_\T->P44 >/\ D?'W_H)_!_\ \$?C3_YH:/(^
M/O\ T$_@_P#^"/QI_P#-#7L%% 'C_D?'W_H)_!__ ,$?C3_YH:/(^/O_ $$_
M@_\ ^"/QI_\ -#7L%% 'C_D?'W_H)_!__P $?C3_ .:&CR/C[_T$_@__ ."/
MQI_\T->P44 >/^1\??\ H)_!_P#\$?C3_P":&CR/C[_T$_@__P""/QI_\T->
MP44 >/\ D?'W_H)_!_\ \$?C3_YH:/(^/O\ T$_@_P#^"/QI_P#-#7L%% 'C
M_D?'W_H)_!__ ,$?C3_YH:/(^/O_ $$_@_\ ^"/QI_\ -#7L%% 'C_D?'W_H
M)_!__P $?C3_ .:&CR/C[_T$_@__ ."/QI_\T->P44 >/^1\??\ H)_!_P#\
M$?C3_P":&CR/C[_T$_@__P""/QI_\T->P44 >/\ D?'W_H)_!_\ \$?C3_YH
M:/(^/O\ T$_@_P#^"/QI_P#-#7L%% 'C_D?'W_H)_!__ ,$?C3_YH:/(^/O_
M $$_@_\ ^"/QI_\ -#7L%% 'C_D?'W_H)_!__P $?C3_ .:&CR/C[_T$_@__
M ."/QI_\T->P44 >/^1\??\ H)_!_P#\$?C3_P":&CR/C[_T$_@__P""/QI_
M\T-8?[2_QN?]G3X2W_Q=F\,_\)3H?AWQ=\,]-\80?VO_ &*?#_@?QC\2?"G@
MGQAX]-P=-U-;JV^'7A_Q%?\ CK4=,:*U&I:7X?OK1=1L))4N$^4_"_\ P4.A
M\8_%SXJ_"+1?A/<?VIX'_:-^&WP7\&:G>^,8(+/XD^!]?\2_$?PA\4?BSI\2
M>'II=)MOA1XD^ ?[1VE7/AIVU%M=E^%<,\FN:'9^)$N=*!V9]D>1\??^@G\'
M_P#P1^-/_FAH\CX^_P#03^#_ /X(_&G_ ,T-?/-K_P %'?V2KVQN[VV\:^.)
M)MW@-O#>BGX&?'2+Q1\2K#XHW_B73OAWKGP>\*S?#F/Q%\8?#?C&?P;XJFT3
MQ'\--,\4:)<Z=H&I:NU_'I5NUZ>,UK_@II\ /#/Q&N] \0KXQM/AHG[/W@?X
M^P_%'3OAM\7]?71=$\0_$;XN?#SQBGQ/\(Z-\-;S5_@WH'PPO/A<DWC3Q9\3
M)_#EEH5YK-UI6O6FB3:#=S7 %GV9]<^1\??^@G\'_P#P1^-/_FAH\CX^_P#0
M3^#_ /X(_&G_ ,T-?-6M?\%&?V;? NO^+O"WQ*\57NB:WX0U;QM-K'_"(^ O
MC'\0]&\-_#[P7XZO_ &H_$?X@^(] ^%RZ+X \,Z7KFGRV_BW7=<O!X-\+N\,
MTOB^_P!+GM]3F[GQ%^W1^S?X9^);_".[\2^,]2\:GQ7KGP_LX_#/P>^,'BSP
MUJ_Q'\-?#[7OBEK_ ,--!\=^&O NJ^!]>^(^D>"/#6JZM?\ @31_$-]XJMYH
MHM(;2O[:N(M/8"S[,]<\CX^_]!/X/_\ @C\:?_-#1Y'Q]_Z"?P?_ /!'XT_^
M:&OE+X5?\%,/V=/'OPC^ GQ-\5S>,_AKJ/QS^&/AGXJGP?K'PX^*&JS_  W\
M(^(]0MM!B\6_$O7;#P)'I?@3X8R>)IY=&T+XN^.!X5^'?BR*SN];\/:Y>Z):
MW=[;>S?"_P#;0_9X^,7Q'O/A3X"\6>(=0\7VU]\5-+M?[6^&GQ-\+>&/$&K?
M _QO_P *[^+FD>$/'7BGPAH_@GQGJOP^\7-#IGB73O"OB#5[O3UN;>^>$V,G
MVE0+/L]/^&_0]'\CX^_]!/X/_P#@C\:?_-#1Y'Q]_P"@G\'_ /P1^-/_ )H:
MX']JGX\>+?@+X5^&][X$\!^'?B)XQ^*7QN^&_P $_#NB>+O'6I_#KPU::G\1
M+V^M(=;UKQ/HW@3XDZI;6.EBR>22WL?".I7%R75%,(!>OG*+]NCXJ7'Q$'[,
MMO\ L[>'3^V"OB/Q!!+X F^--Q'\$8_AMX9\'>!/&>I_&D?&A/A5+XOD\$ ?
M$GPEX+M])7X(?\)O)\0;^?27\-1>&[.;Q> +-_UVW/LOR/C[_P!!/X/_ /@C
M\:?_ #0T>1\??^@G\'__  1^-/\ YH:YGP7\7_B-<?"+Q_XZ^*?P'\7>"/'O
MPR_X3:/6/AEX.U*'XH3>.W\(:.-=L;[X+:U9:;X<O_'^D^.+*6VM/!ZZGX7\
M(>(KC7WN?#VK>'-*U&RE1OC\?\% OBAIOBR\^"OBG]F_P[I7[2&J^*?@/X9\
M"^!-(^.4GB'X=SW/QZ\*_&'QYI]A\2/B<OPHT[5?A]XH^'?@GX#_ !'\1_$/
MPUIWPZ\;31V,7A2;PC>^*[7Q;I]U"!9GW-Y'Q]_Z"?P?_P#!'XT_^:&CR/C[
M_P!!/X/_ /@C\:?_ #0U\(>(?^"C'C?2_AN?B_IW[,]_<?#KP#:1VWQWUW7?
MB.WAYM(\=6/QZ\>?LY>+OA3^S^H\ :I8?'_XB^%OB#\-O$<SZ!=ZE\+GUG1M
M9^'4>ER2^(_'NG^'[/TKXC_M_P"A?"[QA^UKX>\6?!?XHZ1HO[)_[/6D_'^^
M\2ZH/#EA#\5=*U77_B5X?2Q^'=B-7N2-)2\^',T8\5>*+KP_:-)J;/+I]OIV
MFS:E,!9_U\O\U]Y]D^%X_B<FH3'QK>> [C2OL<@MT\+Z;XAL]0&H>?;F)II=
M6U6^MFLQ;"[$D:0K.9VMV601K(K]Y7R3^S_^TAXG^)GQ-^+WP-^*?@#PK\./
MC!\'_#GPI\>ZOH_@7XG2?%GPEJ?@#XSQ>,T\$ZO:>)KWP/\ #C5K36H]5^'?
MC+2=?T&_\)00VGV#3-5TK5]:TK6[.Y3ZVH%L%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;&0^+)^P/XRMO%\/Q_L_VE=9C_:^7Q?XCU^Z^,]S\,?#ES\/[SPAXJ\%^"_
M>J_!A_@JFMV_D?"=-+^'?@SQ!86EK\1(?'T'CS1%\47/Q!O(]0U72;_]):*
MN_Z_K8^8?!'P%\?^"_@[\5_""_M >,]>^,WQ:N?'/B34/CGKNCZ?>_\ "(>/
M/%GAVU\.:)JGP_\ AH]Z?#/A?P;\/;/2M!'A+X?P7L]C*^DRZCXEU;7_ !'K
MWB/Q!JWS%X._X)]^-/"GPX\->$;?XW>!M-\8_#/XN>&OCS\*_B1X4^ ^IZ?K
M?_"VK#P]XO\ !?C7Q=\;Y?&?QM^(?B'X[ZA\3/!'C77/"WBG5M9\6>&O%@L[
MR>ZL_%$5]%I,^D_IW10%V?EKIO\ P3Q\?>&/&?PQ\5>&OV@O"6M67PRM=:\0
M:/X:^+GP%N?B+HFF?&OXA?$[X@?%OXS?'?PEI6D_&7P%X>\-_$#XC>*OB'J$
M%CJ=_P"'_$NJ?#OP]IEEHG@K6=.MM3\5MXC^L/&'[-6E^,_BE\7_ (DWWBN]
MLU^+W[,VA_LUW^BP>'_#VIKHNF:/XC^*^OOXLMCXGM/$'A_6;VY_X6G<6JZ!
MXC\*:KX?;^QH3JEIK%EJ%UIJ?35% 79\,?L;_L/>$_V2-1^)/BBRU+P?K'C/
MXG:=X!\-ZQ=?#_X3^&_@MX/LO"/PP3Q4WA#3++P5X;U#6HY-8;4/''BS5O$'
MB&^UJ[DU&XU.TTO2;#P_X8T'0/#^F_<]%% F[A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!^:?\ P4Q_;_N?V$_ _P "--\$> M/^*'Q\_:O_:'^'O[,/P \
M%:]K5UX;\(-X\^(%ZT,GBKQWKMC8ZCJ%GX.\(Z='+J6IVVEVCZIJ]U)IVC6<
MVGB_EU73^8^/GQ&_X*5_L_?LY?&/XAZMXI_8Q\8^(?A3^S9\8/C9<?%'2/@3
M\8]#\$MX\^&B^'O%.E_"J[^!.H?M5:CXMET7Q1X*M?'=A;_$VP^.LCV>O6^E
MZOJ/@#3[2P3PYXK]A_;^_8%^'W[?/P\^&WA[Q)XO\3?"[XE? GXQ>"OV@?@#
M\8_!MMI>H^(?AA\7/ -V]SH>M_V'KD,^B>*-"O(9;C3O$'AC5HTM=4L9@T-U
MI^HVMCJ%KS'Q*_9:_;&^,_[-'QS^#7Q._; ^#E]\0OC'\+/$?P9M?%WA/]D3
MQ/X8^$/A?PAXUL3HGC'Q)=?!N\_:P\1^.?$OQ1U#P_=:E8Z-XB?]H+1_!'A^
M\DL;Z#X9W4$.KZ=KW'BUBGDF<PP?,L]G5S5Y=4J2A]5^J5,HR^CD,,+>\:6*
MPV</-,3FDL1!>TC]2JNIB<LI5<LJ]V#E@UG.02QD>;)82R[^V(4XS^L.I'/W
M6SB5>TN:MAJW#L*>&R^.%<7"M/$TN2EFE7#9GA_B7_@G1^W+^V9^W;^S39?M
M"^&OVHO^"<OC6YO?V?G\3^/OA[\+OV:?CDVJ_LV_'OQ-X1L?%?@CP-X[UP?M
MP^.=&^)=MH21:U:?$3P+'+\%_'.GHVBW9U#19+P6,OR=_P $Z/\ @M#^V3^U
MSKO[!\\M_P#L4_M)G]IZZ\?6O[3GP+_94^'OQ0\*_&']@GP_X;N]6M- ^*OQ
MJ\5ZO^TQ^T!H-MX)UJ?2K:SM]&\>^ O@_K7B#4O$FBV'A&_UBX5TN?T(_9A_
MX)V?MH?LT_!#X8_ #2/VV/V;=0\$_!SX)S?"3PIJ>@?L$^-_!_C+QU=Z+\/=
M9^'_ ,--9^/7B!OVZ_$B?$GPYX!BUV\\0+X*\+Z?\,3K&MP:?+%XDT6"V>&?
MY>_9L_X(/?$_]D_0_P!C_P 6?!?]M/P)X8_:=_9&L_&/PO7XVV_[)GB"/PC^
MT#^RSXRUG5/&,WP&_:!^$,'[5\,WBJ^T#Q[K6H^(?"WQ'\/?$?PI=:)9_8M-
MM_"QO[)=>D^AF\NEG>+G3Y:>33JX&GA(2A4YZ=.IF7%=+$SE":JUH8-8;&<-
MU<8YU<1GN#RW"1K9=B,9FV#Q6&QWS\H8^65T:?,XYFHYI[>JI4XTW%Y?D\L
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M)=.ENO"^NVWPA30] T*XCT;5O"7BK4+=O$-QXC\0/^"8O[6^N?MH?M4?MA^
M/VS_ -G/PI>_M/\ P#T[]F&^\ ^,/V&?B9X\M?!WPAT&_P!;N] FM/$>B_M]
M?#J76OB1#%KEQ!K'BN;1=-\,:G)##/9?#[15WP-\W5CC?[-PL*#:S!Y5X@PJ
MSG*#]GF<L+FE#@"=:<^:$HQQ$\FKXB:C6IKV&)K9E";>(HXKVI.G+'UZGN1P
M?]H\ 5?9PBXQGE\L;@\5QW1PT$G.$X899AA*4.>E-*>'P^6UIJ-+%4OCS_@G
M%_P5$_;P_P""@_['&L?M-^%?VCO^":=K\0?!_P *?'?CWXO_ +/?AO\ 9:_:
M"\0^*?@/>:9J7Q+M/AK!XL\0VO[>=Q9^(;KX@0?"_4+^3P?J>E_#'7](\/>(
M+#Q9%?ZC86FE6/C#5^#O_!93]J;QI^RM_P $RVU'PW^SGXR_;B_X*P>)O%/_
M  I70- \!_$WX;? 7X#_  Y\&62W'CGQK\3--U7XR?%'QM\4Y/ T-N^J1Z7X
M;\9_#"Z\>'5[70+&+PF=%OO$6H_:W[$?_!+WXJ_L3?\ !.G7?V&/#'[17P6\
M9^,H?"'BOX<^ /VA-4_9+\1Z+>:;X \9>(_%/BG4=&^)?@;3_P!J>?5?B3?:
M-JGQ!^($GA"ZT7XF_#71=".N6,L_AK5+BTUN;Q/XM\._^"'VM>#/V7OV'_A3
M>?M5:.G[2'_!-SQ9K.N_L??M2>!?V>9/"L6C>']>LE@UOP-\9_A!XK^.'Q*L
M_BCX>\5W$EPGC/\ X1KQ[\*[G4M)ATFR\./X0U.ROM>U?Z#$RR[^V\?[",WD
M/MN$94XTU46)J8=8[.J_$M/+G5E];H.-.IPY3Q%/$5X8VIE^&SO"9?CI8NMA
M<2>7AHXU83!RJU(+'>RXO4O:NG4HT\;_ &7E%+A2ICX1I^PKX-XZEG=11H0E
M0A6Q&6U\RPDJ-+%TZGZE^"O%O[2OPS@\>ZC^U1J?P-\1_#WP#\+;+QH?C+\'
MO"WC/X:)X@\16-UXJOO'.DWWP<\9?$3XOZIX,TSPUX<T[PW-HMY;_%+QX_BJ
M[U+4Y97\.264&D3_  [^P%^WY^TA^W;\#/VQ?#C_  _^%W[/W[<G[,GQ\^)_
MP0O?AW\1=)\6:[\./"#->?V]\%O$GC;1_#_C6'Q=XHTZ^\ ZC8IXDF\/^*/"
ML'BSQ/H.O7/AM_"^B7]@MC[M\6?V4_VNOC7\'Y_A[\0_VJ_@%XBU?Q?XN\''
MXN:)JO[%VN:I^SKXZ^#WAC4M1U+7/A)I_P $=1_:ONO&>F)\45GT[2/BAK_C
M+X[_ !*TKQ!X=L;SP_IG@O0=*UBZMH_"/V;?^"3)_9#_ ."B'Q9_:^_9K^(G
MP%^!?[.7QH^&GA3X;^.?V*/A!^R-:_#KPM?OX'T^ZE\,>/[7QWX<^-]MX;TC
MX@VGB74-2NK[4]"^"VE:#J_A74;S0=0\-R^)KB;Q])RT5">)Q<,9.E'#8C+,
M5A:%3#*=-X7,<"\'G>$QS=.,7*&;2^M<*S="'N0M6JX?!TX5,TQ/36DXX2FL
M+3J?6J&-P&*G[5JHL5@JD<3DV-P$/:5)6KT(5*?$[EB'3I3KT*=/#U:CKPRO
M"^*_LG_M8_\ !4O]H;]K[]N']FZ\^)W[ 46C?L+?&7X'_#OQ/K-M^R/^T3X:
MU/XK>%_BKX*M_''B'Q#H,\O[=GC>U\ Z_P"$=+DN8=&T#4-*\;Z=XNO[6"VO
MM?\ !]O?27^G^4?\$[O^"F'[;G[:'QN^-GP6US]I/_@FOI'Q3_9W_:[^+'P;
M\5?LXZ-^S9\>=)^+?Q'_ &?/@-X_\#^%?B%\=='\0?\ #<GC\_"27Q#8^*KZ
MS\"VGBSX5^-O"]SXRTZ/0CXDU>WCUJ\T;[X_8]_X)^?'C]F#]J?]N_\ ::\1
M_M-?"/XE3_MQZ[X9\::KX,T3]ESQE\/(OAUXW^'WAB'P3X N]/U^_P#VKOB&
M_B/PK:>&%F7QAX=N='T?5_$^O21:IHOBWP7I\+Z%/\[?LF_\$I/VQ?V3Y?C#
M9^&OVZ?V<M4TKX__ +4GQ*_:=^(_B"T_8 \;:%\7O#]]\:]>\)ZI\7O /P3^
M)-U^WEXCT_X:>'?%&F>$;+1M,U'6? _Q US0V:#5KB\UN_TS36MM<OG0C/+?
MK<:=WPGD_P!:E5@Y4Z?%=3.,/_:;Q*BY4I4*&70K5<1"-'$86KA95,+ELX9A
MB<+7P6%6G65'-U&<YU?]9\P_L[V51)3X8AEV+^I*DW&G*-:KBITJ=*4I4,;'
M%?5,1BW]3PN+AB?IC_@H+^WOXV_9Q^,G[&/[(/P%\-^"=<_:<_;K^(7B_P (
M_#K7_BI#K][\*OA;X/\ AQX?@\1_$+XF>,O#_A;5_#7B/QU+HEC>V,>@_#W1
M?%W@JY\57LDUM+XS\.10BZD^-_B%_P %.?VMOA#\2/V[?V+O']U^S*_[7?[,
M'[&U_P#MV_!GXS:!\&_BF_P%^-7P<\._;9O%/A7Q7\!;O]HT^/OAOXZLK[3G
M\)V]W9_M&>,=)?[?!XY6TN(+*3P1>_HO^VQ^P3H'[6OBO]G'XT^&?B!>?!;]
MIO\ 9"\>ZO\ $3]GOXPVWA>S\=:1H]]XCT?^P_%O@SXA> ;O5_#3>.?AGXUT
MZ*SM?%7A[2_%W@KQ'-!9QMX?\9^&[QY+T_+/B3_@E%\0_'#_ +9?QF\=?M,>
M /$_[:_[97P!C_95U;XVS?LU:U9?!3X-?L]2)J%EJO@/X0?L^6O[1B^-K*\U
MJSU:^UG4/$/C3]I+QE//X\BTSQ#+92^';!_!%WY-6.(>5YC&DYK,7AN,E2DY
MTOWF)KY=E<. 99;*494\+#+\UAC*V?O$)>TPZQWUE9AA\;EF&P?M498)9EE$
MZJ7]GPQ'"#QL.6;DJ5#B'&5>-_KD8VG7I8WAN5+#Y3##R]K'$O!PPCP&.P^+
MQM;D/^"-7[??[2__  47^%?P]^//C;X\_L+^.?#^I?#U-3^-_P "_P!GWX*?
M%WP=\3?V?OB)XDO;\>!?"^N?$WQ%^U3\<?"'B*[N-,\/:Y?^)?".I> ? 7BS
M2+*_\.ZI((;2^M(M5]-T;]NS]H+]J/\ ;Y_:8_8S_8^B^"7P^\(?L.P?"Q/V
MC?C9\=? OCSXMS^,?''Q0TO4]?L?A1\*?AUX%^*OP1_L!M*T;3G.M?%/Q+XU
M\2V=AJR76FVGPVUB."*^N/H/_@F;^Q)X@_X)_?LI_#O]F?Q3\2OA_P#&C4/A
M=H=GX(\/?%/PA\$KWX*>(-<^'VBW&H:EX:T;Q]8:C\6_C'/XFUW0]7\0^*KB
MVUJQUWP_HD=CK*6=AX0TVZBU+4M9\PU3_@G-XX^&?[8WQM_;4_8O_:!\*_ ?
MQW^U+HW@32OVF?AY\7/@7J/[07PE^(>I_#FQO-)\+^/_  QH_AKXV?L_^+_A
M_P#$:UT>[;3+G4X?&_B'P?J4/G7>I^!+S4[F6_/M8R6!_MB'L$Y95# 9DJ#H
MQ<8_VO7PV65,IJXR-:V)JY7A<1/.*=>E5=:O3K+!/%O,LNH.$_G\!''+):JQ
MDD\WE6R]3YVI?[#1S#%K,XX:5%QPL,RQ.7+!.E7A"EAZJ6)6%IY?F%2G7AY'
M\8O^"@'[5VA?M/?LK?\ !.[P7X&^ _@G]LG]HG1_CA\6?&7CSQC%XR^*OP)^
M#'[/OPK\9>*M,\+>++/P7X<\:_"3QO\ %?Q?\2_#VBZ8NE>'!X]^&<6B:I=:
MC?Z]-8QV/]@M\G?&3_@L'^UC\+/A7_P58^&5UHO[-UG^VE_P2Q\/^ OBGJ_B
M:?X;_$W7/V=OVB?@UX_\.6GB?1-4T#X>6WQVT#XA_"'QA):W\.G:SI.K?%KX
MEZ=X<OA;36M[XKMK^8:1^DOQY_X)S:E\2_B[^S1^UA\.?C]J?@/]M']E[0?&
MOA'PW\;/'7P[TWXF>"?B9X'^)*W)\;> _C'\(/"_BCX.G7O",MS>7%_X4M/!
M'C_X>:QX.O5MFT_7+BWCN;:[^8/B=_P1?U[XD? O]OK0+G]I[0%_:J_X*5MX
M5TG]IC]I37/V?;S6O">E_#WP?X?M?#&@_#;X(_ [3/CIX9N_ /AW0-(M GAV
MZ\7?%[XG:S#=WFH7OB6_\63O8'3?)G[5X'$II/&^PSV,G1YXJKCI\0<*2X4K
M9;*511H8/"Y%AN(5GT*JI1Q#KXZG.AB<3C\EJ97[-!X=8JE*JI?5?:\/2PT9
MN+E0P\,%GCXPAF\84U+%5<7BJN5QR!493J8=QP,H5\-' YR\R\__ &2?^"D/
M[9O[2WQ2^(7PO\">.OV*/VD/AS;_ +(&G?&_3/VV/V;O@_\ %"Y^ OP&_:$N
MY()G_9A^,_@]/VLOB7I/Q*\;KHL__"03:-X+_:)^&OB_1M)2"[\0^&M,AU"V
MD3XL_P"";_\ P<&_M'?M%>(/@SJGQVT3]F'XG?#7QO\ LV?M)?'S]HM_V3_
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M>,\_AB.*:F,HN<E2;PN(^L\.4H8NA*A5PE"A0K0P^)H9?G.69M\K>./VJ?\
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M/PY\6? ;3?@?\<_!OQF\5?$/3_&OP6^(/BWXK6S? T^"M0U>T\&?$'0OVAO
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M-8@\*:I\0/"/A?3?B'H5I).D"^,OA]=^*/!EU=+/:6>OW%S;7,47P;_P4O\
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M>_$S0/#_ ,7OB?\ %BS\5?#'XH?"_P '^(8=6\ _#GP1KP\/?##PUX6^(/\
MPD^O>+X;;Q3':6=MJNN^*KOX?>&_"MQ>^(;_ (._X)^^.O#/CNWT_6?VDO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\,_M >!OC5;>)/B1X5_:#^&DWQ&\,>([C4_@YXD^#>D:-8?#&;QC\+O&VA^
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MCJ;:C]F>!_\ @KY\:O%NH?"+P??_ /!.WXS^%O''QH^/5K\"?"6M^-KKXO\
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M5_L\> ?B+J7P3_9D^"W[0G[;>L>&/V@+K2+[PAX4^*'A?5_%%KJ_P1\-7WP
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MX;Z%X^\8>$?!VG>$#XAC\*:;<ZSJ4:75M92+:3^-_&/Q'\;VFBG2O"NI>/\
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M.R\$RW&N6OB^.\?QGX.\+:_HME\0-/TZ*RCUFQT+6TD:+4=-@GT?5?#-^_\
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MO$X&-5U(Q>+_ +-Q>-KUL11JPH4<TG45:K4PU2C&G5_*^]_;U_;RNO'WPY^
MFCZ#^Q]IWCS4O%7[9_PS\9_''4M+^,.M?#W6O%W[+WP\T?QWH'C#X?\ P3L?
M&NC:O;^#?$*^)=)T;QSH.K?M#:SJW@GQ;I/BSP=;>(M;?2H/$5U\F2_\%/\
M]N.R\*_M8_M::#K?[-GB'P[X)_X)A_L*_M2^ OV:_&.C_$3POH&F>-/C9IGQ
M3\7>.[K2?B+H_P 0?$=[XAGT.S\->*?M>C?\*XT^]\?VL?PV\/-XP^&,'@[7
M_$?C/]Y_%'["7[$'C?2? >@^-/V-OV5/%VA_"SPKJ7@7X8:+XH_9Y^$6OZ3\
M./!&LV[V>L>#? >G:KX0N[/PAX5U6TDDM=2\/>'H=.TB^MY'@NK.6)V4P/\
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M (*M?%EG%X<^%'A*_P# UCXLT_4FO[*UO)KWXJ>'+D/*\$,$+)#<7/I^L?\
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M<0XX:I^ 7[6?QQ^/_P"U7_P3:^*GQX\7^(_V?[/X.>/[7P%XP^"WP]^'FO\
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MK87(T_XB>+X/V?/&OC_PI-J$B_ SX23ZQX=\40?T%:E^QW^R-K.K^"-?U?\
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M\7?%=Q:+X'NM'X0_MV_MEZ[\&_V%?VQ?C;XR_9"^&G[,O[4>D:?)\4/".A?
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M<!')ZV4K K$ODYIJ@L#AU7J--X;!49S4\12C&O\ DUXO_P""@_[9'AI/B/\
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MB@ HHHH **** "BBB@ K^>__ (*)WEC\%OV_='^-NC?'(?L>^-/''[ 'Q0\
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M<1#+"4?9PHT*M>,8*62QG6CA^=4H9=BW/%2CAH3I*I3Q>%E3PU7#1J4(U*>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7QPO?V;M2\/Z]X/^..N^&/#>O_"OP#J?P7^('QN_X53%\5M;UKQ ]AX:BMM
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M1/$7P0_:^^(/P\&D7&H^%?$/@OQAX@\/Z5X2^,-QJ=ZGQ:T?X?:CX@TSP_\
M%/1F^(/@_6KRS\8>(=1;\E? _P#P2J_:/O\ X(?M*^!O%O["^B:9X;^*"?\
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MCH'PW_8@\?\ P;^,WB/]D'5O@5\9O#?PM_:'^"WA&^_;B_:HN/'?PIU#P?\
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M'?$O@7P78:-?Z3X[^'GB6WUVXM_^$\L?'>GK!XEN/!7AO0]!\42^-1?:%O\
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M\6_'7AOQ)\-_V;O$GB34=.@TWX5^/OV>=*\$?$76O$.E:DLW@+7'MO@3X\^
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M2?4/ Z6WCGX3Q^./A]X-U2]72/$GC'PW\78=&TWPI9>H_MN_LK_''XZ^/O\
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MPU?2?%;:_!J,4WA#3='M]'UOQ%X]XK_X*^_LM6/Q1\%^ ?A_XD\(?$KPS/\
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MOH6F^)[+Q]JG@#Q;<_$N^^(=S8?$;7_C'\5-<N1<:%^KGQD_;E_9.^ OP_\
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M_P"$!\1:/?P646G:!X2_L779O%7B?3-6LM+\.Z[[%X6_:V^!/Q!.A>+OAO\
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MC/;?![Q!8:[J7B*]O-,U#P[?VG@FP_7O7_C]\._!VK>.-0\;?$KX%>$/A?X
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M\;?#7P_X)^&'Q8U?P$8_&>G_  8^)/B#PI\6[KPQ-;:Y%X*;3KFWN),GPO\
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M]^(?ASXF>$?%4WB#6_@]J7B;XB>,O .J>'1H7C3P=XEU'P_:^+H-2N_$MO\
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M\'PEDL='CU[XAOIES/X@L_#_ (?NM.\62ZM_P1K^)WB_QG^TDOC/Q!HE_/\
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MMXK;18O!?@C7AX@\*^%_B-HOA:+2/VH+6]M/B+\-M(\!>&/"UWIWBWZSOO\
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MG9?$WQ+ID_P0MOA#\?\ X9/X-UK7?"NI:KKT%SHEUX=^L_ '[('[2O@[X\_
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M\-_'6DZ1:>&-3/@#_P $\OVKOV>/V?/V(])\*?#3]B;4?B?^RI)^TOX4\6_
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M2S"/,L30Q<,=1GSU(JGBHUH59UE[.=&3=>,/JU6G*HZ7U:=2%&EAJLEBJ?\
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M!FWTS3?!'AF_\<77CWPQK/AO=XOL+_Q3+XON?%>L>V?M3_LK:3\)KO\ 8/\
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MX[-,3F.&KY7648UG3KY2\FS.IF%9*I3</[(CA*5:IGV"6'VQ,5@XXV>(;C'
M9AB\+5Y(^TG4P6&PD,72S.A'FIJ=''*OA\/A:$ZE.JL3',8XBM1I9/CJS_JD
MHK^;+]I'1/B!X/\ &'[?/[$?A#]H#]J>/X5?"W]B'X=_M??!?XE6_P"U1^T0
M_P >?V>/C1XK\7?&'X>+X7N?CU!\18/BS\5/ .N0>%HOB%H'P^^.OCSXCZ/'
MJNCZK8WECJ7A*/0=$T'N/!_BKQ-\:OVI/@!^Q/\ MA_$OXY^%?VL?@9I/Q6T
M[Q[)\%/VH/VB?V</"/[67P#N/A[J@^&G[4FC^$?@-\5/AQHNI#6M<M%LO&=O
M/8WFN_"/XLZ=J?ANSU2VT#4/#-QK$4J<J\*,J'O/$RI2PM.JG0J5\,\+G];&
M5H1DIIU<MK\/8F&+PL74E/+L5@\\PF(Q.6QS"&6XXFK#"5*M.OS<V&I4JF+=
M*+JQH?6\3D5++FW:GS4<?1SVFX5VJ4,/F&$K9/BXT<5BLLQ.-_H5HK^?3X/_
M  *^)*?&[XI_\$N_B+\5OVP]4\%^!?'6D?MN>&/VI1^W%^TZWQE\=_LY>.+[
M6O"GA'X$:G\4-/\ CII?Q:\-ZWX<^(F@>(/!7B#0]+9?AGK/PL\-V/C".TM?
MC%XHE\5V/W9_P4$\%6F@^%_V?/CY)\1/CQX0\.?LU?'7X6ZI\0=&^&W[0/QJ
M^&OA_P ;?"'QCXHT3X=^,E^+NF>!_'&AZ?\ $?P_X';6]$^*5_/X\@UN=+'P
M3K>G2WJ:-XI\5V>L"C"<,!4IU%*GF6(P-+#RE%TG&EC)4L%.OB(3FW0EA,^G
M7R2MAI2=64\'7S"G4>#J8.GB]9+V=3&4JMX5,#AL?7JI+FC.>&P];,<)3H5&
MZ4*M/,LEIT\UI8J\:.&AB:6$Q,7BJ6,6%_1^BOYQ?V<]&NO'WACXN?L5R?%C
M]LR+7)O^"AL'BKP1\2/%O[;?[36L_&C5/V199->^(_AWQ3HGQ4T[XS'Q]I7P
MH\0>&?A-\1O@?X<T"U\0P:%J<@T;Q;XITS5?'>K:AKMY\M?'GQQ\8?A/X"_X
M+T^%? W@C_@IU\5-+^&_BW6W^&7[0'@C]OO64\'?LO1^'_V2OA%\=-+M-&?X
MQ?M__#SXY^%K#PO\2O&'B#QUXIL?@W\,/%5KXI\$ZO8_#JXB\9^'M*M/AWI1
M&'M*/MZ;;A4RS#YIA>:$J;Q%*O'@^,J<I/FHX65#&<6O U:F)KTZ*KY+CX\\
M:E;"X>/5A<'+&8V&!I5*?/\ VUA<DJU'S2A1KXW-LTRO"5^2E[:M6IUH9;',
M'1H4JF+C@\;A^2AB*BJ'];]%?RZ_$7P)K?A#]KBT\$:)X*_X*Q_M7^#X_P#@
MFY\#/BY)X!_9^_X*A_M(> KCPW\1Y/&'Q!\*ZCX]\43^/O\ @H'\#?$>NW'C
M#1/"^C:=>6?@.R^*6O:CJ]A>ZV? M[XBU::XUN'_ (*/VVL_ G]ICPUI^F^+
MO^"COBWP^_\ P3WUG7M2UWX:?M]?'?X;>#O@_P#$OP1\1/A7\*O!?[3_ ,=]
M @_:%\ ^%YO"'A;3]8>_^,^I>%?@[\3K/6S/K7CSXA?"K6[==?UVW*\)494X
M1A4Q$ZN/SC+Z5*A%>VK8C)Y<14ZE.A2KU,-SU,97X=J8;!.I4PV"G6S'+H5\
MVPTGC%A.&$XSIT:J:C#$8#(<?3E4NE&'$%+ARO05=THXATXX2AQ)1JXSV<,5
MC'' 8WZEE6.;PD<3_4A17\Y?[5'@WXW:-\;/^"77A7XJ:C^VO^U'\2/&'[+G
MQG\/?M%>"_V#/VTOB)^R=H/Q<\?_  H\)_!N_MOBSI^BG]L/]COX806=CXG\
M8^,+^;5;;Q/I?BSQ%I>O:58WNC:UINB:/IN@>L>&(O&'Q3_:+_9D_89\6^./
MVL/@E\#KG]AKQ/\ M8>(? WB+]I'XN:3^U5XR\?Z]\8] T6S^#_C?]JKPSXU
MM?CY=:9^SMINO/8>(!X;^*]IXG\2/J_A.U\6>,_&6@V-_'JNCH-UJM"C5HXB
M<,TSS+*52E*HL-B%D$LVJ8W&4ZE:A1KO#U<#E3QV#4<%4E5^MT,%7G@<;3KP
M@2J1IX?"XJK&I2HXC*LHS2<91C+$4/[:>$HX7"RHTZM6G*K#&XN&&KU)XO#T
MHTXO&THXC#M)?NY17\I'[4GCSXS:=\+?VOO@C!\4OVM?B!HG[$W_  4B_8#^
M$GP/\8?"?]J/XK_"7X__ !%^&O[2>O?LZ77Q*_9O\<?%OPU\7?@M!\4_$6D:
M%\3]<\$>'?&'QE^(G]L6=IXJ\+:_XN\>V/C'1YOB _[U_L/?#\^"?A/J^I/X
M/_:P^&%QXR\;^)-4N/A+^V%^TKXQ_:G^)OP^_L&[/@RS@M/B+XQ^,O[0?V70
MO%>F^&['QO#X?\+?&+QOX.LKSQ#=W.BZFS7EWNJGA_:8-X]3MAY_5Y87FISA
M5K4\7@,OS'#RJTJCI^PG*ACJL*E.E/,'0K8-RJSA@\PRO'8S3$1GAJM.A4BG
M6E4Q5*I&,G*$)X/&2PE?DJ*#]I3M+"UZ52<,+&K3Q,J"MC<'B\+'[,HK\I/V
MB_VY?B]^SU^V/XJ\&ZYX$\!ZI^RY\-/V)O$/[1/BS5+'Q_J-G\7-;\77/Q)L
MO WAK3-#\):A\,9/"T\K:Y:6OA>RMM0^+'A71TL?%^I^+-;U&>?0=,T!WZG_
M ,%#_BOX*\1>)?@;\4?V:/!OAG]K.?Q5\%?#/PB^''AG]HJY\6?!3XF1?M Q
M?%*;P#KFH?'?5?@;X,\3>";+0HO@I\4)/B58M\"?$VMZ&/#,8\#Z7\2SK6CK
M>\M%O$4:5:A&5;VRKJG2A%^VE5P^88C+I8=0;7^TSJ8:>)IT>;FEE\ECG*-&
M%:-&')*KB:+TEA%2GB)*\H4J%; X?'K%SE!5'#!4X8JCAJ^*E35*CF$E@9WK
MSI2J?JQ17\RG@'_@IG^T#^QW^R1\5/B%\5O!4O[2OCCPI^U5^W\WCBU^)/[3
M=M#XK\-_#?\ 9V^()ANO"?PL@^'OP#\8^+/BK/H^E7,5EX6.B_ SX3?!_P ,
M^'],FUOXO>.?@P;_ $ZVU;])8/V[_CE=_%+QG\'H?V>/@Q:>.I_&'[/[? 71
M=8_:B\;:==_&?X+?&RT\9Z[JWQ9OUB_9/O;?P7J?PX\,?#_QK>ZW\/M$NOB1
M-/J_@_Q%I]_XH\/Z++X/\4>,=:%*>(A0G1Y:BK1P23C.+A&OC,JR/-W052ZC
M4=#"Y[1J3K4X^QGA\#FF-AR83+\5*EIB85,(L1*O3J0C0GCU?DE*=2E@,QS+
M+IU51BI58.=7+5)X>HHUZ#Q^74*SE5Q=&4_U&HJM>VD5_9W=C.US'#>VT]I,
M]E>WFG7B17,3PR-::CI\]KJ%A<JCDP7MC<VUY:RA)[:>&>-)%_G2_85_:(^+
M?P \,?"SX=Z/X?\ '7[1]S^U+^VK_P %,/@SHWQ _:1_;B_:%\<>)/ >N_LM
M^-/VD;_X(>!K.U^+?A?]H&]M?AQJOP^^"UIX+\1>*-!\5Z1K&B:D(?%^I^"?
MB5KM]J=Q*J4'56-;]V.#P=+%:1E4E6E5KYG3=&$().$H4,GS'$^TG*4:GL88
M6E3>)Q%!2)Q<,/#$W@J;QD<)5<YJDJ,9X58GZS*<TXRI0<Z-.K%*,J<:DL1)
MNA0K\O\ 1M17\^OAS]L/]IWXI_'[]F[]HOX2^%=?\17GQK_X)+?&/X^:;^PA
MXF^/B>&?@O%\4/"/QJ_9X7%A\2O#_P $=9U34O']QX>\:^(O#.E^,/$_@/6M
M-N9+32=*T;3/AYINO^+-8N_TT_9/_:I\5_M132>(--\"_#*Q^%,/PF^#OBF3
MQWX.^,?BOQKJZ?%KXD^#].\=>)?A1-X+\0_ OX:RV&F^ _#>M^'K]_%NL:[I
MGB;5AXBTFWU7X7>$KTZA:Z?T5,'6I**GR^U5/%5*]-3C*.'6&S#.,O;]O%RH
M5Z5:>3U'1Q&'DZ$ZV*PN C-XZ?LY959JC5JTIQJ)TL11PDFZ<E)8JIA\/6JT
M*E)<U2A/#3KSI5/;N/,L)C,32Y\+0E4?VM17YP_LIZO\0D_;;_X*1>"?%GQ:
M^(WQ)\*>%O$_[-^L_#W0/'&I:)/H_P ,M,\>_#+7?$NK^$/ NE^'- \-Z=IW
MAV+4WW17&HVFJ^*]1CBM1XC\3Z[+96<L'VG\7?!.A_$#P'K?ASQ5XS\;^!?"
M<UO-=>*=;^'WQ!U[X3^(CX?M+:XEU*UC^)?@_4-"\<^"+1H<W-UXB\#^*?"/
MBG3UM5ET_P 2Z=']H$W![2^#PF,BH\N+P.'QW)4G&FJ$*T\="I3JU6I0OAWE
M^)=2I!.G448NE[LDU=)JIB,5A[2OA<?B<!S0@ZLJ\J$<#*%2E2BXS_VC^T*"
MITIM582;C4;E9/TNBOP'\(^&_CIJDO['W[)?Q2^.7[1>F_!OXW_%K]M3X@>&
MO&(^,7Q-\#?M*:W^S_\ "VU76?V9?A;XV^/>D^*O#_QQ_MVYTGQ/!\1]1U.7
MQ1%\1?$/A3P5I7A7XHZCJN[QW9ZM)!:?&W]I7]@KX#?&+P[\?_C[IW[8UU?1
M?#;]G[6_"'Q8\6>#/ 'B_P 9>!/C'XB\&M\6?BM\)_AOJOA[X;?&'P7XS\ ^
M%S\0OBQ;_$_0/&OAO3?"%MJ=Y\.]+\*:M>Q?VAT4H1K2@H3E%2Q>!H35:E*E
M6H4<9F66Y/5JUZ'/-PQ&7YGF,Z.-P"J3JT\/E>:XR.*]GA84:N=>I&@W!N-2
MI[#,:L%2DIT*L\%@<SS2A&GB5>G[#,,ORN5;#8J<*:57&Y=A_JV(EBO;K]]*
M*_*[X]>%?BY\/?VTO@7\<_'WB[Q%\0?@+XT\=_#GX(^#_ _P[^,O[27P-N/@
M?XV\0Z7XHCMO&'CWX7>!_C0?@)^UGX3\=>-'TS2]5M?B9\,-,U_X;Z?=6%[8
MW7B?1]'N8K?[/_:PT9->_9D^/NGMK7C+PY(OPC\>ZE::]\/?'WCCX7^,](U'
M1?#>H:SIE_X?\>_#?Q#X5\;>'+ZVU"PMI?M>@^(-.N)H5EL[B26RN;FWFX,=
MC(8')\7F\XNI'!4<VK8G#4Y156G_ &31GBZE!SG&-/ZQ6P"I8NE%1E0Y,7A(
MQQ55SQ,L%U82B\9F>'RR$E3GB993&G6FFX_\*U2.'A-TX2E+V>'QCJX2L^=5
M'5PF,:HQA3PT\=]!45^(?B&X^(7P_P#^" FL^/O ?QQ^/.@?%K2O^">3?'JW
M^-FL?%?Q3\5/C-)\1V^$$/Q;UG4Y_B+\;KSXF>()+?7_ !&;[39+4W2#PSX:
MU*71O $O@Y--\/SZ-HR_\%+/C;\/OAQXTT77_P!F?P-/\6OAKJG[/7A_P_IW
MBS]JJ6TT'XA^%/C-\&]5^)6E^+=8UO0?@5XY^*<_Q-A;P?XH\-ZC\&_@U\&_
MVAO%6J>)ET[4M%UG5_!<OB+QEX9]7,\-'*L;GN#KUX-Y#F%7+Z]50J1CB98:
M.->+Q&'BU*7LL/+ U6Z<V\5.A*.+C0]E&I27)EM7^U,JR#-\/#EH<0TG5PE*
MK.G"M2E+"Y?CL-2KIM4U/$83'QGSPJ.C1K4*N%JU74G0JS_:NBOR \"?\%-/
MB?\ $GPE\'_B+X<_9N^'.F>!/VA/V%]<_:Q^#5QXT_:0\4^'O%OB3XG^'X?
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MT;Q/X*\<_$);C4[#7?#4NFVVE1:)XWUWK_#O_!2?X_>'/@!X?^(GBO\ 9X\
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M.$)I2BIQC-1G"5.<5.,9*,Z<O>A.*DE.$O>A-3A+WH2"BBBI*"BBB@ HHHH
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M7E_X9\5:-!/H/B'2=2T34-1T^[\6\8?\$W_V*OB!X_UCXD^-O@;IOBC7M?\
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M8V+G2Q<7&?MJ56K%\DZDJR****R&%%%% !1110 4444 %%%% !1110 4444
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M<7O@O4!'KNI?KO\  :+XI_M<?LDZUX%_;V^ ^A?#OQMXMD\:_#/XR_".+5O
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M=%L]*\*>"M(ATU=+\$^$K/1O@KQ9^W+^UY\4/V?-8\5^'O&W[-/AOP[^U/\
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M/?!UW:Z-K&LZ/:30:9J^I6EU^;M]_P %(OVE?!'Q@D\#?$+QK^QIIWA_2?\
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M;:/-:R0Q/ \;1H1]&45,&Z?L_9MT_8_5/8\C</8_V?&I' >RY'#V7U"-:M'
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M76?B'H/@O5"Q^28:CJ7PO\70SPQ%I;!+:PFNTBBU;3FN/4:_*3PSX>L? ?\
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MQ/\  OA?Q]HMEJEG-%<6FI6NE>*M+U:QM]0M9[>">VO(H$N8)H8I8I$>-&4
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M+RRT#Q/HOBE=.6[FM;P06NIW&B0:?J+Q0K=G3KF[6RN;*\:"\@]?HH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=._\$LO^D:?[ '_B&_[.O_SN:/\ AT[_ ,$LO^D:?[ '_B&_[.O_ ,[FOO\
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M5*HJ-3])?@C^RK_P0$_:8O?$FG?LX?LW_P#!'O\ :!U#P;%8S^,+#X(_!_\
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M*O$7B>S_ &A+[Q?JEO<R7/P(\6> X/@SJ_@"+P9K O+SX>:I\8M-^(UWJ*?
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MB:PTS4K[P]8:7975UK5GI]]<Z;%<PVD[Q^2?#[X3?\&[WQ,N?C#;^&OV:_\
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MY0;A)Q<7*#<9.46XLHHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=0AECPM',<3AZ-7SY<3^ W!^78Z>1Y=5X^HT\!FT\7/!1P=3A5XG(,-@JE3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@<PP=51JX7&8:M1G'2$IE%%%>,>X%%%% !1110 4444 %%%% !1110 4444
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M-J7P-X#\:_\ !/'_ (*P_#/X@1?%+X>^"?A;\<_$]OKO@WQAX9\6:UX*T/\
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MOK.-3T2U5M2TR+2-'O;Z=/"]EI^D]O\ \%4O@C/^S]_PC/\ P4S_ &;[;2/
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MX:-J>JZ'H6@>%?&_Q!CG\7+?^++;PWH?QA'A6:ZDM_B)HOPB\)ZS-8_U2?\
M"A_@W_PM2;XWR?#?P9)\5)-%L-#7QO-X=TA]?MK+3KK5;R&:VU)K/[7!J$C:
MQ=PW&I+-]MDLUALQ,MLC1O\ FM^TQ^T)^QS^WEXB\1_\$V-%\86OCOQI\4O
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MJW]OID(^-?V%?VR?'/[>FM?M(Z#\4/V>-2T;]G*]%I=_ WQ#XX^&FKZ=X?\
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M/,52X>R/$9U2X5P?&F2XJE4Q:S/C.5'"U,>\%PMAHYAE,,D6>/*JV68ZE*>
MJX>&.PL?PSCK@C-L)/,./N,\;P9P31S7(,)6XES_  ^15N+L;P-GN$K4\$\J
MX&A7Q=/+XX[B[%3RW.9Y\\@6<4<UR^M&&8T<3/+\7+]9?A1XPT#]M']D#PGX
MJUS1_P"R-"_:,^""P^*O#Z,]W'I!\=>%IM'\6Z+:SWUM =0MM,O;O5+"QOI[
M2)-0M[>"\,").$'\V/PU\6_$O]ES]K[]CS]H_P",EY:R3P^+O&7_  3D_::\
M0ZAJ$NE6UMX@^%]]9^#/!?Q"\8:S?6BK;6>N?"K7?A=X^L[K7+N^NO%%A\/-
M;\52ZC::5K6F75K^\7_!.S_@H)X&_;W^%U_XCT[3#X4^)_A*[NE^)?P]L[/Q
M/J.D^"[75O$GB:V\!I#XYU+P]I&@>)+G7O"VBV^IW*:7.+NVOAJ,=QI=A!%
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MBZ^('P>^'/BW47FF2XN%U;7/"6DW^KP74\:1QRW=KJDUW;7;I&BM<Q2E548
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M[0GC"!8Y)K9]&U/1_P#@GO<^,]&U&PN8'BEBNK35-&L]2AFAE22&ZMHG5E8
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MU^7'_!:/2/%GQ!^+W_!-*VM?@3H_Q"\;>)M6_:%L#\"_'/BC2K#2/$EVEO\
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M^+_"\6N>'M)E^'WBFV\,_&'QM=:_X0MO"GVSS=-UK1XM+OY'A2]EN+@P1/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHZI^PQ^R_P#%3X5:)I%DEA\9/VH[/PA=^%]?\3Z%I]WX!N/']G=_&3XG>!/
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MIL]/^#VI)H^I6D< :,SRWEA<Q,RH^GWY9KR+V7X8_LX?M1^+_''@7XL?M?\
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M#HX'&X/$8/+Z:Q^#J8F.&G2P6"PV$PM*E#"4:;E0E*?Y2?\ !!J-_P#A<_\
MP4TN-I\F7XN?#R.-L'87B\5_M#O(JM]TE5GB+ '(#(3PRY_I K\!O^#?Z*3Q
M%\&OVI?BU]D6SMOB/^T[K[6L)7]\B:?X9T+Q \9G8*\\$!\:B")L!%FCNL8<
MRJO[\U\MXYUO:^*?%,&E&>"_L++*L4U*U?+.%^',#73:TNJU.<9)-I.+7-+<
M^N^C_1]EX1<)5%)RACO]8,UHR<7'FP^:\6<3X_#M)ZV=&I"46TFU)-QB] HH
MHK\E/V0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OP6_P""R]K!\(?B;_P3T_; EU./2=#^#_[4FG:+XW=[>[O#/H_BT>%/
M$=Y=F*U@NYA;6GA;X2>([&YAL[:6^N!JD;62-<Q**_>FOSZ_X*I_#&;XM?\
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MQ;ZTN= \16VL:'=S6\JZ=J%_HVMP:1J,LMI=-#^3?PB_9H^.?[.GQ/\ B/\
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M!X!_:Y_: _:]_9O\":CX9T:\\"V/PH^(W[-_QX\#P^*?@7JX\9Z'JD6H:/\
M$?5;:YOO&-SX5\=ZS8MJ5K(/#2ZRMC+=Z1/IL=[I6H?I%\;_ !A_P4)T/]N[
MX(Z/\,/ T/B/]C76-%3_ (6,WA"3P5-XA@_LR_L8M>\0>+-<^(]GH5CX6NK3
M4/$FD1:3X/\ ".NZOKWC#P5H?BO4]$$WB& VWA3TS_@H/\:/VD_@;\$-/\7?
MLK?#6X^*/Q2F\<^'-(7P_)X0N?&&AG0]8DGT:X.LV6F^*/"VN6[RZMJ>BIHT
MVA3ZE?2ZNMM;W>G'19-5O;/[.'&V?YGF_"U'$UL@Q>)XQX<S7+,/6PW$V359
MY/E_$N.QKS;+,WS//,@53(*V)QF%JXS&0QM3%5*,:N&KX7&^T52K/X>? ?#N
M59-Q=7PM'B+!X3@CB?)\UQ-#%<*9Y2AG>8\+X# +)\VR;*N'^(G3XBHX7!8N
MC@L#/ 4L'2K2HXK#XO ^R=*C#\:_V1/@=H7@W]G7]IC]F[X'?MV^&_B#\%?B
M_<ZVNI^+?A)^R)\7/C;X^T*X\0P^'?#FN:)JEMI1\0>#8K3Q;\*](U'P]J6F
M1Z,_B*WU36XM9\/ZS;MI%LEU]B?!C_@A%^QSX/L?#\OQ-U_XR?'^QTO3KY]'
M\)?$#Q7?^$/ 6BW^N7-C?WNL:/X.\'6WACQ%HNI7(LX(=0T[5/$]_97+-*=7
MTNXO(+1[+]/O!WBWXK:I^S1H?C#7? GBD?&Z3X1PZAK'P_C_ .$+\*^*;SXG
MVOAHI?Z/ISZYJ^J> ="GU3Q/#+_8]QK.K7GAVQMKJSFU-Y+2.>&OFK_@F_K'
M[=>O?"[Q[JO[=^DZ3I/C>\^)&LKX/M8X],T[Q#9Z%I0'AS4=-U'0?#>GQ>$K
M3PY!J>AG4/!6NZ'J^KMXNTS5KK7;F22UGTW6-<\/-_$+C?%8+C+.<IXJP_#J
MAQ!@:6=T,+F^18;B+B;,JV'JY/#,\%/)LCP=?&PPN%RN3Q698#$X&BL-B:'L
MI0EB<33K^_DOAMP%A,=P/DF<<(8GB9SX<Q]7(<1B\EX@Q7#7"N5T,32SN>58
M^&=Y_C</@:F+QF;QCA,LS#"X^N\7A:_MHSAA<+5H?4_PE^)_P#\07>O?!WX)
M^-/A]K<OP+TGPOX9\0^#/A]JFF:G8?#73S_;?ASPSX5OH]%>?3=$N[!?!>L:
M6/#1FCU+1HM)2*^L+**:R,_Q_J/B3]OJ'_@HOH.D0>%]#O/V([CP7JGAN3Q/
M'HWV2WT_7I]%L?&]UJ.HVT/CJ^U_4?%L6H:5:>"=&\7WFB:5X$CL]9U+3++1
M&\0Q:C<7?@0\7_\ !*W]A3]JCXT?'SQ%^TCI%M\<_C/?:G8^.-&'B"^^(\GA
M'4]3\1WGB7Q':_\ "*_"KPSJESX2;5[NYT>&]B\9P3306WAW2Y;&:TNKK7[O
M6/D']O3_ (*H_M'?#_\ :1\+6G[*'Q)^$VN_! _ C2_C]X7AGT/PYXAT/XU:
M3I&K>)X/'FCW/BR_O[;4K.+2;+PEXO6XT[PIJOASQ/!JG@O4_#,.?$KM9F.&
M_#_-\USW$X?AK(ZV8Y=Q%P;C71SKQ,R3,<FPT<SKY=EU?.\5DV-CAZE*OF6"
MS/%K^Q\P;G&OA:]3'XN#P[Q6*-.*/$?)LHX?PF)XIS^CEF:<,\<8%5\B\*L^
MRS.\5/*:&9YEA\APN>8">)I5:&5X[*L'_P +67)4Y8?&8>GEV#G'$QPF$/LS
M]KW_ (*AZKX7^+"?LO?L1:;\+/C%^T9I?_"<WOQ'/Q&U_P#X1_P!\/+7X=:7
M<:KXET)[J\\1^!T\7^-K:QTW6)K[1/#OB.>;P]!HE^VI6US-:W]I8?F5_P $
MR[WX"?MG_%;QUKWQ#\8^!?@;XG^)^B:U\,?B]^QYX2UC7U^&G[5?@73?!LHT
M#Q/:Z-X[\9:[XG\,>,/ ?V]KNTU#PEXCO=:M3X8G\0>%4\*O-XSO]3[O]L;X
M8?L5_P#!0#]A#Q/^VG\ &^&OP>^-_P .+?6?BW\6M,L3$/$=WXC\4O!<?$/X
M>_$Y]"TY=:U36-8UQS<?#SQGJFB+INI:F4V/H&@^*O$&H:5Q/["'_!.KPU^W
M1IFE>-?VB/V2?^&6_A[\-].33_#>J_"K6?%?P[U#XZ^(;SQEXIN_$UEXH\,>
M/X?''BN\\*:+HAT;P_!XAT_Q3X4U?3=0M-2LM-UGQ58ZO'IGPN_6,HR[@7AK
MPQSZ?_"[P5F^#KKAOBG-,30RVKQ=@.(<'RXV5)9;C,TPN#XERS-<2\!7R&EP
M]@*&8\-X? TLXCG5'%M9I4_',ZS/Q XJ\5^'8?\ &/<=Y-C<.^*.$<IPN(S2
MCP9F'#6-Y\#&M+-,%E.+QO"V:Y1AHYA0XBJ\2YA7RWB?$X^MDL\BKX-?V33^
MG_V%/^";OQR^%W[5/CFSUSXA_M >"/V1/V9?BW>>)_V</#&O^)]#B;XJZ_J\
M%YIVL:I=V^CLT,?@N32T(UY;;0?#]KXQ37+810V5^GB.VM?TW_;@_:CD^#^@
M:3\'/AIXDT72OVC?C/8:I;>!K_6GM$\/_"/P+IMO<W/Q(_:-^(5YJ+QZ1H_@
M3X/>$[/7/%;RZL\D.M:SI%II,5AJ%I_:QM/2_P!HO]HKP1^RM\/_  ]I<-OJ
M?BKXF>+;2X\%?L_?"+3FUCQ-XV^*WC?2]+@@TC0;1YIKW5)=/M)9M,F\8>,]
M>OTL]%TZX;4]:U9KRYMDO/YOO&U]\<OVMOC$?V8/A3\7?#_QX^-_[0GAO0-)
M_;Q_:6\%>%UUSX9_ +X6:-XHCN=-^ ?P6U6U.F:+I'PQ\("WU/6/&5UI6H3S
M?''QMJ>BQS>)K369M?L(_P ]R7"YOXJY_0XUXR> P>0Y+@4XUJ^#CA,!B:.4
M4Z53,^(<VFL#"GB\)+'8>KF.=3QF)E7XEXFQ&#X/R?VL\9F2RS]*SW%Y+X0\
M.8C@3@?^T,=Q%GV8-3HX?'/&9CA*^=5*U+*N&\GIO,*E3!XV&7XFCEF10P6%
MAA^%N%<-CN-L[]C#!94\T]+_ &)?@#;_ +;G[0_P^6/4?$OB']A/_@GE<W>F
M?!_Q7>:7=Z?;_M#_ !ON_&$?C/Q;\0=9OM2*7EW<^-O%8/COQ-ID+WBZ-X9M
M?!/AK5+2VOO%&LZOJW]3]>,_L]_ ?P!^S+\&_ GP-^&%I>6W@SP!I3Z;ILFI
MS6]SK&IW-W>W6J:OKFM75K:V-M=:SKFL7U]JVIS6UE9VK7=W*MI:6EJL-M%[
M-7YCXC\:?ZY9[[3!JM1R#*85L!P_A:ZA&N\-4Q5;%XW-L?"G"G3_ +8XBS&K
MB,[S>4(\D,5BJ6#H*&%R_#TJ?ZMX8<"K@?A_V6-="OQ'G,Z&8\1XO#N<L/'%
M4\)0P> R;+YU)U*G]B<,Y91PV19-&<O:3PF$JXW$.IB\QQ-6H4445^?GZ0%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'Y2?\%&O^"?%]^T3%H/[0G[.6H1_#7]M'X27.F:M\/O'>F7T?
MA]O&-MI-PK)X5\4:EL-N9[>U>X/AS5]1BFA@<'P]J['PUJ=V;+\L/V7OVE?C
M9X/^-B>#O#7AV7X;?MQ:5XD\06/[37[$GB%M$^&'P,_:LETZP6>X^+GPIU!6
MD\#_  Z_:4\0:(NF:EJ&JZ4^G^ /BMIV@V?BG3)9-'E-IKW]55? _P"W9_P3
MY^$7[</@&32];BT_P#\7-'FTZ_\  ?QQT7PWI]YXU\,W>DO=/:Z7?WD<NE:O
MKWA"8WMVUUX9?7;&V2]>VU>QFL]5L+2Z3]JX'\2<'3RZCP;QS1CCN'7"I@\N
MSFKAGF&+R##8F<I3P&/PCG&KG?"<,14>.>4T,1@\WR?&_P#"MPMFN68ZG4P^
M-_">/_"['5,SK\<< 5IX#B95*6.S/)*6*66X/B+%82$(PS#+L9&G*CD/&,\-
M36 6<XC#X[)L[P%\GXMRC-L!5IXG ]=\-_C'^S3_ ,%#/@Y\4?!%M;WOB+PX
M9-6^%GQQ^$OC&QUCP?XZ\$ZS*DUOJ7ACQ5IL-Q9:MH^HPS6]RNG:_P"'M3EM
M5U/3;S^Q=<_M71;Y+'X8^&/_  1LTWPM\5OA7J7Q0_:9^(WQR_9T_9ZU?4O$
M7P _9W\9Z/':V/@[6+O4DU+2U\2>)]/U_P"R^*=.T"ZMK.^%G:>%/#MOK=U;
M6>GWMO;>%[?4_#NO_E3\:O$GQL_8W\7^"_AQ^W9+XNTKXHZ/)I[?LL_\%)O@
M1-#>>*-(\+:!#X>TR7PO\3O#0LO# _:$\):$^G:<WC3PC\4;F]^(5AIFM^(%
MLY?$^E^+]'OM0_7[X<_\%(=?^%GPE^%GCK]IKP__ ,+0^!WBG2-.LK']O/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTSPM\(K.VO[BXM55K4>%K^ZTK5]0U95L([JTWM/#YW_Q#H?L2_\ 14?VI_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2522593d4_ex5-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2522593d4_ex5-1img01.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !0 $ # 2(  A$! Q$!_\0
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MAA\ZPBIM<LZ--5K=(N#=[==4EI?Y],C_ (*#? +XR?$;_@IW_P $V?BAX,\
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M@'[#W[-N-RJGP\B6*+.X1POJ%PT<9?C<8@ JMM&[+D!<$'#\%_L;:CX,T_\
M;/TQ?'%O+:?M8>-?''C;3[ :>\$7@Z\\;Z'9:5J$7_(2E&N2?:;1M1\]4T4R
MM<&U\F/:URWT-^R[\&I/V?/@5\,_@U+K(U^7X?\ AJ/0I-86U:Q74VCN'F^V
??86NK\66?-VBW%]=E>6,QS@9&]&C&$==&MO^'1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2522593d4_ex5-2img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2522593d4_ex5-2img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !7 $4# 2(  A$! Q$!_\0
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MWG_!=GXT"[A2Z.F_L0_"\6+W"),UJ+SQ?XF%R8#(#Y9FP!(4VE@ &)'%9?\
MP2[M(-/_ &I?^"J6FV,?V33K;X]^$9+:PMOW5G#)-X:UOS98[=,1I)*78R,J
M LW)+'FE5R^BL,IJI+G^IY'7;32O+$5'"LM-O:6][K+>3=V;T\?F<L6U#V'L
M7C,\A&-1WDH4*4944TW]A\SBK6C>Z43VC4O^"S?[)6E:GXNL+F#XVW&E?#WQ
MQKWPZ\:^.--^$>J7_@?1?$_AG4/[+UF/4/$$$SP65C9763<7,D( 125V;&!^
MK?C%^V]\"?@K^SN?VIO$GB^?5O@Y/;Z%=6.O^$M*G\02WMOKMW;Z?9R:=86L
M1N+V62YNXU-OO0JZ% X&0?QX_8 TK3M5_8,_X*A0ZI9VVH0Q_M5?MW1!+V"*
MY!6'6=:EA!\Q'W&%T5HF.#&0,;:^>/VB%4?\&]'PN9AYC+8_#".-G^;RE;XE
MV,?[O.=N%QMQ@C /7&.VMEV$CC<7AH/2AC*U)7:;Y%*HXMNR=DHI>G1;''1S
M3.(8' UJD\+*5?"T)-RY6W-PCS-MR=VV[MO6^]]6?O5^SU^W7\/?VEO$NH^%
MO!7A3XX>%KNSL+C6_P"T_B5\&=?\!Z ^EP31VZ0VFJ:R\D,UU=%);BW9RRRV
MYFD6-1&BQ^*^.O\ @L#^R)X%\;>*?"%SJWQ(\1:=X#UJ+0?'/Q$\&?#W4/$?
MPQ\(7\TZ6K)XA\7V^+>T>SN&$5UY4+I$S?O-JC</T"M-.A3P-9FT@2.=_!]@
MBF!!&Y!T@JB;E .%9R0.>K=F-?S<?L2^&+CQ%_P22_X*%Z=I.BGQ!XGUSQ?^
MUOI\>FVEG'<:Y=ZQ'!J<.GV:Q%'FENR[H]BC982*IBP:XZ>'PTW4:VA)046X
MIWYW"4KVM9*SM;Y]3OEF6,ITX4ZR@ZT_?YJ2LG"23A'1[Z.^O8_IMT#QEH7B
MC0M%\3Z#K%AJ.@>)-*T[7="U..XB6WU/2-4LX;RQO[;<H8V]S#*LD9;YN3T&
M "OD3]D/P]JFD?LC_LMZ1K^AWD&M:5\ OA?8:G9:C:LE_I][;>%=.2>QO(FP
MT-Q;R966)@"K[LBBN&6'H\TOWUK2DK72V;7<]"-?$N,7R/6*>TNJ3[GXK?\
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MW&"0NPKSQSCGZ/\ B=<8_P""['[*\87:TW[+GQD(9^-IAL"0IAR)&\TDA"&
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M8G48US\LC65S<VA .=LQ^<@;3U?[="Q>%/VU/^";GQ!,D5O+=_$?XG^ ]3N
M(U2>TUWPW8WNF6?F["TKK-9R@)O"@@G )IC3>;_P6AT*1PD32_LA:R5A9P)0
M4U^Q4L4"]A[]&R. :SE)IZ/HCJI4[0M+>[\M-#]?# P)V2! 3DC9NY/4Y+#J
M>3[Y/4T58HJ>9^7W+_(TY(^?WGD'QA^!GPS^/'AM_!_Q4\(Z/XT\,27=KJ9T
MG6(YFB34].97T^[BDAD22)X6W[FC*G!&,G)KR/PW^PS^S#X0TOQ'HOAWX1^%
M].TSQAJ.B:IXILPM[<IJUUX>N8[S2#++<W$LRKI]Y%'=VJ*X5)XHVP,9HHH4
MFK>0<D7KK]YVWQA_9>^"GQ^MO#EA\8OA_H'CRP\):C/J_AV#6%NP=+U"[$27
M4T$D$\<H$D5M:ICS1N\K+ 5A_"3]CG]GCX%>)/$?B[X3?#/0/!?B/Q791Z9K
MFK:=]MENM0TV.99A93O=7,K"%70; K_+UY(%%%'/+O\ @0Z,&[M.[\V=;X4_
M9T^$G@CPYXU\(>%_!>BZ3X7^(FM^(O$?C/0[>.?[%KFL^*E1=>N[@&7=G4%4
M"8<YQQU-5_#/[-'P;\&ZA\/]6\,^!]%TO4_A5H>L>&_A]=012 ^&=$UPL^H:
M?8JSNJQ7$IW.<!O3&,444<S9I&*BK+1(ZCQW\&_A_P#$J\\(ZAXT\,Z7K]YX
M UZ3Q1X*FOXY';P]KSV8M!J-F592)MID));&)".:@M?@K\/K?XI0?&4^%M(?
MXCV_AN3PC%XLV3_VI%H$[B>XL(V9V18I;B.,E3G$88#DBBBI&>MT444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
